Edwards Lifesciences Corp
Buy, Hold or Sell?

Let's analyse Edwards together

Penke I guess you are interested in Edwards Lifesciences Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Edwards Lifesciences Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Edwards Lifesciences Corp

I send you an email if I find something interesting about Edwards Lifesciences Corp.

Quick analysis of Edwards (30 sec.)

What can you expect buying and holding a share of Edwards? (30 sec.)

How much money do you get?

$0.05

When do you have the money?

1 year

How often do you get paid?

62.5%

What is your share worth?

Current worth

$11.90

Expected worth in 1 year

$13.87

How sure are you?

87.5%

+ What do you gain per year?

Total Gains per Share

$2.03

Return On Investment

2.4%

For what price can you sell your share?

Current Price per Share

$84.70

Expected price per share

$80.80 - $98.67

How sure are you?

50%

1. Valuation of Edwards (5 min.)

Live pricePrice per Share (EOD)

$84.70

Book Value per Share

$11.90

Intrinsic Value Per Share

$-16.02 - $5.11

Total Value Per Share

$-4.12 - $17.00

My calculation of the intrinsic value of Edwards is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($0.30) 3Y: ($0.35) TTM: ($0.10)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($-0.01) 3Y: ($-0.04) TTM: ($-0.16)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$0.73	$1.29	$0.48 - $1.25
2	$0.76	$2.37	$-0.23 - $1.08
3	$0.18	$3.27	$-0.95 - $0.91
4	$-0.95	$3.99	$-1.67 - $0.74
5	$-2.57	$4.55	$-2.39 - $0.57
6	$-4.61	$4.94	$-3.10 - $0.40
7	$-7.02	$5.19	$-3.82 - $0.23
8	$-9.75	$5.29	$-4.54 - $0.07
9	$-12.77	$5.26	$-5.25 - $-0.10
10	$-16.02	$5.11	$-5.97 - $-0.27

2. Growth of Edwards (5 min.)

Is Edwards growing?

	Current year	Previous year	Grow	Grow %
How rich?	$7.1b	$6b	$762.3m	11.3%

How much money is Edwards making?

	Current year	Previous year	Grow	Grow %
Making money	$353.4m	$372.2m	-$18.7m	-5.3%
Net Profit Margin	23.0%	27.1%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Edwards (5 min.)

4. Comparing to competitors in the Medical Devices industry (5 min.)

Industry Rankings (Medical Devices)

Richest
#10 / 334

Most Revenue
#13 / 334

Most Profit
#11 / 334

Most Efficient
#18 / 334

What can you expect buying and holding a share of Edwards? (5 min.)

Welcome investor! Edwards's management wants to use your money to grow the business. In return you get a share of Edwards.

What can you expect buying and holding a share of Edwards?

First you should know what it really means to hold a share of Edwards. And how you can make/lose money.

Speculation

The Price per Share of Edwards is $84.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Edwards.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Edwards, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $11.90. Based on the TTM, the Book Value Change Per Share is $0.49 per quarter. Based on the YOY, the Book Value Change Per Share is $0.16 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Edwards.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	0.58	0.7%	0.58	0.7%	0.60	0.7%	0.51	0.6%	0.39	0.5%
Usd Book Value Change Per Share	0.82	1.0%	0.49	0.6%	0.16	0.2%	0.32	0.4%	0.25	0.3%
Usd Dividend Per Share	0.00	0.0%	0.01	0.0%	0.01	0.0%	0.03	0.0%	0.09	0.1%
Usd Total Gains Per Share	0.82	1.0%	0.51	0.6%	0.17	0.2%	0.36	0.4%	0.34	0.4%
Usd Price Per Share	95.56	-	83.86	-	83.77	-	114.24	-	118.66	-
Price to Earnings Ratio	41.01	-	36.71	-	35.04	-	49.89	-	5.91	-
Price-to-Total Gains Ratio	115.92	-	317.02	-	167.29	-	462.00	-	498.37	-
Price to Book Ratio	8.03	-	7.53	-	8.65	-	15.05	-	22.49	-
Price-to-Total Gains Ratio	115.92	-	317.02	-	167.29	-	462.00	-	498.37	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	84.7
Number of shares	11

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.01	0.03
Usd Book Value Change Per Share	0.49	0.32
Usd Total Gains Per Share	0.51	0.36
Gains per Quarter (11 shares)	5.57	3.91
Gains per Year (11 shares)	22.30	15.66

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	1	22	12	1	14	6
2	1	43	34	3	29	22
3	2	65	56	4	43	38
4	2	87	78	6	57	54
5	3	109	100	7	71	70
6	4	130	122	8	86	86
7	4	152	144	10	100	102
8	5	174	166	11	114	118
9	5	195	188	13	128	134
10	6	217	210	14	143	150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	19.0	1.0	0.0	95.0%	38.0	2.0	0.0	95.0%	91.0	7.0	0.0	92.9%
Book Value Change Per Share	4.0	0.0	0.0	100.0%	11.0	1.0	0.0	91.7%	18.0	2.0	0.0	90.0%	33.0	7.0	0.0	82.5%	69.0	29.0	0.0	70.4%
Dividend per Share	1.0	0.0	3.0	25.0%	2.0	0.0	10.0	16.7%	7.0	0.0	13.0	35.0%	25.0	0.0	15.0	62.5%	44.0	0.0	54.0	44.9%
Total Gains per Share	4.0	0.0	0.0	100.0%	11.0	1.0	0.0	91.7%	18.0	2.0	0.0	90.0%	35.0	5.0	0.0	87.5%	79.0	19.0	0.0	80.6%

Fundamentals of Edwards

About Edwards Lifesciences Corp

https://www.edwards.com
Medical Devices
19800
One Edwards Way, Irvine, CA, United States, 92614
Google Maps Bing Maps

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Fundamental data was last updated by Penke on 2024-05-04 23:29:04.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Edwards Lifesciences Corp.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Edwards earns for each $1 of revenue.

Above 10% is considered healthy but always compare Edwards to the Medical Devices industry mean.
A Net Profit Margin of 22.0% means that $0.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Edwards Lifesciences Corp:

The MRQ is 22.0%. The company is making a huge profit. +2
The TTM is 23.0%. The company is making a huge profit. +2

Trends

Current period		Compared to		+/-
MRQ	22.0%	TTM	23.0%	-1.0%
TTM	23.0%	YOY	27.1%	-4.1%
TTM	23.0%	5Y	24.2%	-1.1%
5Y	24.2%	10Y	23.6%	+0.5%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	22.0%	-11.2%	+33.2%
TTM	23.0%	-17.5%	+40.5%
YOY	27.1%	-13.2%	+40.3%
5Y	24.2%	-19.6%	+43.8%
10Y	23.6%	-25.0%	+48.6%

Measures how much net profit Edwards earns for each $1 of revenue.

Revenue is the amount of profit Edwards generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Edwards earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Edwards to the Medical Devices industry mean.
Can be used to compare companies within the Medical Devices industry.

You typically want a high profit margin. This means that for each $1 in sales, Edwards makes more profit. This shows the investor how efficiently Edwards is operating in general and compared to other companies in the same industry. Edwards operates in the Medical Devices industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Edwards. If profit margins remain low (compared to the Medical Devices industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Edwards is 0.22. This means that Edwards earned $0.22 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Medical Devices industry is -11.2%.
What is the trend?
The trend is important because it shows you how Edwards is performing over time. The most recent quarter might be important if Edwards released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Edwards up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Edwards with other companies in the same industry (Medical Devices).
Net profit margin should rise over the years.
Can be influenced when Edwards sells assets (profit will increase while costs remain the same).
It won’t show what part of Edwards is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Edwards

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Edwards = 351,900
Total revenue MRQ Edwards = 1,598,200
$351,900 / $1,598,200 = 0.22 or 22.0%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Edwards is using its assets to generate profit.

Above 5% is considered healthy but always compare Edwards to the Medical Devices industry mean.
3.6% Return on Assets means that Edwards generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Edwards Lifesciences Corp:

The MRQ is 3.6%. Using its assets, the company is less efficient in making profit.
The TTM is 3.8%. Using its assets, the company is less efficient in making profit.

Trends

Current period		Compared to		+/-
MRQ	3.6%	TTM	3.8%	-0.2%
TTM	3.8%	YOY	4.4%	-0.6%
TTM	3.8%	5Y	4.1%	-0.3%
5Y	4.1%	10Y	4.0%	+0.1%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	3.6%	-4.0%	+7.6%
TTM	3.8%	-4.2%	+8.0%
YOY	4.4%	-4.1%	+8.5%
5Y	4.1%	-3.7%	+7.8%
10Y	4.0%	-4.3%	+8.3%

Shows how efficient Edwards is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Edwards to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Edwards is using its resources to generate profit. If the return on assets (3.6%) from Edwards are higher than the Medical Devices mean (-4.0%) that means Edwards is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Edwards is 3.6%. This means the company generated $0.04 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Medical Devices industry is -4.0%.
What is the trend?
The trend is important because it shows you how Edwards is performing over time. The most recent quarter might be important if Edwards released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Edwards up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Edwards

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Edwards = 351,900
Total assets MRQ (balance sheet) from Edwards = 9,736,300
351,900 / 9,736,300 = 0.04 or 3.6%

ROA is an important ratio as it will tell you how effectively Edwards is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Edwards is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Edwards to the Medical Devices industry mean.
4.9% Return on Equity means Edwards generated $0.05 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Edwards Lifesciences Corp:

The MRQ is 4.9%. Using its investors money, the company is inefficient in making profit. -1
The TTM is 5.3%. Using its investors money, the company is less efficient in making profit.

Trends

Current period		Compared to		+/-
MRQ	4.9%	TTM	5.3%	-0.3%
TTM	5.3%	YOY	6.2%	-1.0%
TTM	5.3%	5Y	6.1%	-0.8%
5Y	6.1%	10Y	6.3%	-0.3%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	4.9%	-3.9%	+8.8%
TTM	5.3%	-5.0%	+10.3%
YOY	6.2%	-4.8%	+11.0%
5Y	6.1%	-5.6%	+11.7%
10Y	6.3%	-6.4%	+12.7%

Shows how efficient Edwards is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Edwards to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Medical Devices industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Edwards is 4.9%. This means Edwards generated $0.05 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Medical Devices industry is -3.9%.
What is the trend?
The trend is important because it shows you how Edwards is performing over time. The most recent quarter might be important if Edwards released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Edwards up to 10 years back (depending if Edwards existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Edwards

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Edwards = 351,900
Shareholders equity (balance sheet) MRQ Edwards = 7,117,900
351,900 / 7,117,900 = 0.05 or 4.9%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of Edwards Lifesciences Corp.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Edwards is operating .

Measures how much profit Edwards makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Edwards to the Medical Devices industry mean.
An Operating Margin of 30.5% means the company generated $0.31 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Edwards Lifesciences Corp:

The MRQ is 30.5%. The company is operating very efficient. +2
The TTM is 29.4%. The company is operating very efficient. +2

Trends

Current period		Compared to		+/-
MRQ	30.5%	TTM	29.4%	+1.1%
TTM	29.4%	YOY	30.9%	-1.5%
TTM	29.4%	5Y	30.7%	-1.3%
5Y	30.7%	10Y	25.9%	+4.8%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	30.5%	-28.0%	+58.5%
TTM	29.4%	-14.7%	+44.1%
YOY	30.9%	-13.1%	+44.0%
5Y	30.7%	-18.5%	+49.2%
10Y	25.9%	-24.8%	+50.7%

Measures how efficient Edwards is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Edwards to the Medical Devices industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Edwards is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Edwards is 30.5%. This means that Edwards earned $0.31 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Medical Devices industry is -28.0%.
What is the trend?
The trend is important because it shows you how Edwards is performing over time. The most recent quarter might be important if Edwards released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Edwards up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Edwards

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Edwards = 437,700
Total revenue MRQ Edwards = 1,598,200
$437,700 / $1,598,200 = 0.31 or 30.5%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Edwards is keeping operating costs low.

Below 1 is considered healthy (always compare to Medical Devices industry mean).
An Operation Ratio of 0.73 means that the operating costs are $0.73 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Edwards Lifesciences Corp:

The MRQ is 0.726. The company is efficient in keeping operating costs low. +1
The TTM is 0.717. The company is efficient in keeping operating costs low. +1

Trends

Current period		Compared to		+/-
MRQ	0.726	TTM	0.717	+0.009
TTM	0.717	YOY	0.676	+0.042
TTM	0.717	5Y	0.700	+0.017
5Y	0.700	10Y	0.714	-0.013

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.726	1.429	-0.703
TTM	0.717	1.425	-0.708
YOY	0.676	1.389	-0.713
5Y	0.700	1.419	-0.719
10Y	0.714	1.376	-0.662

Measures how efficient Edwards is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Edwards to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Edwards is 72.6%. This means that Edwards earned $0.73 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Medical Devices industry is 1.43.
What is the trend?
The trend is important because it shows you how Edwards is performing over time. The most recent quarter might be important if Edwards released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Edwards up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Edwards

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(384,200 +776,300) \ 1,598,200 = 0.73

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of Edwards Lifesciences Corp.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Edwards is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
A Current Ratio of 3.75 means the company has $3.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Edwards Lifesciences Corp:

The MRQ is 3.755. The company is very able to pay all its short-term debts. +2
The TTM is 3.391. The company is very able to pay all its short-term debts. +2

Trends

Current period		Compared to		+/-
MRQ	3.755	TTM	3.391	+0.363
TTM	3.391	YOY	3.308	+0.083
TTM	3.391	5Y	3.408	-0.016
5Y	3.408	10Y	3.606	-0.198

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	3.755	2.643	+1.112
TTM	3.391	2.709	+0.682
YOY	3.308	3.407	-0.099
5Y	3.408	3.617	-0.209
10Y	3.606	3.475	+0.131

Measures if Edwards is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Edwards if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Edwards is 3.75. This means Edwards has $3.75 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Devices industry is 2.64.
What is the trend?
The trend is important because it shows you how Edwards is performing over time. The most recent quarter might be important if Edwards released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Edwards up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Edwards

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
4,170,500 \ 1,110,800) = 3.75

The current ratio measures if Edwards is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Edwards is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Edwards does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Edwards is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Edwards is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Edwards to the Medical Devices industry mean.
A Quick Ratio of 2.74 means the company can pay off $2.74 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Edwards Lifesciences Corp:

The MRQ is 2.744. The company is very able to pay all its short-term debts with the most liquid assets. +2
The TTM is 2.542. The company is very able to pay all its short-term debts with the most liquid assets. +2

Trends

Current period		Compared to		+/-
MRQ	2.744	TTM	2.542	+0.201
TTM	2.542	YOY	2.571	-0.028
TTM	2.542	5Y	2.613	-0.071
5Y	2.613	10Y	3.236	-0.622

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	2.744	1.521	+1.223
TTM	2.542	1.666	+0.876
YOY	2.571	2.107	+0.464
5Y	2.613	2.308	+0.305
10Y	3.236	2.419	+0.817

1.4. Solvency of Edwards Lifesciences Corp.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Edwards assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Edwards to Medical Devices industry mean.
A Debt to Asset Ratio of 0.26 means that Edwards assets are financed with 26.2% credit (debt) and the remaining percentage (100% - 26.2%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Edwards Lifesciences Corp:

The MRQ is 0.262. The company is very able to pay all its debts by selling its assets. +2
The TTM is 0.278. The company is very able to pay all its debts by selling its assets. +2

Trends

Current period		Compared to		+/-
MRQ	0.262	TTM	0.278	-0.016
TTM	0.278	YOY	0.293	-0.016
TTM	0.278	5Y	0.326	-0.048
5Y	0.326	10Y	0.366	-0.040

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.262	0.406	-0.144
TTM	0.278	0.398	-0.120
YOY	0.293	0.347	-0.054
5Y	0.326	0.442	-0.116
10Y	0.366	0.457	-0.091

Measures how much % of Edwards assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Edwards than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Edwards to Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Edwards is 0.26. This means means that Edwards is financed with 26.2% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Devices industry is 264.3%.
What is the trend?
The trend is important because it shows you how Edwards is performing over time. The most recent quarter might be important if Edwards released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Edwards up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Edwards has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Edwards

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
2,549,900 \ 9,736,300 = 26.2% or 0.26.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Edwards is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Edwards to the Medical Devices industry mean.
A Debt to Equity ratio of 35.8% means that company has $0.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Edwards Lifesciences Corp:

The MRQ is 0.358. The company is very able to pay all its debts with equity. +2
The TTM is 0.389. The company is very able to pay all its debts with equity. +2

Trends

Current period		Compared to		+/-
MRQ	0.358	TTM	0.389	-0.030
TTM	0.389	YOY	0.417	-0.028
TTM	0.389	5Y	0.489	-0.101
5Y	0.489	10Y	0.589	-0.100

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.358	0.596	-0.238
TTM	0.389	0.595	-0.206
YOY	0.417	0.495	-0.078
5Y	0.489	0.637	-0.148
10Y	0.589	0.707	-0.118

Measures if Edwards is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Edwards is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Edwards is 0.36. This means that Edwards can pay off $0.36 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Devices industry is 0.60.
What is the trend?
The trend is important because it shows you how Edwards is performing over time. The most recent quarter might be important if Edwards released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Edwards up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Edwards

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
2,549,900 \ 7,117,900 = 0.36 or 35.8%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of Edwards Lifesciences Corp

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Edwards generates.

Above 15 is considered overpriced but always compare Edwards to the Medical Devices industry mean.
A PE ratio of 41.01 means the investor is paying $41.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Edwards Lifesciences Corp:

The EOD is 36.351. Based on the earnings, the company is overpriced. -1
The MRQ is 41.012. Based on the earnings, the company is overpriced. -1
The TTM is 36.706. Based on the earnings, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	36.351	MRQ	41.012	-4.661
MRQ	41.012	TTM	36.706	+4.305
TTM	36.706	YOY	35.043	+1.663
TTM	36.706	5Y	49.885	-13.179
5Y	49.885	10Y	5.908	+43.977

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
EOD	36.351	-1.028	+37.379
MRQ	41.012	-1.706	+42.718
TTM	36.706	-2.264	+38.970
YOY	35.043	-2.813	+37.856
5Y	49.885	-2.443	+52.328
10Y	5.908	-2.020	+7.928

Measures how much money you pay for each share for every $1 in earnings Edwards generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Edwards to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Edwards is 41.01. This means the investor is paying $41.01 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Devices industry is -1.71.
What is the trend?
The trend is important because it shows you how Edwards is performing over time. The most recent quarter might be important if Edwards released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Edwards up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Edwards

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 604,100 = EPS
PE ratio MRQ = 41.01

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Edwards Lifesciences Corp:

The EOD is -92.160. Based on how much money comes from the company's main activities, the company is expensive. -2
The MRQ is -103.977. Based on how much money comes from the company's main activities, the company is expensive. -2
The TTM is -187.564. Based on how much money comes from the company's main activities, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	-92.160	MRQ	-103.977	+11.817
MRQ	-103.977	TTM	-187.564	+83.588
TTM	-187.564	YOY	53.123	-240.688
TTM	-187.564	5Y	28.467	-216.032
5Y	28.467	10Y	7.166	+21.302

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
EOD	-92.160	-1.275	-90.885
MRQ	-103.977	-2.333	-101.644
TTM	-187.564	-2.994	-184.570
YOY	53.123	-5.897	+59.020
5Y	28.467	-5.314	+33.781
10Y	7.166	-5.639	+12.805

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Edwards is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Medical Devices industry mean).
A PB ratio of 8.03 means the investor is paying $8.03 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Edwards Lifesciences Corp:

The EOD is 7.120. Based on the equity, the company is overpriced. -1
The MRQ is 8.033. Based on the equity, the company is overpriced. -1
The TTM is 7.532. Based on the equity, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	7.120	MRQ	8.033	-0.913
MRQ	8.033	TTM	7.532	+0.501
TTM	7.532	YOY	8.645	-1.113
TTM	7.532	5Y	15.047	-7.515
5Y	15.047	10Y	22.494	-7.448

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
EOD	7.120	2.024	+5.096
MRQ	8.033	2.372	+5.661
TTM	7.532	2.487	+5.045
YOY	8.645	3.042	+5.603
5Y	15.047	3.891	+11.156
10Y	22.494	4.381	+18.113

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Edwards Lifesciences Corp.

3.1. Institutions holding Edwards Lifesciences Corp

Institutions are holding 84.151% of the shares of Edwards Lifesciences Corp.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	Vanguard Group Inc	8.6993	0.0872	52363400	729984	1.4138
2023-12-31	BlackRock Inc	8.6676	0.1014	52172777	797331	1.552
2023-12-31	State Street Corporation	4.4782	0.1	26955650	507914	1.9204
2023-12-31	AllianceBernstein L.P.	3.1713	0.5601	19088643	-3653069	-16.0633
2023-12-31	Bank of New York Mellon Corp	2.8788	0.2679	17328435	-280406	-1.5924
2023-12-31	Wellington Management Company LLP	2.7956	0.2392	16827510	393109	2.392
2024-03-31	Brown Advisory Holdings Inc	2.7638	2.1252	16636146	-1545274	-8.4992
2023-12-31	Geode Capital Management, LLC	2.1378	0.1024	12868144	176345	1.3894
2023-12-31	Capital Research & Mgmt Co - Division 3	1.5021	0.1546	9041560	-21212168	-70.1142
2023-12-31	NORGES BANK	1.413	0.1133	8505446	-318977	-3.6147
2023-12-31	JPMorgan Chase & Co	1.293	0.057	7783067	4285357	122.5189
2023-12-31	FMR Inc	1.2463	0.0439	7502054	4390669	141.1162
2023-12-31	Fisher Asset Management, LLC	1.1842	0.2874	7128279	-186188	-2.5455
2023-12-31	Goldman Sachs Group Inc	1.1673	0.0481	7026290	3565427	103.0213
2023-12-31	Amundi	1.0351	0.2127	6230553	318902	5.3945
2023-12-31	Morgan Stanley - Brokerage Accounts	1.0148	0.041	6108161	-985267	-13.8899
2023-12-31	Sands Capital Management, LLC	1.014	1.4146	6103702	1567526	34.5561
2023-12-31	Northern Trust Corp	0.9889	0.0822	5952250	-405223	-6.374
2023-12-31	HHG PLC	0.9255	0.2534	5570618	696509	14.29
2023-12-31	Legal & General Group PLC	0.9123	0.1074	5491184	951845	20.9688
Total		49.2889	6.399	296683869	-10205654	-3.4%

3.2. Funds holding Edwards Lifesciences Corp

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2024-03-31	Vanguard Total Stock Mkt Idx Inv	3.1464	0.113	18938721	-101048	-0.5307
2024-03-31	Vanguard Institutional 500 Index Trust	2.5396	0.1314	15286538	145722	0.9624
2023-12-31	Vanguard Health Care Inv	1.5593	1.5419	9386095	0	0
2024-03-31	SPDR® S&P 500 ETF Trust	1.2151	0.1311	7314155	-56880	-0.7717
2024-02-29	Fidelity 500 Index	1.2085	0.1198	7274026	73198	1.0165
2024-03-28	iShares Core S&P 500 ETF	1.0445	0.1312	6287106	46208	0.7404
2024-03-31	Vanguard Growth Index Investor	0.9483	0.2408	5708280	71990	1.2773
2024-03-31	Health Care Select Sector SPDR® ETF	0.7563	1.0588	4552124	-22932	-0.5012
2024-03-31	Vanguard Institutional Index I	0.6632	0.1312	3992253	-3133	-0.0784
2024-02-29	AllianceBernstein US L/C Growth Eqty MF	0.6058	1.1647	3646542	-559665	-13.3057
2024-02-29	AB Large Cap Growth A	0.5671	1.0973	3413268	-543096	-13.7271
2024-03-31	Brown Advisory Sustainable Growth I	0.5097	2.9688	3067959	0	0
2024-03-31	State St S&P 500® Indx SL Cl III	0.4895	0.1303	2946208	11100	0.3782
2024-03-31	Champlain Mid Cap Fund, LLC	0.4819	2.3533	2900461	-19550	-0.6695
2024-03-28	iShares US Medical Devices ETF	0.4796	4.789	2886750	0	0
2024-02-29	Fidelity Select Medical Tech and Devcs	0.4652	4.0513	2800000	-140000	-4.7619
2023-12-31	Capital Group Wash Mutual Invtrs Comp	0.4615	0.1259	2778147	0	0
2024-02-29	JPMorgan Large Cap Growth I	0.425	0.2571	2557989	0	0
2024-02-29	MainStay Winslow Large Cap Growth A	0.389	1.3251	2341400	2341400	0
2024-03-31	Blackrock Eq Idx Fund CF	0.3598	0.1304	2165470	-2665	-0.1229
Total		18.3153	21.9924	110243492	+1240649	+1.1%

3.3. Insider Transactions

Insiders are holding 0.885% of the shares of Edwards Lifesciences Corp.

Date	Owner	Type	Amount	Price
2024-05-02	Michael A Mussallem	SELL	29350	84.77
2024-05-01	Jean-luc M Lemercier	SELL	14400	84.21
2024-04-30	Scott B Ullem	SELL	7250	85.8
2024-04-08	Jean-luc M Lemercier	SELL	14400	92.32
2024-04-04	Michael A Mussallem	SELL	29350	92.42
2024-04-01	Scott B Ullem	SELL	7255	94.89
2024-03-13	Donald E Bobo Jr	SELL	14500	91.01
2024-03-11	Jean-luc M Lemercier	SELL	14400	91.68
2024-03-07	Daniel J Lippis	SELL	1715	90.98
2024-03-04	Michael A Mussallem	SELL	29350	86.67
2024-02-29	Scott B Ullem	SELL	7255	85.59
2024-02-23	Kieran Gallahue	SELL	3058	87.61
2024-02-21	Daveen Chopra	SELL	8200	86.74
2024-02-15	Catherine M Szyman	SELL	27000	85.62
2024-02-13	Donald E Bobo Jr	SELL	11000	85.83
2024-02-12	Robert W.a. Sellers	SELL	12210	87
2024-02-08	Heisz Leslie Stone	SELL	7056	86.45
2024-02-01	Scott B Ullem	SELL	7255	78.29
2024-01-12	Donald E Bobo Jr	SELL	10000	75.67
2024-01-05	Michael A Mussallem	SELL	29350	72.98

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Edwards Lifesciences Corp compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	0.824	0.493	+67%	0.159	+418%	0.324	+154%	0.246	+235%
Book Value Per Share	-	-	11.896	11.142	+7%	9.697	+23%	8.521	+40%	6.335	+88%
Current Ratio	-	-	3.755	3.391	+11%	3.308	+13%	3.408	+10%	3.606	+4%
Debt To Asset Ratio	-	-	0.262	0.278	-6%	0.293	-11%	0.326	-20%	0.366	-28%
Debt To Equity Ratio	-	-	0.358	0.389	-8%	0.417	-14%	0.489	-27%	0.589	-39%
Dividend Per Share	-	-	-	0.014	-100%	0.011	-100%	0.032	-100%	0.092	-100%
Eps	-	-	0.583	0.581	+0%	0.601	-3%	0.513	+14%	0.386	+51%
Free Cash Flow Per Share	-	-	-0.230	0.097	-336%	0.397	-158%	0.354	-165%	0.300	-177%
Free Cash Flow To Equity Per Share	-	-	-0.128	-0.085	-33%	-0.178	+40%	0.094	-235%	0.094	-236%
Gross Profit Margin	-	-	1.000	1.000	0%	1.000	0%	0.995	+0%	0.998	+0%
Intrinsic Value_10Y_max	-	-	5.109	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-16.020	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	1.285	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	0.728	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	3.273	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	0.180	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	4.549	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	-2.565	-	-	-	-	-	-	-	-
Market Cap	51040220000.000	-13%	57727796000.000	50949920000.000	+13%	51927444250.000	+11%	71698570750.000	-19%	75805060443.500	-24%
Net Profit Margin	-	-	0.220	0.230	-4%	0.271	-19%	0.242	-9%	0.236	-7%
Operating Margin	-	-	0.305	0.294	+4%	0.309	-1%	0.307	-1%	0.259	+18%
Operating Ratio	-	-	0.726	0.717	+1%	0.676	+7%	0.700	+4%	0.714	+2%
Pb Ratio	7.120	-13%	8.033	7.532	+7%	8.645	-7%	15.047	-47%	22.494	-64%
Pe Ratio	36.351	-13%	41.012	36.706	+12%	35.043	+17%	49.885	-18%	5.908	+594%
Price Per Share	84.700	-13%	95.560	83.855	+14%	83.765	+14%	114.245	-16%	118.663	-19%
Price To Free Cash Flow Ratio	-92.160	+11%	-103.977	-187.564	+80%	53.123	-296%	28.467	-465%	7.166	-1551%
Price To Total Gains Ratio	102.745	-13%	115.919	317.015	-63%	167.291	-31%	461.995	-75%	498.368	-77%
Quick Ratio	-	-	2.744	2.542	+8%	2.571	+7%	2.613	+5%	3.236	-15%
Return On Assets	-	-	0.036	0.038	-4%	0.044	-18%	0.041	-12%	0.040	-10%
Return On Equity	-	-	0.049	0.053	-6%	0.062	-21%	0.061	-18%	0.063	-22%
Total Gains Per Share	-	-	0.824	0.507	+63%	0.170	+384%	0.356	+132%	0.338	+144%
Usd Book Value	-	-	7186400000.000	6769850000.000	+6%	6007525000.000	+20%	5305575000.000	+35%	3999202500.000	+80%
Usd Book Value Change Per Share	-	-	0.824	0.493	+67%	0.159	+418%	0.324	+154%	0.246	+235%
Usd Book Value Per Share	-	-	11.896	11.142	+7%	9.697	+23%	8.521	+40%	6.335	+88%
Usd Dividend Per Share	-	-	-	0.014	-100%	0.011	-100%	0.032	-100%	0.092	-100%
Usd Eps	-	-	0.583	0.581	+0%	0.601	-3%	0.513	+14%	0.386	+51%
Usd Free Cash Flow	-	-	-138800000.000	59525000.000	-333%	246350000.000	-156%	222595000.000	-162%	190972500.000	-173%
Usd Free Cash Flow Per Share	-	-	-0.230	0.097	-336%	0.397	-158%	0.354	-165%	0.300	-177%
Usd Free Cash Flow To Equity Per Share	-	-	-0.128	-0.085	-33%	-0.178	+40%	0.094	-235%	0.094	-236%
Usd Market Cap	51040220000.000	-13%	57727796000.000	50949920000.000	+13%	51927444250.000	+11%	71698570750.000	-19%	75805060443.500	-24%
Usd Price Per Share	84.700	-13%	95.560	83.855	+14%	83.765	+14%	114.245	-16%	118.663	-19%
Usd Profit	-	-	351900000.000	353450000.000	0%	372200000.000	-5%	319995000.000	+10%	245227500.000	+43%
Usd Revenue	-	-	1598200000.000	1535850000.000	+4%	1375200000.000	+16%	1297960000.000	+23%	1034205000.000	+55%
Usd Total Gains Per Share	-	-	0.824	0.507	+63%	0.170	+384%	0.356	+132%	0.338	+144%
	EOD	+3 -5	MRQ	TTM	+18 -17	YOY	+19 -16	5Y	+20 -16	10Y	+19 -17

4.2. Fundamental Score

Let's check the fundamental score of Edwards Lifesciences Corp based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	36.351
Price to Book Ratio (EOD)	Between	0-1	7.120
Net Profit Margin (MRQ)	Greater than	0	0.220
Operating Margin (MRQ)	Greater than	0	0.305
Quick Ratio (MRQ)	Greater than	1	2.744
Current Ratio (MRQ)	Greater than	1	3.755
Debt to Asset Ratio (MRQ)	Less than	1	0.262
Debt to Equity Ratio (MRQ)	Less than	1	0.358
Return on Equity (MRQ)	Greater than	0.15	0.049
Return on Assets (MRQ)	Greater than	0.05	0.036
Total			6/10 (60.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of Edwards Lifesciences Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	40.209
Ma 20	Greater than	Ma 50	86.377
Ma 50	Greater than	Ma 100	89.890
Ma 100	Greater than	Ma 200	84.706
Open	Greater than	Close	87.035
Total			3/5 (60.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	9,736,300
Total Liabilities	2,549,900
Total Stockholder Equity	7,117,900

	As reported
Total Liabilities	2,549,900
Total Stockholder Equity	+ 7,117,900
Total Assets	= 9,736,300

Assets

Total Assets	9,736,300
Total Current Assets	4,170,500
Long-term Assets	5,565,800

Total Current Assets

Total Current Assets (as reported)	4,170,500
Cash And Cash Equivalents	1,224,600
Short-term Investments	473,000
Net Receivables	876,900
Inventory	1,207,300
Other Current Assets	388,700
Total Current Assets (calculated)	4,170,500
+/-	0

Long-term Assets

Long-term Assets (as reported)	5,565,800
Property Plant Equipment	1,866,300
Goodwill	1,252,800
Long Term Investments	455,600
Intangible Assets	446,800
Long-term Assets Other	767,600
Long-term Assets (calculated)	4,789,100
+/-	776,700

Liabilities & Shareholders' Equity

Total Current Liabilities	1,110,800
Long-term Liabilities	1,439,100
Total Stockholder Equity	7,117,900

Total Current Liabilities

Total Current Liabilities (as reported)	1,110,800
Short-term Debt	24,800
Accounts payable	1,086,000
Other Current Liabilities	1,086,000
Total Current Liabilities (calculated)	2,196,800
+/-	1,086,000

Long-term Liabilities

Long-term Liabilities (as reported)	1,439,100
Long term Debt	597,200
Capital Lease Obligations	102,000
Long-term Liabilities Other	266,500
Long-term Liabilities (calculated)	965,700
+/-	473,400

Total Stockholder Equity

Total Stockholder Equity (as reported)	7,117,900
Common Stock	651,800
Retained Earnings	9,344,300
Accumulated Other Comprehensive Income	-233,300
Other Stockholders Equity	-2,644,900
Total Stockholder Equity (calculated)	7,117,900
+/-	0

Other

Capital Stock	651,800
Cash and Short Term Investments	1,697,600
Common Stock Shares Outstanding	604,100
Current Deferred Revenue	-1,086,000
Liabilities and Stockholders Equity	9,736,300
Net Debt	-525,400
Net Invested Capital	7,715,100
Net Working Capital	3,059,700
Property Plant and Equipment Gross	1,866,300
Short Long Term Debt Total	699,200

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2024-03-31

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-09-30

2010-06-30

2010-03-31

2009-12-31

2009-09-30

2009-06-30

2009-03-31

2008-12-31

2008-09-30

2008-06-30

2008-03-31

2007-12-31

2007-09-30

2007-06-30

2007-03-31

2006-12-31

2006-09-30

2006-06-30

2006-03-31

2005-12-31

2005-09-30

2005-06-30

2005-03-31

2004-12-31

2004-09-30

2004-06-30

2004-03-31

2003-12-31

2003-09-30

2003-06-30

2003-03-31

2002-12-31

2002-09-30

2002-06-30

2002-03-31

2001-12-31

2001-09-30

2001-06-30

2001-03-31

2000-12-31

2000-09-30

2000-06-30

2000-03-31

1999-12-31

> Total Assets

1,437,000
1,381,000
1,123,000
1,105,800
1,088,000
1,102,900
1,007,200
959,600
973,000
965,400
983,300
918,400
1,008,200
1,035,900
1,079,700
1,070,800
1,101,400
1,103,800
1,089,600
1,071,900
1,112,700
1,123,100
1,150,800
1,145,000
1,229,100
1,240,000
1,259,200
1,240,300
1,246,800
1,249,200
1,251,800
1,299,700
1,345,100
1,310,300
1,348,300
1,381,200
1,400,200
1,358,900
1,465,100
1,588,000
1,615,500
1,604,400
1,641,900
1,725,400
1,767,200
1,931,100
2,002,400
1,982,900
1,980,500
2,004,200
2,075,100
2,195,800
2,221,500
2,296,600
2,339,700
2,530,600
2,724,700
2,651,700
3,326,600
3,350,000
3,524,300
3,488,400
3,608,300
3,876,600
4,059,300
3,853,800
4,051,400
4,339,000
4,510,000
4,780,400
5,138,500
5,488,400
5,696,500
5,825,100
5,686,100
5,958,200
5,323,700
5,469,300
5,573,500
5,966,300
6,488,100
6,076,100
6,424,100
6,800,800
7,237,100
7,213,700
7,662,100
8,160,300
8,502,600
8,419,900
8,425,100
8,638,200
8,292,500
8,651,200
9,004,000
9,370,800
9,363,200
9,736,300

9,736,300

9,363,200

9,370,800

9,004,000

8,651,200

8,292,500

8,638,200

8,425,100

8,419,900

8,502,600

8,160,300

7,662,100

7,213,700

7,237,100

6,800,800

6,424,100

6,076,100

6,488,100

5,966,300

5,573,500

5,469,300

5,323,700

5,958,200

5,686,100

5,825,100

5,696,500

5,488,400

5,138,500

4,780,400

4,510,000

4,339,000

4,051,400

3,853,800

4,059,300

3,876,600

3,608,300

3,488,400

3,524,300

3,350,000

3,326,600

2,651,700

2,724,700

2,530,600

2,339,700

2,296,600

2,221,500

2,195,800

2,075,100

2,004,200

1,980,500

1,982,900

2,002,400

1,931,100

1,767,200

1,725,400

1,641,900

1,604,400

1,615,500

1,588,000

1,465,100

1,358,900

1,400,200

1,381,200

1,348,300

1,310,300

1,345,100

1,299,700

1,251,800

1,249,200

1,246,800

1,240,300

1,259,200

1,240,000

1,229,100

1,145,000

1,150,800

1,123,100

1,112,700

1,071,900

1,089,600

1,103,800

1,101,400

1,070,800

1,079,700

1,035,900

1,008,200

918,400

983,300

965,400

973,000

959,600

1,007,200

1,102,900

1,088,000

1,105,800

1,123,000

1,381,000

1,437,000

> Total Current Assets

356,000
318,000
295,000
277,200
282,000
306,400
316,200
274,900
293,000
287,000
311,700
297,300
326,400
351,100
388,200
368,300
360,200
326,700
333,300
326,200
367,500
400,600
437,100
430,400
514,200
526,000
542,300
524,900
531,600
542,100
541,200
564,800
581,700
591,600
635,100
676,300
691,900
649,000
745,600
863,000
889,200
872,700
918,900
992,400
1,032,600
1,150,300
1,216,800
1,181,900
1,168,500
1,188,000
1,278,800
1,387,700
1,291,900
1,360,700
1,390,600
1,570,400
1,725,800
1,603,300
2,278,100
2,309,200
2,294,600
2,254,800
2,297,000
2,145,500
2,047,900
1,819,300
1,985,100
2,171,400
2,240,000
2,018,400
2,283,400
2,566,400
2,532,100
2,716,900
2,696,000
2,912,600
2,286,900
2,368,800
2,354,700
2,739,700
2,984,000
2,507,900
2,690,300
2,980,400
3,091,000
3,069,200
3,322,900
3,515,500
3,180,700
3,241,300
3,263,100
3,513,900
3,095,800
3,257,200
3,647,000
4,067,500
4,035,700
4,170,500

4,170,500

4,035,700

4,067,500

3,647,000

3,257,200

3,095,800

3,513,900

3,263,100

3,241,300

3,180,700

3,515,500

3,322,900

3,069,200

3,091,000

2,980,400

2,690,300

2,507,900

2,984,000

2,739,700

2,354,700

2,368,800

2,286,900

2,912,600

2,696,000

2,716,900

2,532,100

2,566,400

2,283,400

2,018,400

2,240,000

2,171,400

1,985,100

1,819,300

2,047,900

2,145,500

2,297,000

2,254,800

2,294,600

2,309,200

2,278,100

1,603,300

1,725,800

1,570,400

1,390,600

1,360,700

1,291,900

1,387,700

1,278,800

1,188,000

1,168,500

1,181,900

1,216,800

1,150,300

1,032,600

992,400

918,900

872,700

889,200

863,000

745,600

649,000

691,900

676,300

635,100

591,600

581,700

564,800

541,200

542,100

531,600

524,900

542,300

526,000

514,200

430,400

437,100

400,600

367,500

326,200

333,300

326,700

360,200

368,300

388,200

351,100

326,400

297,300

311,700

287,000

293,000

274,900

316,200

306,400

282,000

277,200

295,000

318,000

356,000

Cash And Cash Equivalents

0
6,000
2,000
13,200
28,000
17,900
61,600
23,500
48,000
28,000
35,500
39,000
34,200
29,800
50,700
38,300
61,100
37,900
40,000
31,000
48,900
72,600
96,100
88,000
178,600
189,000
167,100
151,300
182,800
180,200
164,900
175,700
141,800
162,900
188,200
202,400
218,700
146,700
183,100
287,600
334,100
321,200
320,300
361,000
396,100
433,800
468,200
451,100
171,200
213,300
304,300
305,800
310,900
401,500
372,700
471,000
420,400
295,700
498,600
404,100
653,800
457,000
597,600
646,100
718,400
501,400
369,900
645,000
930,100
819,300
508,200
630,300
818,300
1,227,000
1,226,400
1,261,300
714,100
709,200
726,800
1,186,600
1,179,100
662,900
903,500
1,024,000
1,183,200
1,174,200
1,312,800
1,506,900
862,800
1,030,900
1,198,100
1,247,800
769,000
872,500
1,042,600
1,410,100
1,144,000
1,224,600

1,224,600

1,144,000

1,410,100

1,042,600

872,500

769,000

1,247,800

1,198,100

1,030,900

862,800

1,506,900

1,312,800

1,174,200

1,183,200

1,024,000

903,500

662,900

1,179,100

1,186,600

726,800

709,200

714,100

1,261,300

1,226,400

1,227,000

818,300

630,300

508,200

819,300

930,100

645,000

369,900

501,400

718,400

646,100

597,600

457,000

653,800

404,100

498,600

295,700

420,400

471,000

372,700

401,500

310,900

305,800

304,300

213,300

171,200

451,100

468,200

433,800

396,100

361,000

320,300

321,200

334,100

287,600

183,100

146,700

218,700

202,400

188,200

162,900

141,800

175,700

164,900

180,200

182,800

151,300

167,100

189,000

178,600

88,000

96,100

72,600

48,900

31,000

40,000

37,900

61,100

38,300

50,700

29,800

34,200

39,000

35,500

28,000

48,000

23,500

61,600

17,900

28,000

13,200

2,000

6,000

Short-term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,400
26,700
19,900
12,100
8,100
3,700
5,200
1,900
0
0
0
0
0
0
0
0
279,300
196,200
201,700
316,700
210,500
156,400
202,300
286,600
516,500
535,900
985,500
1,111,000
785,000
913,800
811,400
604,400
506,300
450,400
690,300
555,300
341,000
98,900
623,600
772,500
519,200
272,300
174,400
334,400
242,400
253,800
207,500
170,300
337,800
368,200
260,300
271,300
219,400
156,400
248,400
287,800
604,000
465,000
317,700
490,900
446,300
381,700
466,700
453,800
500,500
473,000

473,000

500,500

453,800

466,700

381,700

446,300

490,900

317,700

465,000

604,000

287,800

248,400

156,400

219,400

271,300

260,300

368,200

337,800

170,300

207,500

253,800

242,400

334,400

174,400

272,300

519,200

772,500

623,600

98,900

341,000

555,300

690,300

450,400

506,300

604,400

811,400

913,800

785,000

1,111,000

985,500

535,900

516,500

286,600

202,300

156,400

210,500

316,700

201,700

196,200

279,300

1,900

5,200

3,700

8,100

12,100

19,900

26,700

49,400

Net Receivables

0
132,000
162,000
154,300
129,000
136,200
116,400
119,000
101,000
109,300
114,400
113,200
108,400
124,900
124,400
115,600
118,500
113,500
110,100
113,200
119,400
127,700
124,900
125,900
118,500
123,000
133,700
130,200
127,100
129,300
137,400
136,700
145,300
155,300
173,300
213,600
204,700
255,800
274,500
280,500
272,100
278,600
294,000
303,400
302,500
354,200
364,100
346,800
320,700
346,700
336,400
325,400
347,500
329,700
341,800
327,800
328,000
305,100
327,500
322,900
325,000
345,300
351,000
338,400
344,100
388,500
425,800
454,200
414,600
510,200
510,700
475,000
462,200
446,800
520,100
530,100
537,300
578,000
609,600
570,000
599,100
585,100
567,900
671,700
602,800
664,300
700,300
664,200
664,900
686,200
679,200
661,400
699,100
779,300
816,900
802,100
836,900
876,900

876,900

836,900

802,100

816,900

779,300

699,100

661,400

679,200

686,200

664,900

664,200

700,300

664,300

602,800

671,700

567,900

585,100

599,100

570,000

609,600

578,000

537,300

530,100

520,100

446,800

462,200

475,000

510,700

510,200

414,600

454,200

425,800

388,500

344,100

338,400

351,000

345,300

325,000

322,900

327,500

305,100

328,000

327,800

341,800

329,700

347,500

325,400

336,400

346,700

320,700

346,800

364,100

354,200

302,500

303,400

294,000

278,600

272,100

280,500

274,500

255,800

204,700

213,600

173,300

155,300

145,300

136,700

137,400

129,300

127,100

130,200

133,700

123,000

118,500

125,900

124,900

127,700

119,400

113,200

110,100

113,500

118,500

115,600

124,400

124,900

108,400

113,200

114,400

109,300

101,000

119,000

116,400

136,200

129,000

154,300

162,000

132,000

Inventory

169,000
156,000
95,000
78,400
73,000
88,400
77,200
80,700
87,000
86,100
89,400
84,400
111,800
116,300
125,600
125,300
120,500
114,500
119,500
120,500
127,700
126,100
131,300
135,500
131,500
135,000
139,000
148,900
142,100
141,500
143,500
158,300
152,600
139,500
136,800
143,800
151,800
146,100
160,900
168,700
165,900
174,600
182,300
212,200
203,600
217,700
229,400
247,900
261,300
268,300
265,400
286,000
281,000
288,500
299,500
313,900
308,900
308,000
317,100
303,600
296,800
298,500
313,300
333,500
339,900
356,600
367,600
401,000
396,600
431,400
491,600
538,400
554,900
573,900
568,100
583,800
607,000
630,900
624,900
611,100
640,900
662,200
735,100
773,300
802,300
767,900
759,500
737,800
726,700
730,600
740,000
757,800
875,500
914,300
980,200
1,032,400
1,168,200
1,207,300

1,207,300

1,168,200

1,032,400

980,200

914,300

875,500

757,800

740,000

730,600

726,700

737,800

759,500

767,900

802,300

773,300

735,100

662,200

640,900

611,100

624,900

630,900

607,000

583,800

568,100

573,900

554,900

538,400

491,600

431,400

396,600

401,000

367,600

356,600

339,900

333,500

313,300

298,500

296,800

303,600

317,100

308,000

308,900

313,900

299,500

288,500

281,000

286,000

265,400

268,300

261,300

247,900

229,400

217,700

203,600

212,200

182,300

174,600

165,900

168,700

160,900

146,100

151,800

143,800

136,800

139,500

152,600

158,300

143,500

141,500

142,100

148,900

139,000

135,000

131,500

135,500

131,300

126,100

127,700

120,500

119,500

114,500

120,500

125,300

125,600

116,300

111,800

84,400

89,400

86,100

87,000

80,700

77,200

88,400

73,000

78,400

95,000

156,000

169,000

Other Current Assets

187,000
24,000
36,000
31,300
15,000
63,900
61,000
51,700
20,000
63,600
72,400
60,700
23,400
80,100
87,500
89,100
6,400
60,800
63,700
61,500
8,200
74,200
84,800
81,000
10,500
79,000
102,500
94,500
79,600
91,100
95,400
94,100
37,000
41,600
44,600
38,600
35,500
25,900
38,800
38,900
35,100
22,300
35,500
26,600
43,100
45,900
53,300
67,800
57,100
90,200
95,500
69,300
57,000
106,500
97,700
83,200
71,800
77,200
60,300
89,600
121,700
138,400
112,400
96,600
94,100
73,600
81,500
66,100
111,800
105,600
95,200
97,400
116,900
118,900
137,100
150,400
131,800
141,500
130,200
144,400
168,000
163,700
166,200
171,500
208,200
229,100
233,300
241,900
237,100
234,500
248,800
267,600
195,900
190,300
217,400
235,800
239,300
388,700

388,700

239,300

235,800

217,400

190,300

195,900

267,600

248,800

234,500

237,100

241,900

233,300

229,100

208,200

171,500

166,200

163,700

168,000

144,400

130,200

141,500

131,800

150,400

137,100

118,900

116,900

97,400

95,200

105,600

111,800

66,100

81,500

73,600

94,100

96,600

112,400

138,400

121,700

89,600

60,300

77,200

71,800

83,200

97,700

106,500

57,000

69,300

95,500

90,200

57,100

67,800

53,300

45,900

43,100

26,600

35,500

22,300

35,100

38,900

38,800

25,900

35,500

38,600

44,600

41,600

37,000

94,100

95,400

91,100

79,600

94,500

102,500

79,000

10,500

81,000

84,800

74,200

8,200

61,500

63,700

60,800

6,400

89,100

87,500

80,100

23,400

60,700

72,400

63,600

20,000

51,700

61,000

63,900

15,000

31,300

36,000

24,000

187,000

> Long-term Assets

1,081,000
1,063,000
828,000
828,600
806,000
796,500
691,000
684,700
680,000
678,400
671,600
621,100
681,800
684,800
691,500
702,500
741,200
777,100
756,300
745,700
745,200
722,500
713,700
714,600
714,900
714,000
716,900
715,400
715,200
707,100
710,600
734,900
763,400
718,700
713,200
704,900
708,300
709,900
719,500
725,000
726,300
731,700
723,000
733,000
734,600
780,800
785,600
801,000
812,000
816,200
796,300
808,100
929,600
935,900
949,100
960,200
998,900
1,048,400
1,048,500
1,040,800
1,229,700
1,233,600
1,311,300
1,731,100
2,011,400
2,034,500
2,066,300
2,167,600
2,270,000
2,762,000
2,855,100
2,922,000
3,164,400
3,108,200
2,990,100
3,045,600
3,036,800
3,100,500
3,218,800
3,226,600
3,504,100
3,568,200
3,733,800
3,820,400
4,146,100
4,144,500
4,339,200
4,644,800
5,321,900
5,178,600
5,162,000
5,124,300
5,196,700
5,394,000
5,357,000
5,303,300
5,327,500
5,565,800

5,565,800

5,327,500

5,303,300

5,357,000

5,394,000

5,196,700

5,124,300

5,162,000

5,178,600

5,321,900

4,644,800

4,339,200

4,144,500

4,146,100

3,820,400

3,733,800

3,568,200

3,504,100

3,226,600

3,218,800

3,100,500

3,036,800

3,045,600

2,990,100

3,108,200

3,164,400

2,922,000

2,855,100

2,762,000

2,270,000

2,167,600

2,066,300

2,034,500

2,011,400

1,731,100

1,311,300

1,233,600

1,229,700

1,040,800

1,048,500

1,048,400

998,900

960,200

949,100

935,900

929,600

808,100

796,300

816,200

812,000

801,000

785,600

780,800

734,600

733,000

723,000

731,700

726,300

725,000

719,500

709,900

708,300

704,900

713,200

718,700

763,400

734,900

710,600

707,100

715,200

715,400

716,900

714,000

714,900

714,600

713,700

722,500

745,200

745,700

756,300

777,100

741,200

702,500

691,500

684,800

681,800

621,100

671,600

678,400

680,000

684,700

691,000

796,500

806,000

828,600

828,000

1,063,000

1,081,000

Property Plant Equipment

226,000
205,000
178,000
177,100
183,000
185,400
173,500
176,700
178,000
177,400
178,000
180,100
209,400
205,100
205,800
205,900
209,900
203,700
193,500
189,500
201,700
195,400
193,000
192,100
201,900
199,000
205,700
211,500
213,000
216,700
220,200
228,000
228,200
223,600
224,600
224,000
230,100
229,800
239,100
240,700
252,000
247,200
249,800
260,300
269,800
274,300
281,000
286,400
304,300
308,200
315,800
328,700
373,300
385,400
399,200
409,000
421,600
418,700
422,500
429,300
442,900
445,100
450,600
454,800
482,500
497,300
516,200
543,700
580,000
588,800
627,900
649,600
679,700
711,600
770,200
826,100
867,500
962,100
1,002,300
1,046,900
1,140,400
1,176,100
1,280,300
1,365,800
1,489,400
1,506,400
1,530,400
1,549,400
1,638,700
1,642,300
1,644,100
1,654,100
1,725,100
1,734,500
1,747,100
1,772,200
1,843,400
1,866,300

1,866,300

1,843,400

1,772,200

1,747,100

1,734,500

1,725,100

1,654,100

1,644,100

1,642,300

1,638,700

1,549,400

1,530,400

1,506,400

1,489,400

1,365,800

1,280,300

1,176,100

1,140,400

1,046,900

1,002,300

962,100

867,500

826,100

770,200

711,600

679,700

649,600

627,900

588,800

580,000

543,700

516,200

497,300

482,500

454,800

450,600

445,100

442,900

429,300

422,500

418,700

421,600

409,000

399,200

385,400

373,300

328,700

315,800

308,200

304,300

286,400

281,000

274,300

269,800

260,300

249,800

247,200

252,000

240,700

239,100

229,800

230,100

224,000

224,600

223,600

228,200

228,000

220,200

216,700

213,000

211,500

205,700

199,000

201,900

192,100

193,000

195,400

201,700

189,500

193,500

203,700

209,900

205,900

205,800

205,100

209,400

180,100

178,000

177,400

178,000

176,700

173,500

185,400

183,000

177,100

178,000

205,000

226,000

Goodwill

839,000
829,000
528,000
520,200
511,000
503,700
408,000
403,000
402,000
333,800
333,800
333,800
333,800
333,800
338,200
338,200
338,200
337,700
337,700
337,700
337,700
337,700
337,700
337,700
337,700
338,000
337,700
337,700
337,700
337,700
337,700
337,700
350,300
315,700
315,700
315,700
315,700
315,700
315,700
315,200
315,200
315,200
315,200
315,200
315,200
349,900
349,900
349,800
349,800
349,800
349,800
349,800
384,700
380,200
381,500
383,800
385,400
385,400
384,300
379,000
376,000
368,400
370,900
621,200
628,300
630,900
629,400
630,000
626,100
945,200
965,100
980,500
1,126,500
1,144,800
1,118,600
1,122,300
1,112,200
1,103,400
1,173,900
1,156,600
1,167,700
1,166,200
1,167,700
1,170,000
1,173,200
1,170,800
1,171,800
1,170,400
1,167,900
1,166,300
1,164,100
1,158,700
1,164,300
1,308,400
1,299,500
1,297,400
1,253,500
1,252,800

1,252,800

1,253,500

1,297,400

1,299,500

1,308,400

1,164,300

1,158,700

1,164,100

1,166,300

1,167,900

1,170,400

1,171,800

1,170,800

1,173,200

1,170,000

1,167,700

1,166,200

1,167,700

1,156,600

1,173,900

1,103,400

1,112,200

1,122,300

1,118,600

1,144,800

1,126,500

980,500

965,100

945,200

626,100

630,000

629,400

630,900

628,300

621,200

370,900

368,400

376,000

379,000

384,300

385,400

383,800

381,500

380,200

384,700

349,800

349,900

315,200

315,700

350,300

337,700

338,000

337,700

338,200

333,800

402,000

403,000

408,000

503,700

511,000

520,200

528,000

829,000

839,000

Long Term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,900
22,300
25,000
27,300
24,800
21,400
46,400
43,300
33,000
33,100
31,000
33,300
34,900
31,800
29,200
101,100
106,600
100,100
246,700
261,300
331,200
371,500
381,500
375,000
397,000
472,800
532,100
519,000
551,500
567,500
567,000
532,100
470,400
479,000
506,300
453,700
412,900
386,000
585,500
587,800
594,400
599,000
801,600
802,200
1,014,200
1,282,000
1,834,200
1,623,700
1,490,800
1,381,000
1,239,000
1,066,700
856,200
704,600
583,900
455,600

455,600

583,900

704,600

856,200

1,066,700

1,239,000

1,381,000

1,490,800

1,623,700

1,834,200

1,282,000

1,014,200

802,200

801,600

599,000

594,400

587,800

585,500

386,000

412,900

453,700

506,300

479,000

470,400

532,100

567,000

567,500

551,500

519,000

532,100

472,800

397,000

375,000

381,500

371,500

331,200

261,300

246,700

100,100

106,600

101,100

29,200

31,800

34,900

33,300

31,000

33,100

33,000

43,300

46,400

21,400

24,800

27,300

25,000

22,300

21,900

Intangible Assets

0
829,000
528,000
520,200
511,000
511,000
0
0
402,000
67,600
63,200
396,300
395,700
403,300
418,700
418,900
419,200
491,200
488,600
487,800
490,300
480,800
483,600
479,500
475,400
133,000
127,500
123,200
116,100
108,900
107,500
107,000
122,500
111,900
109,600
107,900
96,900
92,600
91,300
91,000
86,700
83,600
74,300
71,700
67,100
76,300
72,900
70,200
66,900
65,100
61,700
59,600
67,000
65,500
64,600
63,100
57,200
31,600
29,500
25,800
23,400
20,500
18,900
207,300
205,400
203,700
208,700
207,000
204,800
402,100
408,600
414,900
468,000
480,500
466,000
467,900
343,200
341,300
385,600
381,100
336,500
334,800
333,500
332,400
331,400
330,300
327,000
325,300
323,600
322,000
320,700
266,500
285,200
446,800
431,400
429,800
428,400
446,800

446,800

428,400

429,800

431,400

446,800

285,200

266,500

320,700

322,000

323,600

325,300

327,000

330,300

331,400

332,400

333,500

334,800

336,500

381,100

385,600

341,300

343,200

467,900

466,000

480,500

468,000

414,900

408,600

402,100

204,800

207,000

208,700

203,700

205,400

207,300

18,900

20,500

23,400

25,800

29,500

31,600

57,200

63,100

64,600

65,500

67,000

59,600

61,700

65,100

66,900

70,200

72,900

76,300

67,100

71,700

74,300

83,600

86,700

91,000

91,300

92,600

96,900

107,900

109,600

111,900

122,500

107,000

107,500

108,900

116,100

123,200

127,500

133,000

475,400

479,500

483,600

480,800

490,300

487,800

488,600

491,200

419,200

418,900

418,700

403,300

395,700

396,300

63,200

67,600

402,000

511,000

520,200

528,000

829,000

Long-term Assets Other

15,000
29,000
122,000
131,300
112,000
-11,800
-7,700
-10,400
-11,000
-11,900
-19,200
1,000
14,400
14,200
14,100
14,200
17,400
15,100
16,300
16,000
10,300
10,500
9,900
9,100
15,100
16,000
13,000
13,500
13,900
15,500
15,400
17,500
14,600
19,800
19,100
17,600
13,200
18,300
16,700
13,700
13,000
11,800
11,800
12,100
13,000
12,000
11,900
24,600
49,200
47,200
36,700
35,700
36,200
36,400
38,400
42,100
42,700
41,100
43,300
46,000
55,000
59,100
64,300
60,400
134,800
136,900
131,700
130,100
123,200
127,800
116,800
112,400
108,900
57,800
34,800
35,200
33,600
75,500
80,300
100,200
101,800
145,300
153,800
138,000
119,600
125,500
105,300
133,700
110,800
129,400
234,700
316,500
299,100
293,600
412,100
447,400
463,700
767,600

767,600

463,700

447,400

412,100

293,600

299,100

316,500

234,700

129,400

110,800

133,700

105,300

125,500

119,600

138,000

153,800

145,300

101,800

100,200

80,300

75,500

33,600

35,200

34,800

57,800

108,900

112,400

116,800

127,800

123,200

130,100

131,700

136,900

134,800

60,400

64,300

59,100

55,000

46,000

43,300

41,100

42,700

42,100

38,400

36,400

36,200

35,700

36,700

47,200

49,200

24,600

11,900

12,000

13,000

12,100

11,800

13,000

13,700

16,700

18,300

13,200

17,600

19,100

19,800

14,600

17,500

15,400

15,500

13,900

13,500

13,000

16,000

15,100

9,100

9,900

10,500

10,300

16,000

16,300

15,100

17,400

14,200

14,100

14,200

14,400

1,000

-19,200

-11,900

-11,000

-10,400

-7,700

-11,800

112,000

131,300

122,000

29,000

15,000

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
51,400
44,500
41,000
45,100
48,600
20,000
24,000
10,200
10,900
47,300
45,900
43,500
41,500
70,100
76,400
69,900
68,700
91,500
84,900
82,000
21,400
180,500
196,500
188,600
189,300
203,800
179,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

179,100

203,800

189,300

188,600

196,500

180,500

21,400

82,000

84,900

91,500

68,700

69,900

76,400

70,100

41,500

43,500

45,900

47,300

10,900

10,200

24,000

20,000

48,600

45,100

41,000

44,500

51,400

50,000

> Total Liabilities

213,000
698,000
712,000
681,400
648,000
638,900
591,500
547,000
514,000
479,100
503,700
459,600
468,800
492,900
520,700
492,100
466,300
533,600
503,400
472,600
484,600
475,000
489,100
485,800
539,100
516,000
536,800
512,400
497,400
464,200
444,300
475,900
510,100
532,700
451,000
506,700
521,400
415,600
462,000
497,500
457,600
452,900
524,100
491,900
459,000
573,300
617,200
628,300
642,600
613,900
640,500
659,500
742,200
704,600
759,900
1,093,200
1,165,500
1,310,900
1,411,700
1,306,600
1,332,900
1,274,500
1,319,700
1,455,200
1,556,200
1,554,500
1,580,200
1,647,200
1,891,000
2,037,700
2,198,900
2,325,900
2,701,800
2,579,400
2,521,900
2,596,900
2,183,300
2,021,800
2,073,200
2,151,500
2,339,800
2,175,000
2,585,000
2,590,500
2,662,800
2,555,300
2,528,800
2,619,000
2,666,700
2,575,000
2,481,500
2,420,400
2,485,800
2,589,200
2,557,500
2,643,700
2,643,800
2,549,900

2,549,900

2,643,800

2,643,700

2,557,500

2,589,200

2,485,800

2,420,400

2,481,500

2,575,000

2,666,700

2,619,000

2,528,800

2,555,300

2,662,800

2,590,500

2,585,000

2,175,000

2,339,800

2,151,500

2,073,200

2,021,800

2,183,300

2,596,900

2,521,900

2,579,400

2,701,800

2,325,900

2,198,900

2,037,700

1,891,000

1,647,200

1,580,200

1,554,500

1,556,200

1,455,200

1,319,700

1,274,500

1,332,900

1,306,600

1,411,700

1,310,900

1,165,500

1,093,200

759,900

704,600

742,200

659,500

640,500

613,900

642,600

628,300

617,200

573,300

459,000

491,900

524,100

452,900

457,600

497,500

462,000

415,600

521,400

506,700

451,000

532,700

510,100

475,900

444,300

464,200

497,400

512,400

536,800

516,000

539,100

485,800

489,100

475,000

484,600

472,600

503,400

533,600

466,300

492,100

520,700

492,900

468,800

459,600

503,700

479,100

514,000

547,000

591,500

638,900

648,000

681,400

712,000

698,000

213,000

> Total Current Liabilities

156,000
332,000
331,000
277,400
219,000
228,900
199,100
157,400
184,000
167,800
186,100
175,000
197,900
189,600
186,100
172,000
167,200
156,400
156,000
170,300
195,400
176,400
190,400
204,600
194,200
197,000
226,500
227,500
226,200
179,400
323,600
348,800
375,400
391,600
226,600
229,900
258,500
200,200
245,100
282,100
290,500
242,200
247,700
281,600
337,800
445,200
313,300
302,000
335,200
265,200
284,300
298,600
347,400
300,400
314,200
335,100
345,600
356,200
540,500
427,800
434,400
405,300
445,200
532,500
476,200
458,300
478,200
532,800
532,500
584,800
562,500
735,200
1,399,400
1,314,500
1,183,200
1,261,100
876,600
646,500
697,000
775,800
902,400
746,900
873,200
846,300
893,900
799,000
886,200
966,500
1,032,300
949,900
969,100
917,900
1,022,400
1,082,000
1,157,200
1,238,900
1,195,400
1,110,800

1,110,800

1,195,400

1,238,900

1,157,200

1,082,000

1,022,400

917,900

969,100

949,900

1,032,300

966,500

886,200

799,000

893,900

846,300

873,200

746,900

902,400

775,800

697,000

646,500

876,600

1,261,100

1,183,200

1,314,500

1,399,400

735,200

562,500

584,800

532,500

532,800

478,200

458,300

476,200

532,500

445,200

405,300

434,400

427,800

540,500

356,200

345,600

335,100

314,200

300,400

347,400

298,600

284,300

265,200

335,200

302,000

313,300

445,200

337,800

281,600

247,700

242,200

290,500

282,100

245,100

200,200

258,500

229,900

226,600

391,600

375,400

348,800

323,600

179,400

226,200

227,500

226,500

197,000

194,200

204,600

190,400

176,400

195,400

170,300

156,000

156,400

167,200

172,000

186,100

189,600

197,900

175,000

186,100

167,800

184,000

157,400

199,100

228,900

219,000

277,400

331,000

332,000

156,000

Short-term Debt

0
210,000
210,000
150,600
61,000
61,500
49,200
200
1,000
1,500
600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150,000
150,000
150,000
150,000
0
0
0
0
0
0
0
0
0
100,600
41,800
149,500
0
0
0
0
0
0
0
0
0
0
0
0
0
13,600
598,100
0
0
0
227,600
0
0
0
228,300
847,900
1,016,800
1,034,000
598,000
598,600
599,200
599,900
564,200
22,600
23,800
24,100
25,500
24,900
23,800
24,200
27,200
26,500
25,100
24,200
25,500
23,900
23,300
23,500
25,500
25,100
24,300
24,300
24,900
24,800

24,800

24,900

24,300

25,100

25,500

23,500

23,300

23,900

25,500

24,200

25,100

26,500

27,200

24,200

23,800

24,900

25,500

24,100

23,800

22,600

564,200

599,900

599,200

598,600

598,000

1,034,000

1,016,800

847,900

228,300

227,600

598,100

13,600

149,500

41,800

100,600

150,000

600

1,500

1,000

200

49,200

61,500

61,000

150,600

210,000

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
598,100
0
0
0
596,900
0
0
0
822,300
847,900
1,016,800
1,034,000
1,036,400
1,054,600
1,193,100
0
0
22,600
23,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

23,800

22,600

1,193,100

1,054,600

1,036,400

1,034,000

1,016,800

847,900

822,300

596,900

598,100

Accounts payable

0
122,000
121,000
126,800
158,000
167,400
149,900
157,200
183,000
166,300
185,500
175,000
197,900
189,600
186,100
172,000
167,200
156,400
156,000
170,300
195,400
176,400
190,400
204,600
194,200
197,000
226,500
227,500
57,200
179,400
173,600
198,800
63,900
241,600
226,600
229,900
65,600
200,200
245,100
296,300
51,100
242,200
247,700
281,600
47,600
295,700
313,300
302,000
85,000
265,200
284,300
298,600
74,700
300,400
314,200
335,100
48,400
356,200
540,500
59,900
58,200
68,600
66,200
71,500
63,900
78,600
83,400
87,000
97,100
93,000
104,600
113,400
116,600
121,200
124,600
134,000
134,000
147,200
151,000
135,900
180,400
151,500
153,400
162,500
196,500
150,400
144,600
139,500
204,500
158,800
162,500
154,900
201,900
180,800
193,000
190,600
201,400
1,086,000

1,086,000

201,400

190,600

193,000

180,800

201,900

154,900

162,500

158,800

204,500

139,500

144,600

150,400

196,500

162,500

153,400

151,500

180,400

135,900

151,000

147,200

134,000

124,600

121,200

116,600

113,400

104,600

93,000

97,100

87,000

83,400

78,600

63,900

71,500

66,200

68,600

58,200

59,900

540,500

356,200

48,400

335,100

314,200

300,400

74,700

298,600

284,300

265,200

85,000

302,000

313,300

295,700

47,600

281,600

247,700

242,200

51,100

296,300

245,100

200,200

65,600

229,900

226,600

241,600

63,900

198,800

173,600

179,400

57,200

227,500

226,500

197,000

194,200

204,600

190,400

176,400

195,400

170,300

156,000

156,400

167,200

172,000

186,100

189,600

197,900

175,000

185,500

166,300

183,000

157,200

149,900

167,400

158,000

126,800

121,000

122,000

Other Current Liabilities

156,000
0
0
0
109,000
167,400
149,900
157,200
183,000
166,300
185,500
0
128,400
0
0
0
99,900
0
0
0
133,400
0
0
0
108,300
0
0
0
169,000
0
173,600
198,800
161,500
241,600
0
0
192,900
200,200
245,100
282,100
239,400
242,200
247,700
181,000
226,100
295,700
313,300
302,000
250,200
265,200
284,300
298,600
272,700
300,400
314,200
335,100
297,200
356,200
540,500
2,200
376,200
336,700
379,000
461,000
4,200
379,700
394,800
445,800
3,300
491,800
457,900
621,800
471,200
41,800
5,300
3,300
4,400
4,000
4,600
4,500
524,300
6,600
6,700
21,400
439,300
16,100
7,900
3,500
555,600
767,200
475,700
392,000
311,000
876,100
1,132,900
1,214,600
15,200
1,086,000

1,086,000

15,200

1,214,600

1,132,900

876,100

311,000

392,000

475,700

767,200

555,600

3,500

7,900

16,100

439,300

21,400

6,700

6,600

524,300

4,500

4,600

4,000

4,400

3,300

5,300

41,800

471,200

621,800

457,900

491,800

3,300

445,800

394,800

379,700

4,200

461,000

379,000

336,700

376,200

2,200

540,500

356,200

297,200

335,100

314,200

300,400

272,700

298,600

284,300

265,200

250,200

302,000

313,300

295,700

226,100

181,000

247,700

242,200

239,400

282,100

245,100

200,200

192,900

241,600

161,500

198,800

173,600

169,000

108,300

133,400

99,900

128,400

185,500

166,300

183,000

157,200

149,900

167,400

109,000

156,000

> Long-term Liabilities

57,000
366,000
381,000
404,000
429,000
410,000
392,400
389,600
330,000
311,300
317,600
284,600
270,900
303,300
334,600
320,100
299,100
377,200
347,400
302,300
289,200
298,600
298,700
281,200
344,900
319,000
310,300
284,900
271,200
284,800
120,700
127,100
134,700
141,100
224,400
276,800
262,900
215,400
216,900
215,400
167,100
210,700
276,400
210,300
121,200
128,100
303,900
326,300
307,400
348,700
356,200
360,900
394,800
404,200
445,700
758,100
819,900
954,700
871,200
878,800
898,500
869,200
874,500
922,700
1,080,000
1,096,200
1,102,000
1,114,400
1,358,500
1,452,900
1,636,400
1,590,700
1,302,400
1,264,900
1,338,700
1,335,800
1,306,700
1,375,300
1,376,200
1,375,700
1,437,400
1,428,100
1,711,800
1,744,200
1,768,900
1,756,300
1,642,600
1,652,500
1,634,400
1,625,100
1,512,400
1,502,500
1,463,400
1,507,200
1,400,300
1,404,800
1,448,400
1,439,100

1,439,100

1,448,400

1,404,800

1,400,300

1,507,200

1,463,400

1,502,500

1,512,400

1,625,100

1,634,400

1,652,500

1,642,600

1,756,300

1,768,900

1,744,200

1,711,800

1,428,100

1,437,400

1,375,700

1,376,200

1,375,300

1,306,700

1,335,800

1,338,700

1,264,900

1,302,400

1,590,700

1,636,400

1,452,900

1,358,500

1,114,400

1,102,000

1,096,200

1,080,000

922,700

874,500

869,200

898,500

878,800

871,200

954,700

819,900

758,100

445,700

404,200

394,800

360,900

356,200

348,700

307,400

326,300

303,900

128,100

121,200

210,300

276,400

210,700

167,100

215,400

216,900

215,400

262,900

276,800

224,400

141,100

134,700

127,100

120,700

284,800

271,200

284,900

310,300

319,000

344,900

281,200

298,700

298,600

289,200

302,300

347,400

377,200

299,100

320,100

334,600

303,300

270,900

284,600

317,600

311,300

330,000

389,600

392,400

410,000

429,000

404,000

381,000

366,000

57,000

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
177,500
0
0
0
174,800
175,000
150,400
179,400
185,100
175,400
189,300
192,700
227,300
532,100
593,100
725,400
598,000
596,400
598,100
602,700
600,300
604,900
599,900
602,200
602,500
600,600
822,300
847,900
1,016,800
1,034,000
438,400
456,000
593,900
593,600
593,800
593,900
594,100
594,200
594,400
594,600
594,700
594,900
595,000
595,200
595,400
595,500
595,700
595,900
596,000
596,200
596,300
596,500
596,700
596,800
0
0

596,800

596,700

596,500

596,300

596,200

596,000

595,900

595,700

595,500

595,400

595,200

595,000

594,900

594,700

594,600

594,400

594,200

594,100

593,900

593,800

593,600

593,900

456,000

438,400

1,034,000

1,016,800

847,900

822,300

600,600

602,500

602,200

599,900

604,900

600,300

602,700

598,100

596,400

598,000

725,400

593,100

532,100

227,300

192,700

189,300

175,400

185,100

179,400

150,400

175,000

174,800

177,500

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
51,400
44,500
41,000
45,100
48,600
20,000
24,000
10,200
10,900
47,300
45,900
43,500
41,500
70,100
76,400
69,900
68,700
91,500
84,900
82,000
21,400
180,500
196,500
188,600
189,300
203,800
179,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

179,100

203,800

189,300

188,600

196,500

180,500

21,400

82,000

84,900

91,500

68,700

69,900

76,400

70,100

41,500

43,500

45,900

47,300

10,900

10,200

24,000

20,000

48,600

45,100

41,000

44,500

51,400

50,000

Other Liabilities

0
47,000
60,000
55,800
62,000
57,100
53,400
50,500
20,000
20,500
20,700
4,700
25,400
26,400
27,300
27,000
43,300
42,700
34,600
33,100
22,100
22,800
29,100
29,700
28,800
30,700
30,700
31,900
35,300
60,300
63,100
65,900
73,000
78,200
82,700
74,000
87,400
92,400
103,000
113,100
76,800
81,400
98,900
109,700
121,200
128,100
129,100
151,300
157,000
169,300
171,100
185,500
203,700
211,500
218,400
226,000
222,900
229,300
273,200
282,400
296,900
266,500
274,200
317,800
470,300
494,000
499,500
513,800
527,300
605,000
619,600
556,700
870,700
808,900
744,800
742,200
712,900
731,700
731,700
729,100
784,100
777,800
1,051,100
1,078,300
1,101,200
1,094,000
983,500
992,600
969,600
960,800
852,900
839,200
797,600
844,500
0
738,000
0
0

738,000

844,500

797,600

839,200

852,900

960,800

969,600

992,600

983,500

1,094,000

1,101,200

1,078,300

1,051,100

777,800

784,100

729,100

731,700

712,900

742,200

744,800

808,900

870,700

556,700

619,600

605,000

527,300

513,800

499,500

494,000

470,300

317,800

274,200

266,500

296,900

282,400

273,200

229,300

222,900

226,000

218,400

211,500

203,700

185,500

171,100

169,300

157,000

151,300

129,100

128,100

121,200

109,700

98,900

81,400

76,800

113,100

103,000

92,400

87,400

74,000

82,700

78,200

73,000

65,900

63,100

60,300

35,300

31,900

30,700

28,800

29,700

29,100

22,800

22,100

33,100

34,600

42,700

43,300

27,000

27,300

26,400

25,400

4,700

20,700

20,500

20,000

50,500

53,400

57,100

62,000

55,800

60,000

47,000

> Total Stockholder Equity

1,224,000
683,000
411,000
424,400
440,000
464,000
415,700
412,600
459,000
486,300
479,600
458,800
539,400
543,000
559,000
578,700
635,100
570,200
586,200
599,300
628,100
648,100
661,700
659,200
690,000
724,000
722,400
727,900
749,400
785,000
807,500
823,800
835,000
777,600
897,300
874,500
878,800
943,300
1,003,100
1,090,500
1,157,900
1,151,500
1,117,800
1,233,500
1,308,200
1,357,800
1,385,200
1,354,600
1,337,900
1,390,300
1,434,600
1,536,300
1,479,300
1,592,000
1,579,800
1,437,400
1,559,200
1,340,800
1,914,900
2,043,400
2,191,400
2,213,900
2,288,600
2,421,400
2,503,100
2,299,300
2,471,200
2,691,800
2,619,000
2,742,700
2,939,600
3,162,500
2,994,700
3,245,700
3,164,200
3,361,300
3,140,400
3,447,500
3,500,300
3,814,800
4,148,300
3,901,100
3,839,100
4,210,300
4,574,300
4,658,400
5,133,300
5,541,300
5,835,900
5,844,900
5,943,600
6,217,800
5,806,700
5,978,000
6,375,700
6,657,500
6,650,000
7,117,900

7,117,900

6,650,000

6,657,500

6,375,700

5,978,000

5,806,700

6,217,800

5,943,600

5,844,900

5,835,900

5,541,300

5,133,300

4,658,400

4,574,300

4,210,300

3,839,100

3,901,100

4,148,300

3,814,800

3,500,300

3,447,500

3,140,400

3,361,300

3,164,200

3,245,700

2,994,700

3,162,500

2,939,600

2,742,700

2,619,000

2,691,800

2,471,200

2,299,300

2,503,100

2,421,400

2,288,600

2,213,900

2,191,400

2,043,400

1,914,900

1,340,800

1,559,200

1,437,400

1,579,800

1,592,000

1,479,300

1,536,300

1,434,600

1,390,300

1,337,900

1,354,600

1,385,200

1,357,800

1,308,200

1,233,500

1,117,800

1,151,500

1,157,900

1,090,500

1,003,100

943,300

878,800

874,500

897,300

777,600

835,000

823,800

807,500

785,000

749,400

727,900

722,400

724,000

690,000

659,200

661,700

648,100

628,100

599,300

586,200

570,200

635,100

578,700

559,000

543,000

539,400

458,800

479,600

486,300

459,000

412,600

415,700

464,000

440,000

424,400

411,000

683,000

1,224,000

Common Stock

0
58,000
58,000
58,700
59,000
58,800
58,900
59,200
59,000
59,500
59,800
60,000
60,200
60,400
61,800
62,100
62,600
63,100
63,700
63,800
64,200
64,600
65,000
65,400
65,600
66,000
66,300
66,700
67,000
67,600
67,900
68,400
68,600
68,900
72,700
73,300
73,700
74,300
75,100
75,400
76,100
77,200
115,100
116,100
117,000
117,700
118,800
119,500
120,000
121,100
123,000
123,900
124,200
124,700
125,400
125,700
126,000
126,400
127,100
128,000
128,900
129,400
129,900
130,200
239,100
239,800
241,000
242,000
242,600
243,200
244,700
211,600
212,000
213,000
214,000
214,800
215,200
216,000
216,900
217,500
218,100
218,500
633,500
635,000
636,400
637,500
640,100
641,200
642,000
642,900
645,000
645,700
646,300
647,100
649,100
649,900
650,500
651,800

651,800

650,500

649,900

649,100

647,100

646,300

645,700

645,000

642,900

642,000

641,200

640,100

637,500

636,400

635,000

633,500

218,500

218,100

217,500

216,900

216,000

215,200

214,800

214,000

213,000

212,000

211,600

244,700

243,200

242,600

242,000

241,000

239,800

239,100

130,200

129,900

129,400

128,900

128,000

127,100

126,400

126,000

125,700

125,400

124,700

124,200

123,900

123,000

121,100

120,000

119,500

118,800

117,700

117,000

116,100

115,100

77,200

76,100

75,400

75,100

74,300

73,700

73,300

72,700

68,900

68,600

68,400

67,900

67,600

67,000

66,700

66,300

66,000

65,600

65,400

65,000

64,600

64,200

63,800

63,700

63,100

62,600

62,100

61,800

60,400

60,200

60,000

59,800

59,500

59,000

59,200

58,900

58,800

59,000

58,700

58,000

Retained Earnings

418,000
392,000
83,000
87,100
103,000
111,800
56,100
70,600
88,000
108,500
139,100
121,700
143,400
157,900
179,000
203,500
222,400
160,300
185,800
198,200
224,100
255,300
269,100
264,700
303,400
349,000
385,400
413,200
433,900
468,800
503,700
532,800
548,600
566,800
606,500
639,400
676,900
737,400
784,900
858,400
906,000
953,700
1,011,200
1,059,200
1,124,000
1,187,900
1,246,000
1,297,600
1,360,700
1,425,800
1,493,600
1,562,800
1,653,900
1,798,800
1,892,900
1,969,800
2,045,600
2,091,100
2,638,100
2,732,700
2,841,900
2,965,300
3,078,000
3,196,100
3,336,800
3,479,800
3,606,400
3,747,800
3,906,300
4,145,800
4,331,900
1,964,900
2,000,600
2,179,100
2,461,800
2,687,700
2,694,700
2,944,400
3,186,700
3,461,400
3,741,600
4,052,200
3,930,300
4,255,500
4,565,000
4,903,200
5,392,700
5,732,800
6,068,100
6,441,700
6,848,100
7,191,600
7,590,000
7,930,500
8,237,600
8,622,500
8,992,400
9,344,300

9,344,300

8,992,400

8,622,500

8,237,600

7,930,500

7,590,000

7,191,600

6,848,100

6,441,700

6,068,100

5,732,800

5,392,700

4,903,200

4,565,000

4,255,500

3,930,300

4,052,200

3,741,600

3,461,400

3,186,700

2,944,400

2,694,700

2,687,700

2,461,800

2,179,100

2,000,600

1,964,900

4,331,900

4,145,800

3,906,300

3,747,800

3,606,400

3,479,800

3,336,800

3,196,100

3,078,000

2,965,300

2,841,900

2,732,700

2,638,100

2,091,100

2,045,600

1,969,800

1,892,900

1,798,800

1,653,900

1,562,800

1,493,600

1,425,800

1,360,700

1,297,600

1,246,000

1,187,900

1,124,000

1,059,200

1,011,200

953,700

906,000

858,400

784,900

737,400

676,900

639,400

606,500

566,800

548,600

532,800

503,700

468,800

433,900

413,200

385,400

349,000

303,400

264,700

269,100

255,300

224,100

198,200

185,800

160,300

222,400

203,500

179,000

157,900

143,400

121,700

139,100

108,500

88,000

70,600

56,100

111,800

103,000

87,100

83,000

392,000

418,000

Accumulated Other Comprehensive Income

1,612,000
-31,000
-4,000
1,200
1,000
14,400
19,400
-1,800
26,000
30,200
6,800
8,100
-44,700
-51,600
-48,500
-46,200
-32,200
-28,600
-37,300
-33,800
-20,800
-26,300
-33,900
-22,500
-22,200
-20,000
-20,400
-19,200
-15,800
-13,800
-8,900
2,900
7,500
17,200
19,200
5,000
-35,400
-33,800
-23,700
-6,400
-7,900
-24,900
-53,000
-24,200
-42,100
-15,500
-9,500
-23,200
-37,500
-24,600
-51,000
-37,100
-37,900
-52,000
-48,000
-42,900
-27,600
-32,400
-41,100
-70,600
-100,900
-147,900
-146,600
-169,200
-182,600
-172,600
-178,700
-171,200
-198,400
-181,500
-157,800
-142,700
-132,700
-121,300
-150,800
-139,000
-138,500
-141,200
-138,200
-155,800
-156,000
-152,000
-146,100
-157,900
-161,100
-172,400
-159,600
-155,400
-157,700
-186,600
-224,400
-256,000
-254,900
-255,400
-255,500
-250,100
-242,800
-233,300

-233,300

-242,800

-250,100

-255,500

-255,400

-254,900

-256,000

-224,400

-186,600

-157,700

-155,400

-159,600

-172,400

-161,100

-157,900

-146,100

-152,000

-156,000

-155,800

-138,200

-141,200

-138,500

-139,000

-150,800

-121,300

-132,700

-142,700

-157,800

-181,500

-198,400

-171,200

-178,700

-172,600

-182,600

-169,200

-146,600

-147,900

-100,900

-70,600

-41,100

-32,400

-27,600

-42,900

-48,000

-52,000

-37,900

-37,100

-51,000

-24,600

-37,500

-23,200

-9,500

-15,500

-42,100

-24,200

-53,000

-24,900

-7,900

-6,400

-23,700

-33,800

-35,400

5,000

19,200

17,200

7,500

2,900

-8,900

-13,800

-15,800

-19,200

-20,400

-20,000

-22,200

-22,500

-33,900

-26,300

-20,800

-33,800

-37,300

-28,600

-32,200

-46,200

-48,500

-51,600

-44,700

8,100

6,800

30,200

26,000

-1,800

19,400

14,400

1,000

1,200

-4,000

-31,000

1,612,000

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
145,800
184,400
211,300
246,000
291,400
326,500
300,500
363,300
418,000
458,800
489,000
587,200
615,100
618,000
671,200
711,700
747,400
810,000
878,400
925,000
964,100
1,001,300
946,800
933,400
1,020,200
1,091,100
1,167,800
1,207,600
1,267,000
1,129,500
1,166,900
1,229,100
1,209,500
1,341,200
1,384,400
1,449,400
1,512,300
1,570,400
1,623,300
1,675,900
1,323,900
1,381,600
1,438,100
1,496,800
1,578,700
1,643,100
1,700,400
1,769,400
1,852,500
1,914,500
1,969,300
2,049,300
2,145,500
2,211,300
0
0

2,211,300

2,145,500

2,049,300

1,969,300

1,914,500

1,852,500

1,769,400

1,700,400

1,643,100

1,578,700

1,496,800

1,438,100

1,381,600

1,323,900

1,675,900

1,623,300

1,570,400

1,512,300

1,449,400

1,384,400

1,341,200

1,209,500

1,229,100

1,166,900

1,129,500

1,267,000

1,207,600

1,167,800

1,091,100

1,020,200

933,400

946,800

1,001,300

964,100

925,000

878,400

810,000

747,400

711,700

671,200

618,000

615,100

587,200

489,000

458,800

418,000

363,300

300,500

326,500

291,400

246,000

211,300

184,400

145,800

Treasury Stock

-3,177,600

-2,822,500

-2,416,900

-2,320,400

-2,318,600

-2,206,700

-1,904,100

-1,903,900

-1,902,500

-1,893,500

-1,278,700

-1,277,400

-1,021,100

-1,015,400

-743,400

-570,300

-254,200

-252,100

-800

-2,746,200

-2,672,400

-2,499,300

-2,217,900

-2,217,700

-2,181,100

-1,837,000

-1,737,000

-1,736,800

-1,657,900

-1,556,900

-1,556,700

-1,556,600

-1,556,000

-1,256,000

-1,233,200

-1,005,600

-866,700

-749,900

-572,100

-549,000

-495,300

-405,800

-365,800

-261,500

-178,300

-102,000

-101,300

-970,300

-872,300

-856,400

-831,300

-803,600

-776,800

-755,800

-685,100

-570,300

-470,300

-446,600

-399,200

-364,200

-339,400

-320,700

-279,400

-222,900

-193,500

-176,400

-156,000

-152,500

-140,000

-114,400

-107,300

-95,600

-80,900

-68,100

-39,700

-31,500

-29,100

-21,000

-2,500

-1,000

Other Stockholders Equity

-806,000
233,000
270,000
278,600
422,000
437,400
444,700
426,800
456,000
462,300
424,700
421,100
380,500
376,300
366,700
359,300
382,300
375,400
374,000
371,100
360,600
354,500
361,500
351,600
343,200
329,000
291,100
267,200
264,300
262,400
244,800
219,700
210,300
124,700
198,900
156,800
163,600
165,400
166,800
163,100
183,700
145,500
44,500
82,400
109,300
67,700
29,900
-39,300
-105,300
-132,000
-131,000
-113,300
-260,900
-279,500
-390,500
-615,200
-584,800
-844,300
-809,200
-746,700
-678,500
-732,900
-772,700
-735,700
-890,200
-1,247,700
-1,197,500
-1,126,800
-1,331,500
-1,464,800
-1,479,200
1,128,700
914,800
974,900
639,200
597,800
369,000
428,300
234,900
291,700
344,600
-217,600
-578,600
-522,300
-466,000
-709,900
-739,900
-677,300
-716,500
-1,053,100
-1,325,100
-1,363,500
-2,174,700
-2,344,200
-2,255,500
-2,364,800
-2,750,100
-2,644,900

-2,644,900

-2,750,100

-2,364,800

-2,255,500

-2,344,200

-2,174,700

-1,363,500

-1,325,100

-1,053,100

-716,500

-677,300

-739,900

-709,900

-466,000

-522,300

-578,600

-217,600

344,600

291,700

234,900

428,300

369,000

597,800

639,200

974,900

914,800

1,128,700

-1,479,200

-1,464,800

-1,331,500

-1,126,800

-1,197,500

-1,247,700

-890,200

-735,700

-772,700

-732,900

-678,500

-746,700

-809,200

-844,300

-584,800

-615,200

-390,500

-279,500

-260,900

-113,300

-131,000

-132,000

-105,300

-39,300

29,900

67,700

109,300

82,400

44,500

145,500

183,700

163,100

166,800

165,400

163,600

156,800

198,900

124,700

210,300

219,700

244,800

262,400

264,300

267,200

291,100

329,000

343,200

351,600

361,500

354,500

360,600

371,100

374,000

375,400

382,300

359,300

366,700

376,300

380,500

421,100

424,700

462,300

456,000

426,800

444,700

437,400

422,000

278,600

270,000

233,000

-806,000

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31
Accounts Payable	201,400	201,900	204,500	196,500	180,400	134,000	116,600	97,100	63,900	58,200	48,400	74,700	85,000	47,600	51,100	65,600	63,900	57,200	194,200	195,400	167,200	197,900	183,000	158,000	0
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-242,800	-254,900	-157,700	-161,100	-156,000	-138,500	-132,700	-198,400	-182,600	-100,900	-27,600	-37,900	-37,500	-42,100	-7,900	-35,400	7,500	-15,800	-22,200	-20,800	-32,200	-44,700	26,000	1,000	-27,000
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	97,900	95,000	94,600	99,900	84,400	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	650,500	646,300	642,000	636,400	218,100	215,200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	1,969,300	1,700,400	1,438,100	1,623,300	1,384,400	1,166,900	1,167,800	946,800	878,400	671,200	489,000	300,500	211,300	0	0	0	0	0	0	0	0	0	0	0
Cash	1,144,000	769,000	862,800	1,183,200	1,179,100	714,100	818,300	930,100	718,400	653,800	420,400	310,900	171,200	396,100	334,100	218,700	141,800	182,800	178,600	48,900	61,100	34,200	48,000	28,000	0
Cash And Equivalents	0	769,000	862,800	1,183,200	1,179,100	714,100	818,300	930,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	1,644,500	1,215,300	1,466,800	1,402,600	1,516,900	956,500	1,337,500	1,271,100	1,224,700	1,438,800	936,900	521,400	450,500	396,100	334,100	226,800	191,200	182,800	178,600	48,900	61,100	34,200	48,000	28,000	13,000
Common Stock	650,500	646,300	642,000	636,400	218,100	215,200	212,000	242,600	239,100	128,900	126,000	124,200	120,000	117,000	76,100	73,700	68,600	67,000	65,600	64,200	62,600	60,200	59,000	59,000	0
Common Stock Shares Outstanding	609,400	624,200	631,200	631,900	636,600	640,800	647,700	653,400	660,900	651,000	682,800	709,800	716,400	715,200	704,400	715,200	752,400	766,800	747,600	744,000	733,200	735,600	706,800	697,068	697,068
Common Stock Total Equity	0	646,300	642,000	636,400	218,100	215,200	212,000	242,600	239,100	128,900	126,000	124,200	120,000	117,000	76,100	73,700	68,600	67,000	65,600	64,200	62,600	60,200	59,000	59,000	0
Current Deferred Revenue	953,900	484,000	798,400	630,900	690,100	0	633,100	0	0	0	0	0	0	22,300	0	0	0	0	0	0	0	0	-183,000	0	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	203,800	180,500	91,500	70,100	47,300	20,000	44,500	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	1,253,500	1,164,300	1,167,900	1,173,200	1,167,700	1,112,200	1,126,500	626,100	628,300	376,000	385,400	384,700	349,800	315,200	315,200	315,700	350,300	337,700	337,700	337,700	338,200	333,800	402,000	511,000	839,000
Intangible Assets	428,400	285,200	323,600	331,400	336,500	343,200	468,000	204,800	205,400	23,400	57,200	67,000	66,900	67,100	86,700	96,900	122,500	116,100	475,400	490,300	419,200	395,700	402,000	511,000	0
Inventory	1,168,200	875,500	726,700	802,300	640,900	607,000	554,900	396,600	339,900	296,800	308,900	281,000	261,300	203,600	165,900	151,800	152,600	142,100	131,500	127,700	120,500	111,800	87,000	73,000	169,000
Liabilities And Stockholders Equity	9,363,200	8,292,500	8,502,600	7,237,100	6,488,100	5,323,700	5,696,500	4,510,000	4,059,300	3,524,300	2,724,700	2,221,500	1,980,500	1,767,200	1,615,500	1,400,200	1,345,100	1,246,800	1,229,100	1,112,700	1,101,400	1,008,200	973,000	1,088,000	1,437,000
Long Term Debt	597,000	596,300	595,700	595,000	594,400	593,800	438,400	822,300	596,900	598,100	593,100	189,300	150,400	0	90,300	175,500	61,700	235,900	316,100	267,100	255,800	245,500	310,000	367,000	0
Long Term Debt Total	0	596,300	595,700	595,000	594,400	593,800	438,400	822,300	596,900	598,100	593,100	189,300	150,400	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	583,900	1,239,000	1,834,200	801,600	585,500	506,300	567,000	532,100	381,500	246,700	29,200	31,000	46,400	25,000	0	0	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	-449,100	-77,700	-172,500	-488,300	-500,300	-120,300	218,100	-107,800	-118,500	-55,700	172,700	-121,600	-20,800	-354,300	-243,800	-43,200	69,900	53,100	137,500	218,200	194,700	211,300	263,000	400,000	0
Net Invested Capital	7,247,000	6,403,000	6,431,600	5,169,300	4,742,700	3,734,200	3,992,600	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	836,900	699,100	664,900	602,800	599,100	537,300	462,200	414,600	344,100	325,000	328,000	347,500	320,700	302,500	272,100	204,700	145,300	127,100	118,500	119,400	118,500	108,400	101,000	129,000	155,000
Net Tangible Assets	0	4,357,200	4,344,400	3,357,700	2,939,600	1,944,400	1,755,700	1,788,100	1,669,400	1,792,000	1,116,600	1,027,600	921,200	925,900	0	0	0	0	0	0	0	0	0	0	0
Net Working Capital	2,840,300	2,073,400	2,148,400	2,197,100	2,081,600	1,410,300	1,129,200	1,707,500	1,571,700	1,860,200	1,380,200	944,500	833,300	694,800	598,700	433,400	206,300	305,400	320,000	172,100	193,000	128,500	109,000	63,000	200,000
Non Current Assets Total	5,327,500	5,196,700	5,321,900	4,146,100	3,504,100	3,036,800	3,164,400	2,270,000	2,011,400	1,229,700	998,900	929,600	812,000	734,600	726,300	708,300	763,400	715,200	714,900	745,200	741,200	681,800	680,000	806,000	1,081,000
Non Current Liabilities Other	264,300	511,200	588,300	885,900	547,500	453,500	504,300	536,200	480,100	300,400	226,800	205,500	157,000	121,200	0	0	0	0	0	0	0	0	0	0	0
Non Current Liabilities Total	1,448,400	1,463,400	1,634,400	1,768,900	1,437,400	1,306,700	1,302,400	1,358,500	1,080,000	898,500	819,900	394,800	307,400	121,200	167,100	262,900	134,700	271,200	344,900	289,200	299,100	270,900	330,000	429,000	57,000
Non Currrent Assets Other	463,700	299,100	110,800	119,600	101,800	33,600	108,900	123,200	134,800	55,000	42,700	36,200	49,200	13,000	13,000	13,200	14,600	13,900	15,100	10,300	17,400	14,400	-11,000	112,000	15,000
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	783,100	357,500	1,247,000	274,000	207,600	276,000	326,600	312,300	140,700	105,500	73,600	44,600	57,500	50,100	50,900	28,100	28,200	26,900	32,600	76,700	53,200	7,000	14,000	0
Other Current Assets	239,300	195,900	237,100	208,200	168,000	131,800	116,900	111,800	94,100	121,700	71,800	57,000	57,100	43,100	35,100	35,500	37,000	79,600	10,500	8,200	6,400	23,400	20,000	15,000	19,000
Other Current Liab	15,200	311,000	3,900	39,300	6,400	742,600	51,700	435,400	412,300	376,200	297,200	272,700	250,200	226,100	239,400	192,900	161,500	169,000	108,300	133,400	99,900	128,400	183,000	109,000	156,000
Other Liab	0	797,600	969,600	1,101,200	784,100	712,900	851,800	536,200	480,100	296,900	222,900	203,700	157,000	121,200	76,800	87,400	73,000	35,300	28,800	22,100	43,300	25,400	20,000	62,000	0
Other Stockholder Equity	-2,750,100	-2,174,700	-716,500	-466,000	344,600	369,000	914,800	-1,331,500	-890,200	-678,500	-584,800	-260,900	-105,300	109,300	183,700	163,600	210,300	264,300	343,200	360,600	382,300	380,500	456,000	422,000	833,000
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Gross	2,700,800	1,725,100	1,638,700	1,489,400	1,140,400	867,500	679,700	580,000	482,500	442,900	421,600	373,300	304,300	269,800	252,000	230,100	228,200	213,000	201,900	201,700	209,900	209,400	178,000	183,000	226,000
Property Plant And Equipment Net	1,843,400	1,725,100	1,638,700	1,489,400	1,140,400	867,500	679,700	580,000	482,500	442,900	421,600	373,300	304,300	269,800	252,000	230,100	228,200	213,000	201,900	201,700	209,900	209,400	178,000	183,000	226,000
Property Plant Equipment	0	1,725,100	1,638,700	1,395,200	1,060,300	867,500	679,700	580,000	482,500	442,900	421,600	373,300	304,300	269,800	252,000	230,100	228,200	213,000	201,900	201,700	209,900	209,400	178,000	183,000	0
Retained Earnings	8,992,400	7,590,000	6,068,100	4,565,000	3,741,600	2,694,700	2,000,600	3,906,300	3,336,800	2,841,900	2,045,600	1,653,900	1,360,700	1,124,000	906,000	676,900	548,600	433,900	303,400	224,100	222,400	143,400	88,000	103,000	418,000
Retained Earnings Total Equity	0	7,590,000	6,068,100	4,565,000	3,741,600	2,694,700	1,962,100	3,906,300	0	2,841,900	2,045,600	1,653,900	1,360,700	1,124,000	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt	0	0	0	0	0	0	598,000	822,300	596,900	598,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	694,900	691,300	690,300	694,900	678,800	593,800	1,036,400	822,300	599,900	598,100	593,100	189,300	150,400	41,800	90,300	175,500	211,700	235,900	316,100	267,100	255,800	245,500	311,000	428,000	0
Short Term Debt	24,900	25,500	25,500	27,200	25,500	0	598,000	822,300	596,900	598,100	0	0	0	41,800	0	0	150,000	0	0	0	0	0	1,000	61,000	0
Short Term Investments	500,500	446,300	604,000	219,400	337,800	242,400	519,200	341,000	506,300	785,000	516,500	210,500	279,300	0	0	8,100	49,400	0	0	0	0	0	0	0	0
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	9,363,200	8,292,500	8,502,600	7,237,100	6,488,100	5,323,700	5,696,500	4,510,000	4,059,300	3,524,300	2,724,700	2,221,500	1,980,500	1,767,200	1,615,500	1,400,200	1,345,100	1,246,800	1,229,100	1,112,700	1,101,400	1,008,200	973,000	1,088,000	1,437,000
Total Current Assets	4,035,700	3,095,800	3,180,700	3,091,000	2,984,000	2,286,900	2,532,100	2,240,000	2,047,900	2,294,600	1,725,800	1,291,900	1,168,500	1,032,600	889,200	691,900	581,700	531,600	514,200	367,500	360,200	326,400	293,000	282,000	356,000
Total Current Liabilities	1,195,400	1,022,400	1,032,300	893,900	902,400	876,600	1,399,400	532,500	476,200	434,400	345,600	347,400	335,200	337,800	290,500	258,500	375,400	226,200	194,200	195,400	167,200	197,900	184,000	219,000	156,000
Total Liab	2,643,800	2,485,800	2,666,700	2,662,800	2,339,800	2,183,300	2,701,800	1,891,000	1,556,200	1,332,900	1,165,500	742,200	642,600	459,000	457,600	521,400	510,100	497,400	539,100	484,600	466,300	468,800	514,000	648,000	213,000
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	6,650,000	5,806,700	5,835,900	4,574,300	4,148,300	3,140,400	2,994,700	2,619,000	2,503,100	2,191,400	1,559,200	1,479,300	1,337,900	1,308,200	1,157,900	878,800	835,000	749,400	690,000	628,100	635,100	539,400	459,000	440,000	1,224,000
Treasury Stock	0	0	-2,416,900	-1,904,100	-1,278,700	-1,015,400	-252,100	-2,499,300	-1,837,000	-1,556,900	-1,256,000	-749,900	-405,800	-102,000	-872,300	-776,800	-470,300	-339,400	-193,500	-140,000	-80,900	-31,500	-1,000	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31
Accounts Payable	1,086,000	201,400	190,600	193,000	180,800	201,900	154,900	162,500	158,800	204,500	139,500	144,600	150,400	196,500	162,500	153,400	151,500	180,400	135,900	151,000	147,200	134,000	134,000	124,600	121,200	116,600	113,400	104,600	93,000	97,100	87,000	83,400	78,600	63,900	71,500	66,200	68,600	58,200	59,900	540,500	356,200	48,400	335,100	314,200	300,400	74,700	298,600	284,300	265,200	85,000	302,000	313,300	295,700	47,600	281,600	247,700	242,200	51,100	296,300	245,100	200,200	65,600	229,900	226,600	241,600	63,900	198,800	173,600	179,400	57,200	227,500	226,500	197,000	194,200	204,600	190,400	176,400	195,400	170,300	156,000	156,400	167,200	172,000	186,100	189,600	197,900	175,000	185,500	166,300	183,000	157,200	149,900	167,400	158,000	126,800	121,000	122,000	0
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-233,300	-242,800	-250,100	-255,500	-255,400	-254,900	-256,000	-224,400	-186,600	-157,700	-155,400	-159,600	-172,400	-161,100	-157,900	-146,100	-152,000	-156,000	-155,800	-138,200	-141,200	-138,500	-139,000	-150,800	-121,300	-132,700	-142,700	-157,800	-181,500	-198,400	-171,200	-178,700	-172,600	-182,600	-169,200	-146,600	-147,900	-100,900	-70,600	-41,100	-32,400	-27,600	-42,900	-48,000	-52,000	-37,900	-37,100	-51,000	-24,600	-37,500	-23,200	-9,500	-15,500	-42,100	-24,200	-53,000	-24,900	-7,900	-6,400	-23,700	-33,800	-35,400	5,000	19,200	17,200	7,500	2,900	-8,900	-13,800	-15,800	-19,200	-20,400	-20,000	-22,200	-22,500	-33,900	-26,300	-20,800	-33,800	-37,300	-28,600	-32,200	-46,200	-48,500	-51,600	-44,700	8,100	6,800	30,200	26,000	-1,800	19,400	14,400	1,000	1,200	-4,000	-31,000	1,612,000
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	102,000	97,900	94,300	87,800	91,300	95,000	90,600	86,800	92,300	94,600	88,600	88,800	93,600	99,900	95,200	89,800	80,600	84,400	76,500	74,200	72,300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	651,800	650,500	649,900	649,100	647,100	646,300	645,700	645,000	642,900	642,000	641,200	640,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	0	2,211,300	2,145,500	2,049,300	1,969,300	1,914,500	1,852,500	1,769,400	1,700,400	1,643,100	1,578,700	1,496,800	1,438,100	1,381,600	1,323,900	1,675,900	1,623,300	1,570,400	1,512,300	1,449,400	1,384,400	1,341,200	1,209,500	1,229,100	1,166,900	1,129,500	1,267,000	1,207,600	1,167,800	1,091,100	1,020,200	933,400	946,800	1,001,300	964,100	925,000	878,400	810,000	747,400	711,700	671,200	618,000	615,100	587,200	489,000	458,800	418,000	363,300	300,500	326,500	291,400	246,000	211,300	184,400	145,800	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash	1,224,600	1,144,000	1,410,100	1,042,600	872,500	769,000	1,247,800	1,198,100	1,030,900	862,800	1,506,900	1,312,800	1,174,200	1,183,200	1,024,000	903,500	662,900	1,179,100	1,186,600	726,800	709,200	714,100	1,261,300	1,226,400	1,227,000	818,300	630,300	508,200	819,300	930,100	645,000	369,900	501,400	718,400	646,100	597,600	457,000	653,800	404,100	498,600	295,700	420,400	471,000	372,700	401,500	310,900	305,800	304,300	213,300	171,200	451,100	468,200	433,800	396,100	361,000	320,300	321,200	334,100	287,600	183,100	146,700	218,700	202,400	188,200	162,900	141,800	175,700	164,900	180,200	182,800	151,300	167,100	189,000	178,600	88,000	96,100	72,600	48,900	31,000	40,000	37,900	61,100	38,300	50,700	29,800	34,200	39,000	35,500	28,000	48,000	23,500	61,600	17,900	28,000	13,200	2,000	6,000	0
Cash And Equivalents	0	0	1,410,100	1,042,600	872,500	769,000	1,247,800	1,198,100	1,030,900	862,800	1,506,900	1,312,800	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	1,697,600	1,644,500	1,863,900	1,509,300	1,254,200	1,215,300	1,738,700	1,515,800	1,495,900	1,466,800	1,794,700	1,561,200	1,330,600	1,402,600	1,295,300	1,163,800	1,031,100	1,516,900	1,356,900	934,300	963,000	956,500	1,595,700	1,400,800	1,499,300	1,337,500	1,402,800	1,131,800	918,200	1,271,100	1,200,300	1,060,200	951,800	1,224,700	1,250,500	1,409,000	1,370,800	1,438,800	1,515,100	1,484,100	831,600	936,900	757,600	575,000	557,900	521,400	622,500	506,000	409,500	450,500	451,100	468,200	433,800	396,100	361,000	320,300	321,200	334,100	289,500	188,300	150,400	226,800	214,500	208,100	189,600	191,200	175,700	164,900	180,200	182,800	151,300	167,100	189,000	178,600	88,000	96,100	72,600	48,900	31,000	40,000	37,900	61,100	38,300	50,700	29,800	34,200	39,000	35,500	28,000	48,000	23,500	61,600	17,900	28,000	13,200	2,000	6,000	0
Common Stock	651,800	650,500	649,900	649,100	647,100	646,300	645,700	645,000	642,900	642,000	641,200	640,100	637,500	636,400	635,000	633,500	218,500	218,100	217,500	216,900	216,000	215,200	214,800	214,000	213,000	212,000	211,600	244,700	243,200	242,600	242,000	241,000	239,800	239,100	130,200	129,900	129,400	128,900	128,000	127,100	126,400	126,000	125,700	125,400	124,700	124,200	123,900	123,000	121,100	120,000	119,500	118,800	117,700	117,000	116,100	115,100	77,200	76,100	75,400	75,100	74,300	73,700	73,300	72,700	68,900	68,600	68,400	67,900	67,600	67,000	66,700	66,300	66,000	65,600	65,400	65,000	64,600	64,200	63,800	63,700	63,100	62,600	62,100	61,800	60,400	60,200	60,000	59,800	59,500	59,000	59,200	58,900	58,800	59,000	58,700	58,000	58,000	0
Common Stock Shares Outstanding	604,100	606,900	609,500	610,300	610,900	616,200	624,500	626,700	629,400	632,000	631,700	629,900	631,300	632,000	631,000	620,300	635,100	637,800	636,300	636,200	636,600	636,600	639,600	642,000	645,300	646,200	648,600	647,100	649,200	653,700	654,300	651,900	653,400	661,800	660,000	660,000	661,800	658,200	650,400	644,400	651,000	666,000	677,400	688,200	699,000	706,800	714,000	710,400	708,000	708,600	714,000	720,000	723,000	681,600	713,400	712,800	714,000	676,800	704,400	702,000	702,000	672,000	708,000	722,400	702,000	685,200	748,800	756,000	762,000	698,400	763,200	770,400	775,200	717,600	717,600	748,800	778,800	716,400	745,200	777,600	715,200	709,200	733,200	736,800	730,800	704,400	704,400	738,000	741,600	708,000	736,800	705,600	723,600	700,800	728,400	698,400	697,068	231,500
Common Stock Total Equity	0	0	0	649,100	647,100	646,300	645,700	645,000	642,900	642,000	641,200	640,100	637,500	636,400	635,000	633,500	218,500	218,100	217,500	216,900	216,000	215,200	214,800	214,000	213,000	212,000	211,600	244,700	243,200	242,600	242,000	241,000	239,800	239,100	130,200	129,900	129,400	128,900	128,000	127,100	126,400	126,000	125,700	125,400	124,700	124,200	123,900	123,000	121,100	120,000	119,500	118,800	117,700	117,000	116,100	115,100	77,200	76,100	75,400	75,100	74,300	73,700	73,300	72,700	68,900	68,600	68,400	67,900	67,600	67,000	66,700	66,300	66,000	65,600	65,400	65,000	64,600	64,200	63,800	63,700	63,100	62,600	62,100	61,800	60,400	60,200	60,000	59,800	59,500	59,000	59,200	58,900	58,800	59,000	58,700	58,000	58,000	0
Current Deferred Revenue	-1,086,000	953,900	-190,600	-193,000	0	484,000	347,500	307,600	0	246,700	799,300	708,600	606,000	230,900	638,200	689,300	563,900	172,200	611,300	517,600	472,700	174,000	523,900	454,100	552,900	213,600	0	0	0	203,800	0	0	0	180,500	0	0	0	0	352,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22,300	0	0	0	0	0	0	0	0	0	0	-241,600	0	-198,800	-173,600	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-185,500	-166,300	-183,000	-157,200	-149,900	-167,400	0	0	0	0	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	179,100	203,800	189,300	188,600	196,500	180,500	21,400	82,000	84,900	91,500	68,700	69,900	76,400	70,100	41,500	43,500	45,900	47,300	10,900	10,200	24,000	20,000	48,600	45,100	41,000	44,500	51,400	50,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	1,252,800	1,253,500	1,297,400	1,299,500	1,308,400	1,164,300	1,158,700	1,164,100	1,166,300	1,167,900	1,170,400	1,171,800	1,170,800	1,173,200	1,170,000	1,167,700	1,166,200	1,167,700	1,156,600	1,173,900	1,103,400	1,112,200	1,122,300	1,118,600	1,144,800	1,126,500	980,500	965,100	945,200	626,100	630,000	629,400	630,900	628,300	621,200	370,900	368,400	376,000	379,000	384,300	385,400	385,400	383,800	381,500	380,200	384,700	349,800	349,800	349,800	349,800	349,800	349,900	349,900	315,200	315,200	315,200	315,200	315,200	315,200	315,700	315,700	315,700	315,700	315,700	315,700	350,300	337,700	337,700	337,700	337,700	337,700	337,700	338,000	337,700	337,700	337,700	337,700	337,700	337,700	337,700	337,700	338,200	338,200	338,200	333,800	333,800	333,800	333,800	333,800	402,000	403,000	408,000	503,700	511,000	520,200	528,000	829,000	839,000
Intangible Assets	446,800	428,400	429,800	431,400	446,800	285,200	266,500	320,700	322,000	323,600	325,300	327,000	330,300	331,400	332,400	333,500	334,800	336,500	381,100	385,600	341,300	343,200	467,900	466,000	480,500	468,000	414,900	408,600	402,100	204,800	207,000	208,700	203,700	205,400	207,300	18,900	20,500	23,400	25,800	29,500	31,600	57,200	63,100	64,600	65,500	67,000	59,600	61,700	65,100	66,900	70,200	72,900	76,300	67,100	71,700	74,300	83,600	86,700	91,000	91,300	92,600	96,900	107,900	109,600	111,900	122,500	107,000	107,500	108,900	116,100	123,200	127,500	133,000	475,400	479,500	483,600	480,800	490,300	487,800	488,600	491,200	419,200	418,900	418,700	403,300	395,700	396,300	63,200	67,600	402,000	0	0	511,000	511,000	520,200	528,000	829,000	0
Inventory	1,207,300	1,168,200	1,032,400	980,200	914,300	875,500	757,800	740,000	730,600	726,700	737,800	759,500	767,900	802,300	773,300	735,100	662,200	640,900	611,100	624,900	630,900	607,000	583,800	568,100	573,900	554,900	538,400	491,600	431,400	396,600	401,000	367,600	356,600	339,900	333,500	313,300	298,500	296,800	303,600	317,100	308,000	308,900	313,900	299,500	288,500	281,000	286,000	265,400	268,300	261,300	247,900	229,400	217,700	203,600	212,200	182,300	174,600	165,900	168,700	160,900	146,100	151,800	143,800	136,800	139,500	152,600	158,300	143,500	141,500	142,100	148,900	139,000	135,000	131,500	135,500	131,300	126,100	127,700	120,500	119,500	114,500	120,500	125,300	125,600	116,300	111,800	84,400	89,400	86,100	87,000	80,700	77,200	88,400	73,000	78,400	95,000	156,000	169,000
Liabilities And Stockholders Equity	9,736,300	9,363,200	9,370,800	9,004,000	8,651,200	8,292,500	8,638,200	8,425,100	8,419,900	8,502,600	8,160,300	7,662,100	7,213,700	7,237,100	6,800,800	6,424,100	6,076,100	6,488,100	5,966,300	5,573,500	5,469,300	5,323,700	5,958,200	5,686,100	5,825,100	5,696,500	5,488,400	5,138,500	4,780,400	4,510,000	4,339,000	4,051,400	3,853,800	4,059,300	3,876,600	3,608,300	3,488,400	3,524,300	3,350,000	3,326,600	2,651,700	2,724,700	2,530,600	2,339,700	2,296,600	2,221,500	2,195,800	2,075,100	2,004,200	1,980,500	1,982,900	2,002,400	1,931,100	1,767,200	1,725,400	1,641,900	1,604,400	1,615,500	1,588,000	1,465,100	1,358,900	1,400,200	1,381,200	1,348,300	1,310,300	1,345,100	1,299,700	1,251,800	1,249,200	1,246,800	1,240,300	1,259,200	1,240,000	1,229,100	1,145,000	1,150,800	1,123,100	1,112,700	1,071,900	1,089,600	1,103,800	1,101,400	1,070,800	1,079,700	1,035,900	1,008,200	918,400	983,300	965,400	973,000	959,600	1,007,200	1,102,900	1,088,000	1,105,800	1,123,000	1,381,000	1,437,000
Long Term Debt	597,200	597,000	596,800	596,700	596,500	596,300	596,200	596,000	595,900	595,700	595,500	595,400	595,200	595,000	594,900	594,700	594,600	594,400	594,200	594,100	593,900	593,800	593,600	593,900	456,000	438,400	1,034,000	1,016,800	847,900	822,300	600,600	602,500	602,200	599,900	604,900	600,300	602,700	598,100	596,400	598,000	725,400	593,100	532,100	227,300	192,700	189,300	175,400	185,100	179,400	150,400	175,000	174,800	0	0	0	177,500	129,300	90,300	102,300	113,900	123,000	175,500	202,800	141,700	62,900	61,700	61,200	57,600	224,500	235,900	253,000	279,600	288,800	316,100	251,500	269,600	275,800	267,100	269,200	312,800	334,500	255,800	293,100	307,300	276,900	245,500	279,900	296,900	290,800	310,000	339,100	339,000	352,900	367,000	348,200	321,000	319,000	0
Long Term Debt Total	0	0	596,800	596,700	596,500	596,300	596,200	596,000	595,900	595,700	595,500	595,400	595,200	595,000	594,900	594,700	594,600	594,400	594,200	594,100	593,900	593,800	593,600	593,900	456,000	438,400	1,034,000	1,016,800	847,900	822,300	600,600	602,500	602,200	599,900	604,900	600,300	602,700	598,100	596,400	598,000	725,400	593,100	532,100	227,300	192,700	189,300	175,400	185,100	179,400	150,400	175,000	174,800	0	0	0	177,500	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	455,600	583,900	704,600	856,200	1,066,700	1,239,000	1,381,000	1,490,800	1,623,700	1,834,200	1,282,000	1,014,200	802,200	801,600	599,000	594,400	587,800	585,500	386,000	412,900	453,700	506,300	479,000	470,400	532,100	567,000	567,500	551,500	519,000	532,100	472,800	397,000	375,000	381,500	371,500	331,200	261,300	246,700	100,100	106,600	101,100	29,200	31,800	34,900	33,300	31,000	33,100	33,000	43,300	46,400	21,400	24,800	27,300	25,000	22,300	21,900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	-525,400	-449,100	-719,000	-358,100	-184,700	-77,700	-561,000	-515,300	-342,700	-172,500	-822,800	-628,600	-485,400	-488,300	-333,900	-219,000	12,300	-500,300	-515,900	-58,500	-43,000	-120,300	-67,800	-33,300	-172,400	218,100	403,700	508,600	28,600	-107,800	-44,400	232,600	100,800	-118,500	-41,200	2,700	145,700	-55,700	192,300	99,400	429,700	172,700	61,100	-145,400	-208,800	-121,600	-130,400	-119,200	-33,900	-20,800	-276,100	-293,400	-284,300	-354,300	-260,400	-142,800	-191,900	-243,800	-185,300	-69,200	-23,700	-43,200	400	-46,500	50,000	69,900	35,500	42,700	44,300	53,100	101,700	112,500	100,000	137,500	163,500	173,500	203,200	218,200	238,200	272,800	296,600	194,700	254,800	256,600	247,100	211,300	240,900	262,000	264,300	263,000	315,800	326,600	396,500	400,000	485,600	529,000	523,000	0
Net Invested Capital	7,715,100	7,247,000	7,254,300	6,972,400	6,574,500	6,403,000	6,814,000	6,539,600	6,440,800	6,431,600	6,136,800	5,728,700	5,253,600	5,169,300	4,805,200	4,433,800	4,495,700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	876,900	836,900	802,100	816,900	779,300	699,100	661,400	679,200	686,200	664,900	664,200	700,300	664,300	602,800	671,700	567,900	585,100	599,100	570,000	609,600	578,000	537,300	530,100	520,100	446,800	462,200	475,000	510,700	510,200	414,600	454,200	425,800	388,500	344,100	338,400	351,000	345,300	325,000	322,900	327,500	305,100	328,000	327,800	341,800	329,700	347,500	325,400	336,400	346,700	320,700	346,800	364,100	354,200	302,500	303,400	294,000	278,600	272,100	280,500	274,500	255,800	204,700	213,600	173,300	155,300	145,300	136,700	137,400	129,300	127,100	130,200	133,700	123,000	118,500	125,900	124,900	127,700	119,400	113,200	110,100	113,500	118,500	115,600	124,400	124,900	108,400	113,200	114,400	109,300	101,000	119,000	116,400	136,200	129,000	154,300	162,000	132,000	0
Net Tangible Assets	0	0	4,930,300	4,644,800	4,222,800	4,357,200	4,792,600	4,458,800	4,356,600	4,344,400	4,045,600	3,634,500	3,439,700	3,357,700	2,993,100	2,618,100	2,695,100	2,939,600	2,566,000	2,227,900	2,311,900	1,944,400	2,035,600	1,842,900	1,911,200	1,755,700	1,767,100	1,565,900	1,395,400	1,788,100	1,854,800	1,633,100	1,464,700	1,669,400	1,592,900	1,898,800	1,825,000	1,792,000	1,638,600	1,501,100	923,800	1,116,600	990,500	1,133,700	1,146,300	1,027,600	1,126,900	1,023,100	975,400	921,200	934,600	962,400	931,600	925,900	846,600	728,300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Working Capital	3,059,700	2,840,300	2,828,600	2,489,800	2,175,200	2,073,400	2,596,000	2,294,000	2,291,400	2,148,400	2,549,000	2,436,700	2,270,200	2,197,100	2,134,100	1,817,100	1,761,000	2,081,600	1,963,900	1,657,700	1,722,300	1,410,300	1,651,500	1,512,800	1,402,400	1,132,700	1,831,200	1,720,900	1,433,600	1,707,500	1,638,600	1,506,900	1,361,000	1,571,700	1,613,000	1,851,800	1,849,500	1,860,200	1,881,400	1,737,600	1,247,100	1,380,200	1,235,300	1,076,400	1,060,300	944,500	1,089,100	994,500	922,800	833,300	879,900	903,500	705,100	694,800	710,800	671,200	630,500	598,700	580,900	500,500	448,800	433,400	446,400	408,500	200,000	206,300	216,000	217,600	362,700	305,400	297,400	315,800	329,000	320,000	225,800	246,700	224,200	172,100	155,900	177,300	170,300	193,000	196,300	202,100	161,500	128,500	122,300	125,600	119,200	109,000	117,500	117,100	77,500	63,000	-200	-36,000	-14,000	200,000
Non Current Assets Total	5,565,800	5,327,500	5,303,300	5,357,000	5,394,000	5,196,700	5,124,300	5,162,000	5,178,600	5,321,900	4,644,800	4,339,200	4,144,500	4,146,100	3,820,400	3,733,800	3,568,200	3,504,100	3,226,600	3,218,800	3,100,500	3,036,800	3,045,600	2,990,100	3,108,200	3,164,400	2,922,000	2,855,100	2,762,000	2,270,000	2,167,600	2,066,300	2,034,500	2,011,400	1,731,100	1,311,300	1,233,600	1,229,700	1,040,800	1,048,500	1,048,400	998,900	960,200	949,100	935,900	929,600	808,100	796,300	816,200	812,000	801,000	785,600	780,800	734,600	733,000	723,000	731,700	726,300	725,000	719,500	709,900	708,300	704,900	713,200	718,700	763,400	734,900	710,600	707,100	715,200	715,400	716,900	714,000	714,900	714,600	713,700	722,500	745,200	745,700	756,300	777,100	741,200	702,500	691,500	684,800	681,800	621,100	671,600	678,400	680,000	684,700	691,000	796,500	806,000	828,600	828,000	1,063,000	1,081,000
Non Current Liabilities Other	266,500	264,300	240,300	242,700	910,700	511,200	906,300	916,400	589,500	588,300	601,000	581,600	878,700	885,900	864,100	836,900	538,500	547,500	492,600	495,000	472,300	453,500	477,700	481,500	518,100	504,300	556,700	619,600	605,000	536,200	513,800	499,500	494,000	480,100	317,800	274,200	266,500	300,400	282,400	273,200	229,300	226,800	226,000	218,400	211,500	205,500	185,500	171,100	169,300	157,000	151,300	129,100	128,100	121,200	109,700	98,900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Current Liabilities Total	1,439,100	1,448,400	1,404,800	1,400,300	1,507,200	1,463,400	1,502,500	1,512,400	1,625,100	1,634,400	1,652,500	1,642,600	1,756,300	1,768,900	1,744,200	1,711,800	1,428,100	1,437,400	1,375,700	1,376,200	1,375,300	1,306,700	1,335,800	1,338,700	1,264,900	1,302,400	1,590,700	1,636,400	1,452,900	1,358,500	1,114,400	1,102,000	1,096,200	1,080,000	922,700	874,500	869,200	898,500	878,800	871,200	954,700	819,900	758,100	445,700	404,200	394,800	360,900	356,200	348,700	307,400	326,300	303,900	128,100	121,200	210,300	276,400	210,700	167,100	215,400	216,900	215,400	262,900	276,800	224,400	141,100	134,700	127,100	120,700	284,800	271,200	284,900	310,300	319,000	344,900	281,200	298,700	298,600	289,200	302,300	347,400	377,200	299,100	320,100	334,600	303,300	270,900	284,600	317,600	311,300	330,000	389,600	392,400	410,000	429,000	404,000	381,000	366,000	57,000
Non Currrent Assets Other	767,600	463,700	447,400	412,100	293,600	299,100	316,500	234,700	129,400	110,800	133,700	105,300	125,500	119,600	138,000	153,800	145,300	101,800	100,200	80,300	75,500	33,600	35,200	34,800	57,800	108,900	112,400	116,800	127,800	123,200	130,100	131,700	136,900	134,800	60,400	64,300	59,100	55,000	46,000	43,300	41,100	42,700	42,100	38,400	36,400	36,200	35,700	36,700	47,200	49,200	24,600	11,900	12,000	13,000	12,100	11,800	11,800	13,000	13,700	16,700	18,300	13,200	17,600	19,100	19,800	14,600	17,500	15,400	15,500	13,900	13,500	13,000	16,000	15,100	9,100	9,900	10,500	10,300	16,000	16,300	15,100	17,400	14,200	14,100	14,200	14,400	1,000	-19,200	-11,900	-11,000	-10,400	-7,700	-11,800	112,000	131,300	122,000	29,000	15,000
Noncontrolling Interest In Consolidated Entity	0	0	0	70,800	84,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	0	1,099,300	1,022,800	837,600	783,100	664,000	542,300	424,300	357,500	317,700	295,800	334,800	1,247,000	353,200	357,900	303,300	274,000	256,000	244,100	240,000	207,600	150,300	164,900	2,396,600	2,484,000	2,272,400	2,227,200	2,173,200	1,690,000	1,623,900	1,550,100	1,537,200	1,528,900	1,276,300	860,700	788,500	786,800	611,500	626,000	629,700	577,300	551,200	549,900	550,500	556,300	479,400	480,500	508,000	507,700	514,600	504,600	506,500	464,800	472,700	473,200	484,500	474,300	484,200	480,400	480,100	478,200	480,900	488,600	495,100	535,200	506,900	490,400	490,400	502,200	503,900	511,200	514,200	513,000	522,500	520,700	527,100	543,500	556,200	562,800	573,400	531,300	496,600	485,700	479,700	472,400	441,000	493,600	501,000	502,000	508,000	517,500	611,100	623,000	651,500	650,000	858,000	0
Other Current Assets	388,700	239,300	235,800	217,400	190,300	195,900	267,600	248,800	234,500	237,100	241,900	233,300	229,100	208,200	171,500	166,200	163,700	168,000	144,400	130,200	141,500	131,800	150,400	137,100	118,900	116,900	97,400	95,200	105,600	111,800	66,100	81,500	73,600	94,100	96,600	112,400	138,400	121,700	89,600	60,300	77,200	71,800	83,200	97,700	106,500	57,000	69,300	95,500	90,200	57,100	67,800	53,300	45,900	43,100	26,600	35,500	22,300	35,100	38,900	38,800	25,900	35,500	38,600	44,600	41,600	37,000	94,100	95,400	91,100	79,600	94,500	102,500	79,000	10,500	81,000	84,800	74,200	8,200	61,500	63,700	60,800	6,400	89,100	87,500	80,100	23,400	60,700	72,400	63,600	20,000	51,700	61,000	63,900	15,000	31,300	36,000	24,000	187,000
Other Current Liab	1,086,000	15,200	1,214,600	1,132,900	876,100	311,000	392,000	475,700	767,200	555,600	3,500	7,900	16,100	439,300	21,400	6,700	6,600	524,300	4,500	4,600	4,000	4,400	3,300	5,300	41,800	471,200	621,800	457,900	491,800	3,300	445,800	394,800	379,700	4,200	461,000	379,000	336,700	376,200	2,200	540,500	356,200	297,200	335,100	314,200	300,400	272,700	298,600	284,300	265,200	250,200	302,000	313,300	295,700	226,100	181,000	247,700	242,200	239,400	282,100	245,100	200,200	192,900	0	0	241,600	161,500	198,800	173,600	0	169,000	0	0	0	108,300	0	0	0	133,400	0	0	0	99,900	0	0	0	128,400	0	185,500	166,300	183,000	157,200	149,900	167,400	109,000	0	0	0	156,000
Other Liab	0	0	738,000	0	844,500	797,600	839,200	852,900	960,800	969,600	992,600	983,500	1,094,000	1,101,200	1,078,300	1,051,100	777,800	784,100	729,100	731,700	731,700	712,900	742,200	744,800	808,900	870,700	556,700	619,600	605,000	527,300	513,800	499,500	494,000	470,300	317,800	274,200	266,500	296,900	282,400	273,200	229,300	222,900	226,000	218,400	211,500	203,700	185,500	171,100	169,300	157,000	151,300	129,100	128,100	121,200	109,700	98,900	81,400	76,800	113,100	103,000	92,400	87,400	74,000	82,700	78,200	73,000	65,900	63,100	60,300	35,300	31,900	30,700	30,700	28,800	29,700	29,100	22,800	22,100	33,100	34,600	42,700	43,300	27,000	27,300	26,400	25,400	4,700	20,700	20,500	20,000	50,500	53,400	57,100	62,000	55,800	60,000	47,000	0
Other Stockholder Equity	-2,644,900	-2,750,100	-2,364,800	-2,255,500	-2,344,200	-2,174,700	-1,363,500	-1,325,100	-1,053,100	-716,500	-677,300	-739,900	-709,900	-466,000	-522,300	-578,600	-217,600	344,600	291,700	234,900	428,300	369,000	597,800	639,200	974,900	914,800	1,128,700	-1,479,200	-1,464,800	-1,331,500	-1,126,800	-1,197,500	-1,247,700	-890,200	-735,700	-772,700	-732,900	-678,500	-746,700	-809,200	-844,300	-584,800	-615,200	-390,500	-279,500	-260,900	-113,300	-131,000	-132,000	-105,300	-39,300	29,900	67,700	109,300	82,400	44,500	145,500	183,700	163,100	166,800	165,400	163,600	156,800	198,900	124,700	210,300	219,700	244,800	262,400	264,300	267,200	291,100	329,000	343,200	351,600	361,500	354,500	360,600	371,100	374,000	375,400	382,300	359,300	366,700	376,300	380,500	421,100	424,700	462,300	456,000	426,800	444,700	437,400	422,000	278,600	270,000	233,000	-806,000
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Gross	1,866,300	2,700,800	1,772,200	1,747,100	1,734,500	1,725,100	1,654,100	0	0	0	0	1,530,400	1,506,400	1,489,400	1,365,800	1,280,300	1,176,100	1,140,400	1,046,900	1,002,300	962,100	867,500	826,100	770,200	711,600	679,700	649,600	627,900	588,800	580,000	543,700	516,200	497,300	482,500	454,800	450,600	445,100	442,900	429,300	422,500	418,700	421,600	409,000	399,200	385,400	373,300	328,700	315,800	308,200	304,300	286,400	281,000	274,300	269,800	260,300	249,800	247,200	252,000	240,700	239,100	229,800	230,100	224,000	224,600	223,600	228,200	228,000	220,200	216,700	213,000	211,500	205,700	199,000	201,900	192,100	193,000	195,400	201,700	189,500	193,500	203,700	209,900	205,900	205,800	205,100	209,400	180,100	178,000	177,400	178,000	176,700	173,500	185,400	183,000	177,100	178,000	205,000	226,000
Property Plant And Equipment Net	1,866,300	1,843,400	1,772,200	1,747,100	1,734,500	1,725,100	1,654,100	1,644,100	1,642,300	1,638,700	1,549,400	1,530,400	1,506,400	1,489,400	1,365,800	1,280,300	1,176,100	1,140,400	1,046,900	1,002,300	962,100	867,500	826,100	770,200	711,600	679,700	649,600	627,900	588,800	580,000	543,700	516,200	497,300	482,500	454,800	450,600	445,100	442,900	429,300	422,500	418,700	421,600	409,000	399,200	385,400	373,300	328,700	315,800	308,200	304,300	286,400	281,000	274,300	269,800	260,300	249,800	247,200	252,000	240,700	239,100	229,800	230,100	224,000	224,600	223,600	228,200	228,000	220,200	216,700	213,000	211,500	205,700	199,000	201,900	192,100	193,000	195,400	201,700	189,500	193,500	203,700	209,900	205,900	205,800	205,100	209,400	180,100	178,000	177,400	178,000	176,700	173,500	185,400	183,000	177,100	178,000	205,000	226,000
Property Plant Equipment	0	0	1,772,200	1,747,100	1,646,000	1,725,100	1,654,100	1,644,100	1,552,200	1,638,700	1,549,400	1,530,400	1,417,900	1,395,200	1,276,300	1,195,600	1,100,600	1,060,300	973,600	931,100	892,200	867,500	826,100	770,200	711,600	679,700	649,600	627,900	588,800	580,000	543,700	516,200	497,300	482,500	454,800	450,600	445,100	442,900	429,300	422,500	418,700	421,600	409,000	399,200	385,400	373,300	328,700	315,800	308,200	304,300	286,400	281,000	274,300	269,800	260,300	249,800	247,200	252,000	240,700	239,100	229,800	230,100	224,000	224,600	223,600	228,200	228,000	220,200	216,700	213,000	211,500	205,700	199,200	201,900	192,100	193,000	195,400	201,700	189,500	193,500	203,700	209,900	205,900	205,800	205,100	209,400	180,100	178,000	177,400	178,000	176,700	173,500	185,400	183,000	177,100	178,000	205,000	0
Retained Earnings	9,344,300	8,992,400	8,622,500	8,237,600	7,930,500	7,590,000	7,191,600	6,848,100	6,441,700	6,068,100	5,732,800	5,392,700	4,903,200	4,565,000	4,255,500	3,930,300	4,052,200	3,741,600	3,461,400	3,186,700	2,944,400	2,694,700	2,687,700	2,461,800	2,179,100	2,000,600	1,964,900	4,331,900	4,145,800	3,906,300	3,747,800	3,606,400	3,479,800	3,336,800	3,196,100	3,078,000	2,965,300	2,841,900	2,732,700	2,638,100	2,091,100	2,045,600	1,969,800	1,892,900	1,798,800	1,653,900	1,562,800	1,493,600	1,425,800	1,360,700	1,297,600	1,246,000	1,187,900	1,124,000	1,059,200	1,011,200	953,700	906,000	858,400	784,900	737,400	676,900	639,400	606,500	566,800	548,600	532,800	503,700	468,800	433,900	413,200	385,400	349,000	303,400	264,700	269,100	255,300	224,100	198,200	185,800	160,300	222,400	203,500	179,000	157,900	143,400	121,700	139,100	108,500	88,000	70,600	56,100	111,800	103,000	87,100	83,000	392,000	418,000
Retained Earnings Total Equity	0	0	0	8,237,600	7,930,500	7,590,000	7,191,600	6,848,100	6,441,700	6,068,100	5,732,800	5,392,700	4,903,200	4,565,000	4,255,500	3,930,300	4,052,200	3,741,600	3,461,400	3,186,700	2,944,400	2,694,700	2,687,700	2,461,800	2,179,100	1,962,100	1,964,900	4,331,900	4,145,800	3,906,300	3,747,800	3,606,400	3,479,800	3,336,800	3,196,100	3,078,000	2,965,300	2,841,900	2,732,700	2,638,100	2,091,100	2,045,600	1,969,800	1,892,900	1,798,800	1,653,900	1,562,800	1,493,600	1,425,800	1,360,700	1,297,600	1,246,000	1,187,900	1,124,000	1,059,200	1,011,200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23,800	22,600	0	0	1,193,100	1,054,600	1,036,400	1,034,000	1,016,800	847,900	822,300	0	0	0	596,900	0	0	0	598,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	699,200	694,900	691,100	684,500	687,800	691,300	686,800	682,800	688,200	690,300	684,100	684,200	688,800	694,900	690,100	684,500	675,200	678,800	670,700	668,300	666,200	593,800	1,193,500	1,193,100	1,054,600	1,036,400	1,034,000	1,016,800	847,900	822,300	600,600	602,500	602,200	599,900	604,900	600,300	602,700	598,100	596,400	598,000	725,400	593,100	532,100	227,300	192,700	189,300	175,400	185,100	179,400	150,400	175,000	174,800	149,500	41,800	100,600	177,500	129,300	90,300	102,300	113,900	123,000	175,500	202,800	141,700	212,900	211,700	211,200	207,600	224,500	235,900	253,000	279,600	289,000	316,100	251,500	269,600	275,800	267,100	269,200	312,800	334,500	255,800	293,100	307,300	276,900	245,500	279,900	297,500	292,300	311,000	339,300	388,200	414,400	428,000	498,800	531,000	529,000	0
Short Term Debt	24,800	24,900	24,300	24,300	25,100	25,500	23,500	23,300	23,900	25,500	24,200	25,100	26,500	27,200	24,200	23,800	24,900	25,500	24,100	23,800	22,600	564,200	599,900	599,200	598,600	598,000	1,034,000	1,016,800	847,900	228,300	0	0	0	227,600	0	0	0	598,100	13,600	0	0	0	0	0	0	0	0	0	0	0	0	0	149,500	41,800	100,600	0	0	0	0	0	0	0	0	0	150,000	150,000	150,000	150,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	600	1,500	1,000	200	49,200	61,500	61,000	150,600	210,000	210,000	0
Short Term Investments	473,000	500,500	453,800	466,700	381,700	446,300	490,900	317,700	465,000	604,000	287,800	248,400	156,400	219,400	271,300	260,300	368,200	337,800	170,300	207,500	253,800	242,400	334,400	174,400	272,300	519,200	772,500	623,600	98,900	341,000	555,300	690,300	450,400	506,300	604,400	811,400	913,800	785,000	1,111,000	985,500	535,900	516,500	286,600	202,300	156,400	210,500	316,700	201,700	196,200	279,300	0	0	0	0	0	0	0	0	1,900	5,200	3,700	8,100	12,100	19,900	26,700	49,400	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	9,736,300	9,363,200	9,370,800	9,004,000	8,651,200	8,292,500	8,638,200	8,425,100	8,419,900	8,502,600	8,160,300	7,662,100	7,213,700	7,237,100	6,800,800	6,424,100	6,076,100	6,488,100	5,966,300	5,573,500	5,469,300	5,323,700	5,958,200	5,686,100	5,825,100	5,696,500	5,488,400	5,138,500	4,780,400	4,510,000	4,339,000	4,051,400	3,853,800	4,059,300	3,876,600	3,608,300	3,488,400	3,524,300	3,350,000	3,326,600	2,651,700	2,724,700	2,530,600	2,339,700	2,296,600	2,221,500	2,195,800	2,075,100	2,004,200	1,980,500	1,982,900	2,002,400	1,931,100	1,767,200	1,725,400	1,641,900	1,604,400	1,615,500	1,588,000	1,465,100	1,358,900	1,400,200	1,381,200	1,348,300	1,310,300	1,345,100	1,299,700	1,251,800	1,249,200	1,246,800	1,240,300	1,259,200	1,240,000	1,229,100	1,145,000	1,150,800	1,123,100	1,112,700	1,071,900	1,089,600	1,103,800	1,101,400	1,070,800	1,079,700	1,035,900	1,008,200	918,400	983,300	965,400	973,000	959,600	1,007,200	1,102,900	1,088,000	1,105,800	1,123,000	1,381,000	1,437,000
Total Current Assets	4,170,500	4,035,700	4,067,500	3,647,000	3,257,200	3,095,800	3,513,900	3,263,100	3,241,300	3,180,700	3,515,500	3,322,900	3,069,200	3,091,000	2,980,400	2,690,300	2,507,900	2,984,000	2,739,700	2,354,700	2,368,800	2,286,900	2,912,600	2,696,000	2,716,900	2,532,100	2,566,400	2,283,400	2,018,400	2,240,000	2,171,400	1,985,100	1,819,300	2,047,900	2,145,500	2,297,000	2,254,800	2,294,600	2,309,200	2,278,100	1,603,300	1,725,800	1,570,400	1,390,600	1,360,700	1,291,900	1,387,700	1,278,800	1,188,000	1,168,500	1,181,900	1,216,800	1,150,300	1,032,600	992,400	918,900	872,700	889,200	863,000	745,600	649,000	691,900	676,300	635,100	591,600	581,700	564,800	541,200	542,100	531,600	524,900	542,300	526,000	514,200	430,400	437,100	400,600	367,500	326,200	333,300	326,700	360,200	368,300	388,200	351,100	326,400	297,300	311,700	287,000	293,000	274,900	316,200	306,400	282,000	277,200	295,000	318,000	356,000
Total Current Liabilities	1,110,800	1,195,400	1,238,900	1,157,200	1,082,000	1,022,400	917,900	969,100	949,900	1,032,300	966,500	886,200	799,000	893,900	846,300	873,200	746,900	902,400	775,800	697,000	646,500	876,600	1,261,100	1,183,200	1,314,500	1,399,400	735,200	562,500	584,800	532,500	532,800	478,200	458,300	476,200	532,500	445,200	405,300	434,400	427,800	540,500	356,200	345,600	335,100	314,200	300,400	347,400	298,600	284,300	265,200	335,200	302,000	313,300	445,200	337,800	281,600	247,700	242,200	290,500	282,100	245,100	200,200	258,500	229,900	226,600	391,600	375,400	348,800	323,600	179,400	226,200	227,500	226,500	197,000	194,200	204,600	190,400	176,400	195,400	170,300	156,000	156,400	167,200	172,000	186,100	189,600	197,900	175,000	186,100	167,800	184,000	157,400	199,100	228,900	219,000	277,400	331,000	332,000	156,000
Total Liab	2,549,900	2,643,800	2,643,700	2,557,500	2,589,200	2,485,800	2,420,400	2,481,500	2,575,000	2,666,700	2,619,000	2,528,800	2,555,300	2,662,800	2,590,500	2,585,000	2,175,000	2,339,800	2,151,500	2,073,200	2,021,800	2,183,300	2,596,900	2,521,900	2,579,400	2,701,800	2,325,900	2,198,900	2,037,700	1,891,000	1,647,200	1,580,200	1,554,500	1,556,200	1,455,200	1,319,700	1,274,500	1,332,900	1,306,600	1,411,700	1,310,900	1,165,500	1,093,200	759,900	704,600	742,200	659,500	640,500	613,900	642,600	628,300	617,200	573,300	459,000	491,900	524,100	452,900	457,600	497,500	462,000	415,600	521,400	506,700	451,000	532,700	510,100	475,900	444,300	464,200	497,400	512,400	536,800	516,000	539,100	485,800	489,100	475,000	484,600	472,600	503,400	533,600	466,300	492,100	520,700	492,900	468,800	459,600	503,700	479,100	514,000	547,000	591,500	638,900	648,000	681,400	712,000	698,000	213,000
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	7,117,900	6,650,000	6,657,500	6,375,700	5,978,000	5,806,700	6,217,800	5,943,600	5,844,900	5,835,900	5,541,300	5,133,300	4,658,400	4,574,300	4,210,300	3,839,100	3,901,100	4,148,300	3,814,800	3,500,300	3,447,500	3,140,400	3,361,300	3,164,200	3,245,700	2,994,700	3,162,500	2,939,600	2,742,700	2,619,000	2,691,800	2,471,200	2,299,300	2,503,100	2,421,400	2,288,600	2,213,900	2,191,400	2,043,400	1,914,900	1,340,800	1,559,200	1,437,400	1,579,800	1,592,000	1,479,300	1,536,300	1,434,600	1,390,300	1,337,900	1,354,600	1,385,200	1,357,800	1,308,200	1,233,500	1,117,800	1,151,500	1,157,900	1,090,500	1,003,100	943,300	878,800	874,500	897,300	777,600	835,000	823,800	807,500	785,000	749,400	727,900	722,400	724,000	690,000	659,200	661,700	648,100	628,100	599,300	586,200	570,200	635,100	578,700	559,000	543,000	539,400	458,800	479,600	486,300	459,000	412,600	415,700	464,000	440,000	424,400	411,000	683,000	1,224,000
Treasury Stock	0	0	0	0	0	0	0	-3,177,600	-2,822,500	-2,416,900	-2,320,400	-2,318,600	-2,206,700	-1,904,100	-1,903,900	-1,902,500	-1,893,500	-1,278,700	-1,278,700	-1,277,400	-1,021,100	-1,015,400	-743,400	-570,300	-254,200	-252,100	-800	-2,746,200	-2,672,400	-2,499,300	-2,217,900	-2,217,700	-2,181,100	-1,837,000	-1,737,000	-1,736,800	-1,657,900	-1,556,900	-1,556,700	-1,556,600	-1,556,000	-1,256,000	-1,233,200	-1,005,600	-866,700	-749,900	-572,100	-549,000	-495,300	-405,800	-365,800	-261,500	-178,300	-102,000	-102,000	-101,300	-970,300	-872,300	-856,400	-831,300	-803,600	-776,800	-755,800	-685,100	-570,300	-470,300	-446,600	-399,200	-364,200	-339,400	-320,700	-279,400	-222,900	-193,500	-176,400	-156,000	-152,500	-140,000	-114,400	-107,300	-95,600	-80,900	-80,900	-68,100	-39,700	-31,500	-29,100	-21,000	-2,500	-1,000	0	0	0	0	0	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flow

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31
Begin Period Cash Flow	772,600	867,400	1,200,200	1,184,400	714,100	818,300	930,100	718,400	653,800	420,400	310,900	171,200	396,100	334,100	218,700	141,800	182,800	178,600	48,900	61,100	34,200	47,700	28,000	0	0
Capital Expenditures	266,300	264,800	329,800	407,300	278,400	241,700	175,500	217,400	106,500	93,700	110,100	127,700	90,600	63,000	64,000	78,000	62,500	59,400	48,500	42,500	37,900	40,700	38,000	46,000	42,000
Cash And Cash Equivalents Changes	0	-114,000	-346,700	36,300	468,000	-104,200	-111,800	211,700	64,600	233,400	109,500	139,700	-224,900	62,000	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	1,452,200	1,491,800	1,109,900	1,105,600	739,300	588,800	613,300	501,400	828,300	412,400	325,200	278,200	21,300	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	375,400	-94,800	-332,800	15,800	465,000	-104,200	-111,800	211,700	64,600	233,400	109,500	139,700	-224,900	62,000	115,400	76,900	-41,000	4,200	129,700	-12,200	26,900	-13,500	20,000	28,000	0
Change In Working Capital	-526,300	-421,400	145,300	42,200	-204,300	-42,600	234,200	66,100	64,400	190,300	21,500	11,500	-29,700	-1,100	-68,300	-69,500	4,100	-14,900	-3,600	2,800	-19,900	-36,300	-5,000	-12,000	-1,000
Change Receivables	0	-84,100	-91,100	41,900	-88,000	-28,700	-3,900	-56,700	-38,300	-26,800	8,500	-26,500	-53,700	-34,200	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-141,200	-84,100	-112,400	283,900	-94,800	-13,000	-3,900	-56,700	-38,300	-26,800	8,500	-26,500	-53,700	-34,200	-51,600	-68,500	-6,600	2,500	-12,600	7,100	-11,000	-32,000	0	0	0
Change To Inventory	-289,000	-213,400	19,000	-120,600	-105,400	-65,700	-124,000	-65,600	-67,700	-30,500	-44,400	-21,700	-57,000	-36,800	-13,100	-17,800	-9,000	-12,800	-12,900	-7,100	4,200	13,300	-7,000	15,000	-14,000
Change To Liabilities	0	-27,000	257,200	-137,400	-20,300	34,700	363,600	179,100	163,900	241,000	50,300	41,900	61,700	63,600	0	32,900	14,000	0	25,100	13,000	0	0	7,000	0	0
Change To Netincome	0	-49,100	-79,600	53,300	198,200	169,800	94,300	-36,900	-75,200	-58,300	-22,800	-2,400	27,300	-37,000	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	-96,900	-39,800	258,300	9,400	17,100	-1,500	8,200	6,300	6,600	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	144,900	139,600	134,800	107,200	89,300	77,400	81,900	71,200	65,800	68,600	68,700	57,300	58,000	56,500	58,700	55,600	54,800	56,800	56,200	55,700	45,600	40,400	57,000	74,000	84,000
Dividends Paid	169,900	146,400	158,600	140,500	18,900	688,000	0	253,500	31,400	226,300	1,305,000	407,000	526,100	254,400	129,300	206,300	0	0	0	0	0	0	0	0	0
End Period Cash Flow	1,148,000	772,600	867,400	1,200,200	1,179,100	714,100	818,300	930,100	718,400	653,800	420,400	310,900	171,200	396,100	334,100	218,700	141,800	182,800	178,600	48,900	61,100	34,200	48,000	28,000	0
Exchange Rate Changes	0	0	0	0	0	-6,500	7,900	-12,500	-10,400	-2,900	14,600	12,000	8,600	-24,000	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	629,500	953,400	1,402,300	647,000	901,000	685,100	825,200	487,000	443,200	928,600	362,600	246,100	223,900	188,400	101,300	75,200	147,700	171,400	88,300	138,100	84,400	79,900	63,000	91,000	134,000
Investments	254,400	252,300	-1,335,200	-101,700	-158,200	329,800	-266,900	21,900	128,800	-527,400	-299,500	70,500	-286,600	-4,700	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	160,500	147,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	-200	-1,800	-800	-10,000	-437,300	176,300	222,100	1,900	-12,700	409,600	39,500	104,400	-48,400	0	0	0	0	0	0	0	0	0	0	0
Net Income	1,399,400	1,521,900	1,503,100	823,400	1,046,900	722,200	583,600	569,500	494,900	811,100	391,700	293,200	236,700	218,000	229,100	128,900	113,000	130,500	79,300	1,700	79,000	55,700	-11,000	-272,000	82,000
Other Cashflows From Financing Activities	168,900	142,800	163,500	155,500	35,000	1,360,600	994,700	575,400	95,200	499,900	2,686,700	862,900	1,056,500	561,200	280,200	427,000	-15,900	-81,200	56,300	8,100	-2,200	-52,400	-78,000	-41,000	-127,000
Other Cashflows From Investing Activities	0	517,100	-61,500	-22,400	-183,200	-14,400	-212,200	-57,500	-209,600	-22,700	-4,200	-40,300	-43,300	5,000	97,800	69,700	0	23,500	22,800	4,100	0	0	45,000	12,000	0
Other Non Cash Items	10,500	105,800	-119,000	38,300	154,100	126,100	21,600	-21,900	-30,300	-24,900	-56,700	-38,400	15,100	-40,100	-78,500	33,000	16,200	24,700	18,700	119,600	12,300	74,600	8,000	347,000	11,000
Sale Purchase Of Stock	-879,600	-1,727,100	-512,800	-625,400	-263,300	-795,500	-763,300	-662,300	-280,100	-300,900	-496,900	-344,100	-303,400	-200,000	-95,500	-306,500	-130,900	-145,900	-53,500	-59,100	-49,400	-30,800	0	0	0
Stock Based Compensation	139,400	126,800	109,300	92,600	81,300	71,000	61,600	56,900	49,900	48,300	47,400	42,100	35,000	29,300	28,300	28,700	27,700	26,600	0	0	0	0	82,000	0	0
Total Cash From Financing Activities	-711,000	-1,584,500	-356,300	-486,900	-115,600	-1,101,200	-473,200	-268,500	-158,600	-153,000	34,900	-155,600	-135,200	-103,900	-91,800	-134,100	-108,100	-193,600	29,000	-20,500	-15,000	-69,500	-78,000	-37,000	-127,000
Total Cash From Operating Activities	895,800	1,218,200	1,732,100	1,054,300	1,179,400	926,800	1,000,700	704,400	549,700	1,022,300	472,700	373,800	314,500	251,400	165,300	153,200	210,200	230,800	136,800	180,600	122,300	120,600	101,000	137,000	176,000
Total Cashflows From Investing Activities	0	252,300	-1,722,500	-531,100	-595,800	76,700	-647,200	-211,700	-316,100	-633,000	-412,700	-90,500	-412,800	-61,500	40,100	58,800	0	0	0	0	0	0	0	0	0

	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31
Begin Period Cash Flow	1,148,000	1,413,900	1,047,500	876,400	772,600	1,251,700	1,202,900	1,035,300	867,400	1,519,900	1,325,900	1,190,900	1,200,200	1,024,000	903,500	662,900	1,179,100	1,186,600	726,800	709,200	714,100	1,261,300	1,226,400	1,227,000	818,300	630,300	508,200	819,300	930,100	645,000	369,900	501,400	718,400	646,100	597,600	457,000	653,800	404,100	498,600	295,700	420,400	471,000	372,700	401,500	310,900	305,800	304,300	213,300	171,200	451,100	468,200	433,800	396,100	361,000	320,300	321,200	334,100	287,600	183,100	146,700	218,700	202,400	188,200	162,900	141,800	175,700	164,900	180,200	182,800	151,300	167,100	189,000	179,000	88,000	96,100	72,600	48,900	31,000	40,000	37,900	61,100	38,300	50,700	29,800	34,200	39,000	35,500	28,000	47,700	23,500	61,600	17,900	28,100	13,200	2,000	6,000	0	0
Capital Expenditures	85,300	101,600	55,300	47,900	61,500	89,100	59,900	43,100	72,700	93,800	60,700	69,300	106,000	113,500	103,300	108,300	82,200	71,500	76,100	71,800	59,000	60,600	82,100	52,800	46,200	51,900	43,300	61,700	18,600	63,200	48,300	78,200	27,700	41,300	26,000	18,400	20,800	45,300	18,100	16,000	14,300	20,600	37,600	28,900	23,000	55,800	25,700	28,200	18,000	37,700	19,500	19,200	14,200	21,700	16,400	15,700	9,200	23,700	12,100	17,100	11,100	44,700	12,200	12,000	9,100	18,400	15,700	14,800	13,600	17,400	18,000	16,000	8,000	21,900	10,800	9,800	6,000	19,700	7,900	8,900	6,000	11,800	9,300	27,600	7,800	15,800	8,500	8,800	7,600	9,900	9,300	9,400	9,400	11,100	13,900	11,000	10,000	11,000
Cash And Cash Equivalents Changes	0	0	0	155,900	108,000	-460,900	38,500	153,700	154,700	-654,300	193,500	137,600	-23,500	181,500	123,800	245,100	-514,100	-4,500	459,800	17,600	-4,900	-547,200	34,900	-600	408,700	188,000	122,100	-311,100	-110,800	285,100	275,100	-131,500	-217,000	72,300	48,500	140,600	-196,800	249,700	-94,500	202,900	-124,700	-50,600	98,300	-28,800	90,600	5,100	1,500	91,000	42,100	-279,900	-17,100	34,400	37,700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	0	-512,500	359,000	363,600	321,200	408,000	359,400	338,800	338,600	495,900	318,500	326,200	222,300	267,300	294,100	297,700	271,500	248,100	288,300	10,700	252,600	300,000	176,000	-11,200	169,900	194,200	235,900	166,200	145,600	154,500	147,000	138,400	112,400	112,000	138,600	133,200	87,400	529,600	78,100	77,500	75,100	88,500	171,300	92,700	72,700	91,000	68,800	96,200	188,600	1,100	-7,700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	81,000	-265,900	366,400	171,100	103,800	-479,100	48,800	167,600	167,900	-652,500	194,000	135,000	-9,300	176,200	120,500	240,600	-516,200	-7,500	459,800	17,600	-4,900	-547,200	34,900	-600	408,700	188,000	122,100	-311,100	-110,800	285,100	275,100	-131,500	-217,000	72,300	48,500	140,600	-196,800	249,700	-94,500	202,900	-124,700	-50,600	98,300	-28,800	90,600	5,100	1,500	91,000	42,100	-279,900	-17,100	34,400	37,700	35,100	40,700	-900	-12,900	46,500	104,500	36,400	-72,000	16,300	14,200	25,300	21,100	-33,900	10,800	-15,300	-2,600	31,500	-15,800	-21,900	10,000	90,600	-8,100	23,500	23,700	17,900	-9,000	2,100	-23,200	22,800	-12,400	20,900	-4,400	-4,800	3,500	7,500	-19,700	24,500	-38,100	43,700	-10,200	14,800	11,200	-4,000	6,000	0
Change In Working Capital	-459,000	-216,100	-12,200	-241,400	-56,600	-84,900	-114,500	-92,600	-129,400	60,700	122,600	71,200	-109,200	40,000	-153,300	330,300	-174,800	43,600	88,700	-11,800	-324,800	192,400	74,300	-180,600	-128,700	357,900	120,700	-63,500	-180,900	48,100	52,000	21,600	-55,600	40,200	55,900	41,000	-72,700	25,000	-98,600	210,600	53,300	1,300	42,800	200	-22,800	9,200	31,500	52,200	-81,400	-300	30,400	-6,800	-53,000	16,300	37,700	-15,600	-39,500	700	33,900	-8,100	-94,800	19,900	-39,700	-33,900	-15,800	29,700	12,700	-19,200	-19,100	-4,800	6,500	-9,600	-7,000	4,800	24,800	-1,400	-31,800	9,500	22,800	-14,100	-15,400	37,900	-10,500	-13,400	-33,900	-9,500	3,700	300	-30,800	31,200	7,000	-10,300	-32,900	8,200	13,800	-15,000	-19,000	200,000
Change Receivables	0	0	0	-46,800	-77,500	-1,100	-5,300	-19,900	-57,800	6,800	38,000	-46,400	-89,500	51,100	-30,700	25,700	-4,200	-17,700	18,900	-43,400	-45,800	-28,400	-2,900	-27,300	29,900	10,500	56,100	11,000	-81,500	-1,900	9,900	-32,500	-32,200	-10,000	11,200	-3,000	-36,500	-16,100	-10,500	-22,900	22,700	-700	17,900	-14,100	5,400	-22,500	18,200	2,700	-24,900	-15,200	9,800	-13,400	-34,900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-55,000	-41,300	-28,400	-224,200	-77,500	-6,400	-5,300	-77,700	-57,800	-91,100	16,300	-38,500	-89,500	41,900	-151,200	399,000	-4,200	-88,000	12,500	-42,300	-45,800	-28,700	8,600	-12,400	29,900	-3,900	54,900	15,900	-81,500	-56,700	9,400	-42,900	-32,200	-38,300	10,500	-1,900	-36,500	-26,800	-9,500	-42,100	22,700	8,500	11,800	-16,100	5,400	-22,500	18,200	2,700	-24,900	-15,200	9,800	-13,400	-34,900	-2,400	9,300	-25,500	-15,600	500	10,000	-10,200	-51,900	-61,100	400	500	-3,300	-6,600	900	800	-400	2,500	700	400	2,100	-12,600	300	200	-13,300	7,100	9,900	0	1,600	-11,000	200	0	-14,400	-32,000	0	0	-12,400	0	0	0	-6,700	0	0	0	5,000	0
Change To Inventory	-69,500	-99,300	-76,000	-80,900	-32,800	-62,300	-65,300	-61,800	-24,000	-6,600	8,100	15,000	2,500	-2,400	-19,000	-64,000	-35,200	-21,500	-22,000	-32,500	-29,400	-22,200	-23,000	-17,200	-3,300	-14,200	-37,600	-47,900	-24,300	-22,500	-28,400	-10,100	-4,600	-11,600	-23,800	-13,400	-18,900	-11,500	-7,500	-11,000	-500	-3,100	-9,600	-13,000	-18,700	2,200	-12,500	-3,500	-7,900	-18,700	-23,500	-8,900	-5,900	6,700	-15,900	-14,400	-13,200	800	-5,900	-8,600	600	-6,400	-11,500	300	-200	3,200	-10,800	-2,300	900	2,100	-9,700	-2,200	-3,000	2,000	-5,000	-7,900	-2,000	-182,700	-500	-7,800	1,200	9,200	1,900	-5,100	-1,800	10,900	4,000	-1,300	-300	10,900	-3,900	300	-14,300	4,100	-100	6,000	5,000	0
Change To Liabilities	0	0	36,400	65,200	42,000	19,900	-14,900	-5,700	-26,300	64,100	79,300	94,100	4,800	-17,900	6,700	-14,000	-112,200	71,900	101,900	64,400	-258,500	239,300	73,500	-153,400	-124,700	370,000	103,400	-34,600	-75,200	64,800	66,300	70,800	-22,800	64,100	74,200	58,100	-32,500	39,200	-80,900	261,900	20,800	17,000	36,300	32,900	-35,900	35,100	22,300	36,800	-52,300	18,700	29,100	22,900	-9,000	63,600	65,200	26,700	0	0	0	0	0	32,900	0	0	0	14,000	0	0	0	0	13,300	11,600	0	25,100	33,500	9,900	0	13,000	5,700	0	0	0	0	0	0	0	0	0	0	7,000	0	0	0	0	0	0	0	0
Change To Netincome	0	0	1,900	-73,500	-11,800	-72,700	38,800	-22,500	7,300	-62,500	35,600	-70,400	31,800	10,400	11,200	-8,300	40,000	45,100	43,900	82,900	26,300	73,700	22,900	18,900	54,300	-12,400	-1,700	56,100	52,300	-24,600	-5,700	-10,400	3,800	-91,600	10,000	-400	6,600	-69,900	5,700	4,300	1,600	1,800	8,900	16,600	-50,100	3,800	16,200	5,800	-28,200	47,300	1,300	-15,300	-6,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	0	-49,200	-49,200	-49,200	-41,400	-29,000	-5,200	-21,300	-3,600	-8,600	-600	-27,000	9,200	-110,300	382,600	-23,200	10,900	-10,100	-300	8,900	3,700	26,700	17,300	-30,600	-1,500	-1,200	8,000	100	8,200	5,200	-6,000	0	6,300	0	0	0	6,600	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	38,500	36,700	36,900	36,100	35,200	35,400	35,400	34,100	34,700	33,000	33,600	35,800	32,400	32,600	25,600	24,500	24,500	23,900	23,100	16,000	26,300	19,900	19,200	19,200	19,100	21,200	20,700	18,900	21,100	19,100	18,200	18,000	15,900	14,500	18,500	16,800	16,000	18,300	18,000	16,100	16,200	18,800	18,500	16,100	15,300	15,100	14,400	14,000	13,800	14,800	13,900	14,800	14,500	15,400	13,400	13,700	14,000	14,200	15,400	14,900	14,200	14,300	13,800	14,000	13,500	13,700	14,000	13,700	13,400	14,600	13,800	14,400	14,000	14,400	14,000	14,200	13,600	14,600	15,300	12,900	12,900	11,600	11,900	11,300	10,800	11,000	10,100	9,600	9,700	12,600	12,900	15,200	16,300	14,600	15,400	23,000	21,000	19,000
Dividends Paid	0	32,900	0	0	0	27,500	0	0	0	0	0	0	0	70,000	0	0	7,900	256,400	2,300	6,000	3,700	1,600	600	680,700	5,100	0	0	608,000	377,400	228,900	8,700	6,200	9,700	10,700	7,400	5,900	7,400	6,000	6,200	5,800	208,300	599,900	372,900	168,400	163,800	169,100	32,800	53,500	151,600	20,600	305,000	90,000	110,500	0	28,600	83,700	104,500	0	30,000	69,300	30,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	1,229,000	1,148,000	1,413,900	1,047,500	876,400	772,600	1,251,700	1,202,900	1,035,300	867,400	1,519,900	1,325,900	1,190,900	1,200,200	1,024,000	903,500	662,900	1,179,100	1,186,600	726,800	709,200	714,100	1,261,300	1,226,400	1,227,000	818,300	630,300	508,200	819,300	930,100	645,000	369,900	501,400	718,400	646,100	597,600	457,000	653,800	404,100	498,600	295,700	420,400	471,000	372,700	401,500	310,900	305,800	304,300	213,300	171,200	451,100	468,200	433,800	396,100	361,000	320,300	321,200	334,100	287,600	183,100	146,700	218,700	202,400	188,200	162,900	141,800	175,700	164,900	180,200	182,800	151,300	167,100	189,000	178,600	88,000	96,100	72,600	48,900	31,000	40,000	37,900	61,100	38,300	50,700	29,800	34,200	39,000	35,500	28,000	48,000	23,500	61,600	17,900	28,000	13,200	2,000	6,000	0
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	800	-3,900	-1,300	-1,200	3,500	-5,000	-3,800	3,800	500	2,600	1,000	-1,300	1,500	-10,400	-2,300	900	-2,000	8,600	-17,900	-1,400	-600	-900	0	4,500	4,000	5,400	700	9,900	2,600	-8,000	7,500	5,400	-17,700	5,100	15,800	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	-138,800	35,000	356,200	-14,300	252,600	193,700	250,000	289,100	220,600	279,800	471,200	456,800	194,500	286,500	112,800	122,900	124,800	327,900	361,200	269,400	-57,500	232,400	260,200	87,400	105,100	312,000	267,500	136,000	109,700	137,900	157,600	112,100	79,400	62,500	176,500	151,700	52,500	47,900	-5,900	762,000	124,600	90,700	109,500	98,100	64,300	70,600	105,600	118,600	-48,700	105,400	77,700	40,100	700	72,300	80,000	32,300	3,800	42,200	59,400	46,800	-47,100	35,800	1,600	17,000	20,800	58,500	43,700	23,000	22,500	52,600	42,200	23,600	53,000	22,400	28,200	22,800	14,900	31,200	57,000	19,800	30,100	56,600	35,700	8,500	-16,400	31,400	22,200	34,800	-8,500	36,600	19,200	23,900	-16,700	38,400	28,600	19,000	5,000	58,000
Investments	63,100	14,100	89,000	120,000	233,200	94,700	-75,300	231,700	307,400	-848,700	-299,900	-252,400	55,800	-139,400	-19,900	110,500	-52,900	-361,500	67,900	91,200	44,200	53,900	-164,700	159,800	280,800	213,800	-164,200	-571,900	255,400	148,700	60,400	-262,000	74,800	76,000	167,100	36,300	-159,800	170,800	-137,000	-455,100	-106,100	-226,900	-79,900	-43,700	51,000	108,200	-108,700	-15,400	86,400	-293,500	2,000	-100	5,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	0	0	0	-100	-100	-100	-100	-100	-100	-1,200	-400	900	-500	-900	-300	1,700	-1,200	-10,200	-300	-599,600	-1,300	163,600	163,600	-200	-700	153,200	24,000	223,200	2,300	-3,600	200	1,900	3,300	-600	-800	-14,000	100	-128,800	130,000	64,300	305,100	34,700	5,500	13,200	-9,800	5,000	31,100	-24,400	-400	23,900	105,300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	351,000	369,700	383,700	305,500	340,500	398,400	343,500	406,400	373,600	335,300	340,100	489,500	338,200	309,500	325,200	-121,900	310,600	280,200	274,700	242,300	249,700	7,000	225,900	282,700	206,600	-2,800	170,100	186,100	230,200	158,500	141,400	126,600	143,000	140,700	118,100	112,700	123,400	109,200	94,600	547,000	60,300	75,800	76,900	94,100	144,900	91,100	69,200	67,800	65,100	63,100	51,600	58,100	63,900	64,800	48,000	57,500	47,700	47,600	73,500	47,500	60,500	38,100	32,900	39,700	18,200	15,800	29,100	34,900	33,200	20,700	27,800	36,000	46,000	38,600	-4,400	13,900	31,200	25,900	12,400	25,500	-62,100	18,900	24,500	21,100	14,500	21,700	-17,400	30,600	20,800	17,500	14,500	-55,700	12,700	24,800	-4,800	-309,000	17,000	20,000
Other Cashflows From Financing Activities	-200	35,200	-2,900	-1,200	800	27,700	-1,900	47,100	37,500	34,600	49,500	63,600	33,200	143,700	37,600	36,700	15,400	300	2,500	5,600	12,800	2,400	83,900	1,265,700	8,600	5,400	3,100	1,217,800	753,800	500,500	41,000	59,200	-25,300	34,500	17,800	21,700	21,200	30,100	22,700	18,500	428,600	1,230,100	727,400	338,100	391,100	345,200	73,000	111,100	333,600	-2,200	620,500	200,400	237,800	50,300	60,500	185,600	227,200	8,700	62,600	145,000	63,900	-37,700	62,500	88,600	-4,800	-700	-400	-11,100	-3,700	-20,900	-27,800	-8,500	-24,000	68,200	-21,300	1,400	8,000	-700	-53,200	-17,100	79,100	-33,800	-18,300	18,100	31,800	-8,500	-18,200	-13,700	-12,000	-9,900	-59,500	-23,400	8,300	-23,600	-29,400	-2,000	18,000	-58,000
Other Cashflows From Investing Activities	0	0	324,400	-1,900	-171,200	517,100	-66,300	-59,000	-5,200	-27,400	-16,800	-7,800	500	-7,300	-3,100	-12,100	100	-12,300	-4,500	-114,900	-51,500	9,400	-4,400	-2,100	-17,300	-112,600	-3,000	-8,300	-88,300	-5,300	-8,400	-44,000	200	-11,200	-316,700	-5,400	300	-24,300	300	700	600	100	-4,000	200	-500	-36,700	2,500	-6,100	0	-5,600	-100	6,000	-43,600	5,400	3,900	2,400	900	97,800	92,400	30,500	27,000	69,700	73,600	73,600	74,000	0	3,900	1,400	2,400	23,500	13,200	12,800	3,600	22,800	9,000	9,700	8,900	4,100	0	0	0	0	0	0	0	0	0	0	600	45,000	45,000	45,000	0	12,000	0	0	0	0
Other Non Cash Items	7,200	7,200	16,500	-21,100	7,900	11,800	61,500	7,900	24,600	-18,100	5,100	-106,100	100	8,600	-5,800	16,300	19,200	30,700	34,400	65,300	23,700	114,800	-5,400	11,900	4,800	-1,400	-16,900	33,800	6,100	-3,700	-17,300	36,600	-10,700	-10,600	700	-9,300	-11,100	1,800	-14,200	-8,900	-3,600	5,200	-3,700	3,300	-61,500	-6,800	5,500	2,000	-39,100	59,300	-9,600	-14,900	-19,700	-5,000	-8,700	-23,300	-3,100	300	-55,100	800	-24,500	900	-200	14,600	9,900	-3,400	5,000	6,500	-1,400	2,100	8,100	12,000	-800	-4,000	11,200	7,200	4,300	1,900	13,300	2,900	9,900	-2,500	6,000	17,100	0	2,200	68,800	3,100	-600	6,900	-5,900	84,100	-3,400	1,900	9,300	331,000	-4,000	-170,000
Sale Purchase Of Stock	-200	-448,400	-174,400	-7,500	-249,300	-866,000	-100,400	-355,100	-405,600	-96,500	-1,800	-111,900	-302,600	-200	-1,400	-9,000	-614,800	263,300	-1,300	-256,300	-5,700	-272,000	-173,100	-348,200	-2,200	-251,300	-800	-73,800	-437,400	-281,400	-200	-36,600	-344,100	-100,000	-200	-78,900	-101,000	-200	-100	-600	-300,000	-22,700	-227,600	-138,900	-107,700	-177,800	-23,100	-53,700	-89,500	-40,100	-104,300	-83,200	-75,800	0	-700	-101,300	-98,000	-15,900	-25,100	-27,700	-26,800	-21,000	-70,700	-114,800	-100,000	-23,700	-47,400	-35,000	-24,800	-18,700	-41,300	-56,900	-29,000	-17,100	-20,400	-3,500	-12,500	-25,600	-7,000	-11,800	-14,700	0	-12,800	-28,400	-8,200	-2,300	-8,200	-18,500	-1,800	0	0	0	0	0	0	0	0	0
Stock Based Compensation	44,600	30,500	32,600	37,400	38,900	27,900	30,300	36,200	32,400	24,200	26,600	30,300	28,200	20,900	23,000	24,800	23,900	18,400	19,800	22,300	20,800	16,000	17,400	19,200	18,400	15,300	15,800	15,300	15,200	13,900	14,400	14,300	14,300	12,900	12,600	10,800	13,600	12,200	12,200	11,900	12,000	11,500	11,900	12,800	11,200	10,800	10,900	11,200	9,200	9,000	10,500	7,800	7,700	6,900	8,600	6,300	7,500	7,800	7,900	5,700	6,900	28,700	10,100	-8,900	6,600	27,700	1,300	1,300	6,900	26,600	2,900	-5,400	5,800	0	0	0	0	0	0	0	91,600	0	0	0	0	0	0	0	0	-1,000	0	0	0	0	9,200	0	0	0
Total Cash From Financing Activities	61,700	-413,200	-143,300	52,100	-206,600	-838,400	-69,900	-308,100	-368,100	-62,000	39,000	-59,000	-274,300	41,400	34,000	24,100	-586,400	37,000	34,400	-231,400	44,400	-844,700	-56,700	-240,700	40,900	-229,000	20,300	126,800	-391,300	5,100	63,800	31,700	-369,100	-59,700	23,600	-50,600	-71,900	45,900	48,700	-103,800	-143,800	80,500	68,600	-89,300	-24,900	-146,900	-500	-5,100	-3,100	-97,000	-79,000	-18,700	59,500	-26,600	-56,600	-14,300	-6,400	3,900	-26,300	-15,500	-53,900	-45,600	7,200	2,900	-98,600	-18,300	-36,100	-36,900	-16,800	-32,300	-60,800	-55,500	-45,000	55,200	-34,300	6,000	2,100	-19,000	-56,100	-18,200	72,800	-26,400	-25,400	9,600	27,200	-7,900	-23,000	-28,100	-10,500	-9,900	-56,200	-21,800	9,900	-23,600	-29,400	-2,000	18,000	-58,000
Total Cash From Operating Activities	-53,500	136,600	411,500	33,600	314,100	282,800	309,900	332,200	293,300	373,600	531,900	526,100	300,500	400,000	216,100	231,200	207,000	399,400	437,300	341,200	1,500	293,000	342,300	140,200	151,300	363,900	310,800	197,700	128,300	201,100	205,900	190,300	107,100	103,800	202,500	170,100	73,300	93,200	12,200	778,000	138,900	111,300	147,100	127,000	87,300	126,400	131,300	146,800	-30,700	143,100	97,200	59,300	14,900	94,000	96,400	48,000	13,000	65,900	71,500	63,900	-36,000	80,500	13,800	29,000	29,900	76,900	59,400	37,800	36,100	70,000	60,200	39,600	61,000	44,300	39,000	32,600	20,900	50,900	64,900	28,700	36,100	68,400	26,400	36,100	-8,600	47,200	30,700	43,600	-900	46,500	28,500	33,300	-7,300	49,500	42,500	30,000	15,000	69,000
Total Cashflows From Investing Activities	0	0	159,700	70,200	500	252,300	-201,500	129,600	229,500	-965,900	-377,400	-329,500	-49,700	-259,900	-126,300	-10,200	-134,700	-445,300	-12,700	-88,300	-49,500	5,700	-254,200	104,900	220,300	49,300	-209,500	-638,200	151,200	80,200	3,900	-343,100	47,300	27,300	-175,600	12,500	-180,300	112,000	-154,800	-470,400	-119,800	-246,900	-121,400	-71,900	27,500	15,700	-131,900	-42,700	68,400	-331,400	-17,600	-11,300	-52,500	-61,500	-38,400	-23,200	0	40,100	56,000	2,700	17,300	58,800	75,600	77,800	82,900	0	0	0	0	0	0	0	0	0	0	0	2,800	0	0	0	0	0	0	0	0	0	0	0	0	0	7,900	19,500	0	0	0	0	0	0

Income Statement

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31
Cost Of Revenue	1,379,800	1,080,400	1,248,900	1,080,600	1,114,400	939,400	875,300	797,400	617,200	625,600	522,400	494,600	489,800	408,300	399,100	419,600	378,200	373,600	374,600	370,200	359,400	299,100	324,000	423,000	466,000
Depreciation And Amortization	144,900	81,400	134,800	107,200	183,800	77,400	81,900	71,200	65,800	68,600	68,700	57,300	58,000	56,500	58,700	55,600	54,800	56,800	56,200	55,700	45,600	40,400	57,000	74,000	84,000
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	1,534,100	1,748,500	1,348,500	1,628,400	1,146,800	1,312,700	917,500	814,200	583,900	-245,500	318,500	367,100	258,900	242,400	238,000	118,700	194,000	171,400	224,800	264,500	170,800	96,400	101,000	415,000	113,000
Ebitda	1,534,100	1,829,900	1,483,300	1,735,600	1,330,600	1,390,100	999,400	885,400	649,700	-176,900	387,200	424,400	316,900	298,900	296,700	174,300	248,800	228,200	281,000	320,200	216,400	136,800	158,000	489,000	197,000
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	-2,800	-15,800	-294,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	4,625,000	4,302,000	3,983,600	3,305,700	3,233,600	2,783,400	2,560,000	2,166,300	1,876,500	1,697,300	1,523,100	1,405,000	1,188,800	1,038,700	922,300	818,100	712,900	663,400	623,300	561,300	501,100	404,900	368,000	381,000	439,000
Income Before Tax	1,598,100	1,767,400	1,702,000	916,700	1,166,500	761,400	1,034,900	737,900	622,400	1,144,000	515,300	391,100	283,600	268,200	304,400	164,400	149,800	172,300	116,700	30,100	92,800	56,000	-9,000	-259,000	113,000
Income Tax Expense	198,700	245,500	198,900	93,300	119,600	39,200	412,800	168,400	127,500	332,900	123,600	97,900	46,900	50,200	75,300	35,500	36,800	41,800	37,400	28,400	13,800	300	1,000	13,000	31,000
Interest Expense	17,600	19,200	18,400	15,800	20,700	2,100	2,900	8,400	9,300	10,800	5,200	4,400	3,100	2,400	1,100	7,200	9,100	10,500	9,700	14,200	13,200	11,500	23,000	0	0
Interest Income	67,200	16,300	1,000	7,600	32,200	32,000	20,300	10,800	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	3,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	1,402,400	1,521,900	1,503,100	823,400	1,046,900	722,200	622,100	569,500	494,900	811,100	391,700	293,200	236,700	218,000	229,100	128,900	113,000	130,500	79,300	1,700	79,000	55,700	-12,000	-272,000	82,000
Net Income Applicable To Common Shares	0	1,521,900	1,503,100	823,400	1,046,900	722,200	583,600	569,500	494,900	811,100	391,700	293,200	236,700	218,000	229,100	128,900	113,000	130,500	79,300	1,700	79,000	55,700	0	0	0
Net Income From Continuing Ops	1,428,100	1,521,900	1,503,100	823,400	1,046,900	722,200	583,600	569,500	494,900	811,100	391,700	293,200	236,700	218,000	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	40,700	16,300	-1,000	7,600	11,500	2,100	-2,900	-8,400	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Operating Income Net Other	0	38,100	30,100	34,900	40,400	36,000	12,100	5,900	3,900	-1,300	3,300	3,100	8,200	9,000	0	0	0	0	0	0	0	0	0	0	0
Non Recurring	0	76,500	20,600	405,400	98,000	330,200	-13,400	67,100	7,000	-669,700	-67,300	16,000	21,600	22,700	0	0	0	0	0	0	0	0	0	0	0
Operating Income	1,534,100	1,748,500	1,348,500	1,628,400	1,146,800	748,200	1,022,700	783,800	642,700	482,600	454,500	408,400	300,100	284,300	238,000	198,300	172,600	173,200	175,600	154,400	138,400	52,100	24,000	95,000	117,000
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	4,276,200	3,593,200	3,645,700	3,069,700	3,109,300	2,650,100	2,412,600	2,145,400	1,851,000	1,830,100	1,591,000	1,491,200	1,378,500	1,162,700	1,083,400	1,063,400	918,500	863,800	822,300	777,100	722,100	651,900	668,000	709,000	788,000
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	143,600	139,600	134,800	107,200	89,300	77,400	81,900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Research Development	1,071,800	945,200	903,100	760,700	752,700	622,200	552,600	443,300	383,100	346,500	323,000	291,300	246,300	204,400	175,500	139,200	122,300	114,200	99,000	87,000	72,800	65,200	55,000	55,000	55,000
Selling And Marketing Expenses	0	1,100	300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling General Administrative	1,755,600	1,566,500	1,494,000	1,228,400	1,242,200	1,088,500	984,700	904,700	850,700	858,000	745,600	705,300	642,400	550,000	508,800	480,600	418,000	376,000	348,700	319,900	289,900	227,900	203,000	216,000	233,000
Tax Provision	207,600	245,500	198,900	93,300	119,600	39,200	451,300	168,400	127,500	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Operating Expenses	2,896,400	2,512,800	2,396,800	1,989,100	1,994,900	1,710,700	1,537,300	1,348,000	1,233,800	1,204,500	1,068,600	996,600	888,700	754,400	684,300	643,800	540,300	490,200	447,700	406,900	362,700	352,800	344,000	286,000	322,000
Total Other Income Expense Net	64,000	18,900	353,500	-711,700	19,700	-313,400	15,100	-72,000	-11,000	662,000	66,000	-17,700	-16,800	-14,600	67,500	-32,800	-21,400	1,800	-49,200	-110,100	-32,400	-44,300	-77,000	-320,000	4,000
Total Revenue	6,004,800	5,382,400	5,232,500	4,386,300	4,348,000	3,722,800	3,435,300	2,963,700	2,493,700	2,322,900	2,045,500	1,899,600	1,678,600	1,447,000	1,321,400	1,237,700	1,091,100	1,037,000	997,900	931,500	860,500	704,000	692,000	804,000	905,000

	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31
Cost Of Revenue	384,200	356,900	350,400	343,000	329,500	257,900	253,800	269,400	299,300	309,500	311,700	334,300	293,400	296,300	281,000	238,200	265,100	286,200	292,400	304,000	231,800	234,700	224,900	246,200	233,600	235,300	213,300	211,100	215,600	213,200	201,400	202,500	180,300	175,900	146,700	158,600	136,000	160,400	168,100	151,200	145,900	145,500	129,700	125,000	122,200	125,800	111,700	129,800	127,300	119,600	125,600	127,800	116,800	113,500	95,800	100,400	98,600	101,700	98,500	101,900	97,000	98,800	104,900	113,000	102,900	99,600	90,700	94,700	93,200	97,400	87,400	95,700	93,000	89,600	90,900	97,900	96,200	91,200	87,900	92,400	98,700	93,800	86,900	89,600	89,100	85,700	69,900	74,400	69,100	68,200	64,400	95,200	96,200	142,600	86,600	101,000	106,000	123,000
Depreciation And Amortization	38,500	36,700	4,400	-1,600	88,400	-1,200	103,800	-29,600	8,400	33,000	33,600	35,800	32,400	32,600	25,600	24,500	24,500	23,900	23,100	16,000	26,300	19,900	19,200	19,200	19,100	21,200	20,700	18,900	21,100	19,100	18,200	18,000	15,900	14,500	18,500	16,800	16,000	18,300	18,000	16,100	16,200	18,800	18,500	16,100	15,300	15,100	14,400	14,000	13,800	14,800	13,900	14,800	14,500	15,400	13,400	13,700	14,000	14,200	15,400	14,900	14,200	14,300	13,800	14,000	13,500	13,700	14,000	13,700	13,400	14,600	13,800	14,400	14,000	14,400	14,000	14,200	13,600	14,600	15,300	12,900	12,900	11,600	11,900	11,300	10,800	11,000	10,100	9,600	9,700	12,600	12,900	15,200	16,300	14,600	15,400	23,000	21,000	19,000
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	487,900	331,600	418,400	570,800	388,400	447,800	402,400	459,500	438,800	319,400	368,300	305,900	354,900	338,400	331,000	604,800	354,200	358,900	282,400	281,500	318,500	569,000	232,700	265,700	245,300	134,900	207,200	275,600	299,800	191,700	183,600	240,700	198,200	163,500	139,700	131,000	149,700	143,000	115,400	-594,200	90,300	118,900	82,800	106,200	10,600	125,800	78,700	87,800	71,800	89,600	48,300	65,700	57,700	80,700	54,800	59,900	48,700	64,700	3,000	51,600	55,400	48,400	45,400	52,900	46,000	70,800	34,000	47,000	43,300	62,100	42,900	45,300	43,000	49,500	62,700	73,400	39,500	42,000	47,700	43,300	116,100	47,700	45,600	33,000	41,200	29,700	27,800	11,800	27,100	24,000	19,600	32,800	24,600	45,500	33,900	321,000	27,000	28,000
Ebitda	526,400	368,300	422,800	569,200	476,800	446,600	506,200	429,900	447,200	352,400	401,900	341,700	387,300	371,000	356,600	629,300	378,700	382,800	305,500	297,500	344,800	588,900	251,900	284,900	264,400	156,100	227,900	294,500	320,900	210,800	201,800	258,700	214,100	178,000	158,200	147,800	165,700	161,300	133,400	-578,100	106,500	137,700	101,300	122,300	25,900	140,900	93,100	101,800	85,600	104,400	62,200	80,500	72,200	96,100	68,200	73,600	62,700	78,900	18,400	66,500	69,600	62,700	59,200	66,900	59,500	84,500	48,000	60,700	56,700	76,700	56,700	59,700	57,000	63,900	76,700	87,600	53,100	56,600	63,000	56,200	129,000	59,300	57,500	44,300	52,000	40,700	37,900	21,400	36,800	36,600	32,500	48,000	40,900	60,100	49,300	344,000	48,000	47,000
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2,800	0	0	0	-46,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	500	0	0	0	0	0	0	0	0
Gross Profit	1,214,000	1,177,200	1,130,500	1,187,200	1,130,100	1,090,400	1,065,200	1,104,500	1,041,900	1,020,200	998,500	1,041,700	923,200	895,400	859,900	686,800	863,600	887,900	801,600	782,900	761,200	743,000	681,700	697,500	661,200	653,200	608,200	630,700	667,900	554,500	538,000	556,800	517,000	495,200	468,800	458,200	454,300	457,600	439,300	423,900	376,500	390,500	365,900	392,200	374,500	384,700	336,200	352,200	331,900	310,600	287,100	303,400	287,700	278,900	253,100	264,800	241,900	245,000	227,200	233,600	216,500	210,900	198,700	214,600	193,900	193,400	170,700	177,900	170,900	168,200	160,000	171,600	164,000	160,100	150,000	160,300	152,900	145,900	136,900	142,200	136,300	130,300	119,200	128,200	123,400	117,400	95,900	98,400	93,200	91,700	83,400	97,200	95,700	73,900	99,200	104,000	120,000	111,000
Income Before Tax	409,400	421,700	439,300	338,500	398,600	459,300	407,300	464,700	436,100	376,300	390,900	545,500	389,300	356,100	364,300	-168,200	364,500	315,500	301,700	271,300	278,000	-1,800	248,700	251,000	263,500	323,900	211,800	205,600	293,600	200,400	185,200	169,000	183,300	167,000	150,700	142,200	162,500	132,900	120,600	813,200	77,300	101,500	99,900	121,800	192,100	122,200	93,400	89,900	85,600	68,600	57,600	72,800	84,600	70,100	66,200	66,400	65,500	62,400	94,200	62,800	85,000	34,000	43,600	52,100	34,700	19,600	38,800	46,800	44,600	23,700	36,700	45,500	66,000	43,500	15,300	15,300	42,600	34,100	19,500	34,100	-57,600	27,000	14,700	29,000	22,100	29,300	-45,200	43,800	28,100	22,800	19,900	-71,700	20,000	33,700	7,200	-311,000	23,000	28,000
Income Tax Expense	58,400	52,000	55,600	33,000	58,100	60,900	63,800	58,300	62,500	41,000	50,800	56,000	51,100	46,600	39,100	-46,300	53,900	35,300	27,000	29,000	28,300	-8,800	22,800	-31,700	56,900	288,200	41,700	19,500	63,400	41,900	43,800	42,400	40,300	26,300	32,600	29,500	39,100	23,700	26,000	266,200	17,000	25,700	23,000	27,700	47,200	31,100	24,200	22,100	20,500	5,500	6,000	14,700	20,700	5,300	18,200	8,900	17,800	14,800	20,700	15,300	24,500	-4,100	10,700	12,400	16,500	3,800	9,700	11,900	11,400	3,000	8,900	9,400	21,000	4,900	19,700	1,400	11,400	8,200	7,100	8,600	4,500	8,100	-9,800	7,900	7,600	7,600	-27,800	13,200	7,300	5,800	5,400	-16,000	5,800	8,900	2,800	-2,000	6,000	8,000
Interest Expense	0	27,800	0	9,100	10,200	7,900	6,900	900	600	500	800	1,000	300	15,800	800	1,800	4,500	27,900	2,800	2,400	2,000	1,800	500	200	800	1,000	100	1,400	2,400	1,500	2,100	2,400	2,400	2,600	2,500	1,800	2,400	1,700	2,500	3,100	3,500	4,000	1,000	400	1,400	1,200	900	1,200	1,100	900	1,000	700	500	500	700	500	200	500	900	200	800	7,200	400	400	400	9,100	400	400	200	10,500	800	600	900	9,700	2,200	3,300	2,800	14,200	3,400	3,600	3,700	13,200	3,500	3,500	2,700	11,500	2,700	3,000	2,800	23,000	3,200	10,900	5,500	6,100	7,500	6,400	0	0
Interest Income	0	0	15,100	9,100	8,600	7,900	6,900	3,700	600	500	800	3,100	300	500	6,100	1,800	4,500	4,300	10,700	2,400	2,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	900	200	1,200	1,600	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	351,900	369,900	384,900	307,100	340,500	398,400	343,500	406,400	373,600	335,300	340,100	489,500	338,200	309,500	325,200	-121,900	310,600	280,200	274,700	242,300	249,700	7,000	225,900	282,700	206,600	35,700	170,100	186,100	230,200	158,500	141,400	126,600	143,000	140,700	118,100	112,700	123,400	109,200	94,600	547,000	60,300	75,800	76,900	94,100	144,900	91,100	69,200	67,800	65,100	63,100	51,600	58,100	63,900	64,800	48,000	57,500	47,700	47,600	73,500	47,500	60,500	38,100	32,900	39,700	18,200	15,800	29,100	34,900	33,200	20,700	27,800	36,100	46,000	38,600	-4,400	13,900	31,200	25,900	12,400	25,500	-62,100	18,900	24,500	21,100	14,500	21,700	-17,400	30,600	20,800	16,500	14,500	-55,700	12,700	24,800	4,400	-309,000	17,000	20,000
Net Income Applicable To Common Shares	0	0	384,900	305,500	340,500	398,400	343,500	406,400	373,600	335,300	340,100	489,500	338,200	309,500	325,200	-121,900	310,600	280,200	274,700	242,300	249,700	7,000	225,900	282,700	206,600	-2,800	170,100	186,100	230,200	158,500	141,400	126,600	143,000	140,700	118,100	112,700	123,400	109,200	94,600	547,000	60,300	75,800	76,900	94,100	144,900	91,100	69,200	67,800	65,100	63,100	51,600	58,100	63,900	64,800	48,000	57,500	47,700	47,600	73,500	47,500	60,500	38,100	32,900	39,700	18,200	15,800	29,100	34,900	33,200	20,700	27,800	36,100	45,900	38,600	-13,900	13,900	31,200	25,900	12,400	25,500	0	18,900	24,500	21,100	14,500	21,700	-30,600	30,600	20,800	17,000	14,500	-14,200	14,200	15,600	4,400	-17,300	17,300	0
Net Income From Continuing Ops	351,000	369,700	383,700	305,500	340,500	398,400	343,500	406,400	373,600	335,300	340,100	489,500	338,200	309,500	325,200	-121,900	310,600	280,200	274,700	242,300	249,700	7,000	225,900	282,700	206,600	-2,800	170,100	186,100	230,200	158,500	141,400	126,600	143,000	140,700	118,100	112,700	123,400	109,200	94,600	547,000	60,300	75,800	76,900	94,100	144,900	91,100	69,200	67,800	65,100	63,100	51,600	58,100	63,900	0	48,000	57,500	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	16,500	16,800	15,100	9,100	8,600	7,900	6,900	900	600	500	-800	-1,000	300	500	800	1,800	4,500	4,300	2,800	2,400	2,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Operating Income Net Other	0	0	0	2,200	1,600	39,100	-2,000	4,300	-3,300	18,800	1,400	4,400	5,500	27,600	5,700	-300	1,900	32,600	4,600	1,400	1,800	33,700	300	-1,100	3,100	19,500	-1,600	-3,500	-2,300	11,500	-1,500	-100	-4,000	6,100	-200	-1,800	-200	1,300	-2,500	-400	300	5,000	-400	-100	-1,200	4,100	-1,500	1,000	-500	3,100	-2,300	1,200	6,200	0	3,100	1,600	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Recurring	0	0	0	147,900	43,500	-1,100	64,400	6,100	7,100	7,100	4,700	2,400	6,400	4,600	8,400	379,900	12,500	54,500	7,900	7,000	28,600	311,100	7,900	5,500	5,700	-86,400	23,900	38,900	10,200	67,100	-48,100	9,100	0	3,300	2,400	1,000	300	10,800	3,900	-697,400	13,000	16,300	0	0	-83,600	9,000	0	7,000	0	17,600	0	4,000	0	0	3,900	8,300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	437,700	400,100	418,400	327,200	388,400	447,800	402,400	459,500	438,800	374,400	390,300	542,100	383,500	351,400	357,800	-169,700	358,100	310,800	294,300	267,500	274,200	-5,300	248,900	252,100	252,500	239,900	220,700	252,500	309,600	206,000	195,300	180,600	201,900	174,700	155,800	146,800	165,400	140,300	129,500	119,300	93,500	121,400	101,300	122,300	109,500	131,900	94,600	95,800	86,100	86,500	59,900	75,300	78,400	80,600	67,400	73,600	62,700	64,400	56,400	62,500	54,700	54,900	44,300	52,700	34,700	45,400	36,600	47,100	44,600	43,100	40,200	45,700	66,000	47,200	40,100	46,000	42,600	39,800	35,300	40,500	23,400	39,100	31,900	31,100	33,000	31,000	-40,900	31,100	30,900	27,000	23,300	-53,300	27,000	46,000	24,300	8,000	25,000	25,000
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	1,160,500	1,105,700	1,060,300	1,082,000	1,027,000	901,100	864,700	929,200	898,200	966,300	914,100	934,100	831,200	830,500	783,700	695,200	760,300	827,300	794,100	804,400	683,500	685,900	656,200	675,200	632,800	648,600	600,800	589,300	573,900	561,700	544,100	544,200	495,400	496,400	459,700	470,000	424,900	467,500	477,900	455,800	428,900	414,600	394,300	394,900	387,200	378,600	353,300	386,200	373,100	343,700	352,800	355,900	326,100	311,800	281,500	291,600	277,800	282,300	269,100	273,000	258,800	254,800	259,300	274,900	262,100	247,600	224,800	225,500	219,500	222,500	207,200	221,600	191,000	202,500	200,800	212,200	206,500	197,300	189,500	194,100	211,600	185,000	174,200	186,700	179,500	172,100	206,700	141,700	131,400	132,900	124,500	245,700	164,900	170,500	161,500	197,000	201,000	209,000
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	38,500	36,700	36,900	36,100	35,200	35,400	35,400	34,100	34,700	33,000	33,600	35,800	32,400	32,600	25,600	24,500	24,500	23,900	23,100	16,000	26,300	19,900	19,200	19,200	19,100	21,200	20,700	18,900	21,100	19,100	18,200	18,000	15,900	14,500	18,500	16,800	16,000	18,300	18,000	16,100	16,200	18,800	18,500	16,100	15,300	15,100	14,400	14,000	13,800	14,800	13,900	14,800	14,500	15,400	13,400	13,700	14,000	14,200	15,400	14,900	14,200	14,300	13,800	14,000	13,500	13,700	14,000	13,700	13,400	14,600	13,800	14,400	14,000	14,400	14,000	14,200	13,600	14,600	15,300	12,900	12,900	11,600	11,900	11,300	10,800	11,000	10,100	9,600	9,700	12,600	12,900	15,200	16,300	14,600	15,400	23,000	21,000	19,000
Research Development	285,200	270,000	270,300	270,300	261,200	232,200	233,600	250,800	228,600	232,800	238,000	225,300	207,000	195,700	195,500	182,100	187,400	193,900	195,500	191,900	171,400	163,100	161,800	154,100	143,200	146,600	142,900	134,400	128,700	114,900	113,100	112,900	102,400	98,200	101,000	97,500	86,400	84,000	87,600	89,100	85,800	78,600	84,100	80,500	79,800	74,900	73,800	74,000	68,600	60,700	61,700	64,900	59,000	55,900	52,700	50,600	45,200	48,300	44,700	42,600	39,900	35,800	35,100	35,400	32,900	33,500	30,900	29,100	28,800	30,000	28,100	28,900	27,000	25,800	24,000	24,200	25,000	23,400	21,900	20,700	21,000	19,000	16,800	18,000	19,000	17,700	15,500	16,600	15,400	14,400	14,000	13,500	13,100	14,700	12,900	14,000	14,000	17,000
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	30,700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12,000
Selling General Administrative	489,700	478,800	439,600	468,700	437,000	411,000	377,300	388,100	370,300	424,000	364,400	374,500	326,300	307,800	307,200	274,900	307,800	347,200	306,200	308,500	280,300	288,100	269,500	274,900	256,000	266,700	244,600	243,800	229,600	233,600	229,600	228,800	212,700	222,300	212,000	213,900	202,500	223,100	222,200	215,500	197,200	190,500	180,500	189,400	185,200	177,900	167,800	182,400	177,200	163,400	165,500	163,200	150,300	142,400	133,000	140,600	134,000	132,300	126,100	128,500	121,900	120,200	119,300	126,500	114,600	114,500	103,200	101,700	98,600	95,100	91,700	97,000	92,000	87,100	85,900	90,100	85,600	82,700	79,700	81,000	76,500	72,200	70,500	75,800	71,400	68,700	54,200	54,300	50,700	50,100	46,400	52,700	53,800	57,600	46,600	59,000	60,000	57,000
Tax Provision	58,400	52,000	55,600	33,000	58,100	60,900	63,800	58,300	62,500	41,000	50,800	56,000	51,100	46,600	39,100	-46,300	53,900	35,300	27,000	29,000	28,300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Operating Expenses	776,300	748,800	709,900	739,000	697,500	643,200	610,900	659,800	598,900	656,800	602,400	599,800	537,800	534,200	502,700	457,000	495,200	541,100	501,700	500,400	451,700	451,200	431,300	429,000	399,200	413,300	387,500	378,200	358,300	348,500	342,700	341,700	315,100	320,500	313,000	311,400	288,900	307,100	309,800	304,600	283,000	269,100	264,600	269,900	265,000	252,800	241,600	256,400	245,800	224,100	227,200	228,100	209,300	198,300	185,700	191,200	179,200	180,600	170,600	171,100	161,800	156,000	154,400	161,900	159,200	148,000	134,100	130,800	126,300	125,100	119,800	125,900	98,000	112,900	109,900	114,300	110,300	106,100	101,600	101,700	112,900	91,200	87,300	97,100	90,400	86,400	136,800	67,300	62,300	64,700	60,100	150,500	68,700	27,900	74,900	96,000	95,000	86,000
Total Other Income Expense Net	-28,300	-23,500	3,600	-118,800	10,200	11,500	4,900	5,200	-2,700	12,400	-4,400	104,600	3,600	-5,600	6,300	-399,800	-8,400	-35,600	-1,000	-13,600	-33,500	-295,400	-1,200	-17,500	700	83,000	-8,800	-45,500	-13,600	-4,100	-8,000	-43,700	-16,200	-5,100	-2,600	-2,800	-500	-15,900	-6,400	697,000	-12,700	-15,900	-400	-100	82,400	-9,700	1,500	-6,000	500	-17,900	-2,300	-5,200	6,200	-10,100	-800	-6,700	3,000	-1,800	38,200	-3,500	30,400	-20,200	-1,100	-200	-11,300	-25,400	2,600	100	1,300	-19,000	-2,700	400	23,000	-2,300	-22,600	-27,400	3,100	-2,200	-12,400	-2,800	-92,700	-8,600	-13,700	-1,900	-8,200	1,300	-68,700	19,300	3,800	3,000	3,700	-86,100	2,400	500	-9,600	-313,000	-2,000	3,000
Total Revenue	1,598,200	1,534,100	1,480,900	1,530,200	1,459,600	1,348,300	1,319,000	1,373,900	1,341,200	1,329,700	1,310,200	1,376,000	1,216,600	1,191,700	1,140,900	925,000	1,128,700	1,174,100	1,094,000	1,086,900	993,000	977,700	906,600	943,700	894,800	888,500	821,500	841,800	883,500	767,700	739,400	759,300	697,300	671,100	615,500	616,800	590,300	618,000	607,400	575,100	522,400	536,000	495,600	517,200	496,700	510,500	447,900	482,000	459,200	430,200	412,700	431,200	404,500	392,400	348,900	365,200	340,500	346,700	325,700	335,500	313,500	309,700	303,600	327,600	296,800	293,000	261,400	272,600	264,100	265,600	247,400	267,300	257,000	249,700	240,900	258,200	249,100	237,100	224,800	234,600	235,000	224,100	206,100	217,800	212,500	203,100	165,800	172,800	162,300	159,900	147,800	192,400	191,900	216,500	185,800	205,000	226,000	234,000

Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue	6,004,800
Cost of Revenue	-1,379,800
Gross Profit	4,625,000	4,625,000

Operating Income (+$)
Gross Profit	4,625,000
Operating Expense	-2,896,400
Operating Income	1,534,100	1,728,600

Operating Expense (+$)
Research Development	1,071,800
Selling General Administrative	1,755,600
Selling And Marketing Expenses	0
Operating Expense	2,896,400	2,827,400

Net Interest Income (+$)
Interest Income	67,200
Interest Expense	-17,600
Other Finance Cost	-8,900
Net Interest Income	40,700

Pretax Income (+$)
Operating Income	1,534,100
Net Interest Income	40,700
Other Non-Operating Income Expenses	0
Income Before Tax (EBT)	1,598,100	1,470,100 EBIT - interestExpense = 1,516,500 1,601,100 1,420,000
Interest Expense	17,600
Earnings Before Interest and Taxes (EBIT)	1,534,100	1,615,700
Earnings Before Interest and Taxes (EBITDA)	1,534,100

After tax Income (+$)
Income Before Tax	1,598,100
Tax Provision	-207,600
Net Income From Continuing Ops	1,428,100	1,390,500
Net Income	1,402,400
Net Income Applicable To Common Shares	0

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	4,276,200
Total Other Income/Expenses Net	64,000	-40,700

Technical Analysis of Edwards
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Edwards. The general trend of Edwards is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Edwards's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (14.3%)		Bearish trend (-14.3%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of Edwards Lifesciences Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 96.12 < 98.35 < 98.67.

The bearish price targets are: 83.61 > 83.50 > 80.80.

Tweet this

Edwards Lifesciences Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Edwards Lifesciences Corp. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

MA 20 trending down: The MA 20 is trending down. -1
Close < MA 20: The price is below the MA 20. -1
MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
MA 50 trending down: The MA 50 is trending down. -1
Close < MA 50: The price is below the MA 50. -1
MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
MA 100 trending up: The MA 100 is trending up. +1
Close < MA 100: The price is below the MA 100. -1
MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
MA 200 trending up: The MA 200 is trending up. +1
Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

Edwards Lifesciences Corp Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Edwards Lifesciences Corp. The current macd is -1.14697653.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Edwards price going up in the near term. +2
MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Edwards. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Edwards price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1

Edwards Lifesciences Corp Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of Edwards Lifesciences Corp. The current adx is 18.08.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Edwards shares, leading to potential downward momentum in its price. -1
PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.

Edwards Lifesciences Corp Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Edwards Lifesciences Corp. The current sar is 83.77.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1

Edwards Lifesciences Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Edwards Lifesciences Corp. The current rsi is 40.21. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Trending down: The RSI is trending down. -1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

Edwards Lifesciences Corp Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Edwards Lifesciences Corp. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Edwards price going down in the near term. -2
Trending down: The STOCH %K is trending down. -1

Edwards Lifesciences Corp Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Edwards Lifesciences Corp. The current cci is -62.55444415.

Edwards Lifesciences Corp Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Edwards Lifesciences Corp. The current cmo is -21.97193788.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1

Edwards Lifesciences Corp Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of Edwards Lifesciences Corp. The current willr is -78.83597884.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Edwards is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.

Edwards Lifesciences Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of Edwards Lifesciences Corp.

Edwards Lifesciences Corp Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Edwards Lifesciences Corp. The current atr is 1.97774942.

Edwards Lifesciences Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Edwards Lifesciences Corp. The current obv is -2,958,699.

Edwards Lifesciences Corp Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Edwards Lifesciences Corp. The current mfi is 37.50.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

MFI < 50: -1

Edwards Lifesciences Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for Edwards Lifesciences Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-12-20	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2023-12-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-29	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-03	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-04	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-05	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-08	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-01-10	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-01-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-12	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-16	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-01-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-19	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-22	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-24	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-25	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-01-26	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-29	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-30	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-31	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-02	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-06	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-07	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-09	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
2024-02-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-13	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
2024-02-14	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-23	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-26	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
2024-02-29	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-01	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-04	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-06	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-07	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-08	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-13	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-15	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-19	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-25	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-03-27	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-28	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2024-04-01	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-04	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-09	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-04-10	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-11	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-12	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-04-15	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-16	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-17	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-18	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2024-04-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2024-04-24	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-04-25	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-26	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-04-29	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-05-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2024-05-02	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2024-05-08	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-05-09	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-05-10	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-05-13	STOCH	LONG EXIT		The %K line crosses below the %D line.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).

6.3. Candlestick Patterns

Edwards Lifesciences Corp Daily Candlestick Chart

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of Edwards Lifesciences Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	40.209
Ma 20	Greater than	Ma 50	86.377
Ma 50	Greater than	Ma 100	89.890
Ma 100	Greater than	Ma 200	84.706
Open	Greater than	Close	87.035
Total			3/5 (60.0%)

Create your own Symbol Scanner

Get notifications about Edwards Lifesciences Corp

I send you an email if I find something interesting about Edwards Lifesciences Corp.

Edwards Lifesciences Corp Buy, Hold or Sell?

Let's analyse Edwards together

Get notifications about Edwards Lifesciences Corp

Quick analysis of Edwards (30 sec.)

What can you expect buying and holding a share of Edwards? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Edwards (5 min.)

$84.70

$11.90

$-16.02 - $5.11

$-4.12 - $17.00

2. Growth of Edwards (5 min.)

Is Edwards growing?

How much money is Edwards making?

How much money comes from the company's main activities?

3. Financial Health of Edwards (5 min.)

4. Comparing to competitors in the Medical Devices industry (5 min.)

Industry Rankings (Medical Devices)

What can you expect buying and holding a share of Edwards? (5 min.)

What can you expect buying and holding a share of Edwards?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Edwards

About Edwards Lifesciences Corp

Financial Health

Valuation

1.1. Profitability of Edwards Lifesciences Corp.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Medical Devices)

1.1.2. Return on Assets

Trends

Compared to industry (Medical Devices)

1.1.3. Return on Equity

Trends

Compared to industry (Medical Devices)

1.2. Operating Efficiency of Edwards Lifesciences Corp.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Medical Devices)

1.2.2. Operating Ratio

Trends

Compared to industry (Medical Devices)

1.3. Liquidity of Edwards Lifesciences Corp.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Medical Devices)

1.3.2. Quick Ratio

Trends

Compared to industry (Medical Devices)

1.4. Solvency of Edwards Lifesciences Corp.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Medical Devices)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Medical Devices)

2. Market Valuation of Edwards Lifesciences Corp

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Medical Devices)

Edwards Lifesciences Corp
Buy, Hold or Sell?